| PROFOLDIN PROTEIN
FOLDING SERVICES |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number 321 |
|
| 290
TURNPIKE ROAD, SUITE 6 |
|
| WESTBOROUGH,
MA 01581 |
|
| USA |
|
| TEL:
508-845-9258 |
|
| FAX:
508-845-9258 |
|
|
|
| MATERIAL
SAFETY DATA SHEET -PROFOLDIN PROTEIN FOLDING COLUMNS |
|
|
| SECTION 1. CHEMICAL IDENTIFICATION |
|
|
|
CATALOG #: SFC01-10, SFC01, SFC02, SFC03, SFC04,
SFC05, SFC06, SFC07, SFC08, SFC09, SFC10 |
|
|
|
|
PFC01, PFC02, PFC03,
PFC04, PFC05, PFC06, PFC07, PFC08, PFC09, PFC10 |
|
|
NAME: ZINC CHLORIDE |
|
|
| SECTION
2. COMPOSITION/INFORMATION ON
INGREDIENT |
|
|
|
SUBSTANCE NAME |
CAS
# |
SARA |
|
|
|
ZINC CHLORIDE |
7646-85-7 |
YES |
|
|
|
FORMULA: ZNCL2 |
|
|
|
SYNONYMS BUTTER OF ZINC *
CHLORURE DE ZINC (FRENCH) * ZINC |
|
|
|
BUTTER * ZINC CHLORIDE
FUME (ACGIH: OSHA) * ZINC |
|
|
|
(CHLORURE DE) (FRENCH) *
ZINC DICHLORIDE * ZINCO |
|
|
|
(CLORURO DI) (ITALIAN) *
ZINKCHLORID (GERMAN) * |
|
|
|
ZINKCHLORIDE (DUTCH) |
|
|
|
RTECS NUMBER: ZH1400000 |
|
|
| SECTION
3. HAZARDS IDENTIFICATION |
|
|
| EMERGENCY
OVERVIEW |
|
|
|
CORROSIVE. |
|
|
|
HARMFUL IF SWALLOWED.
CAUSES BURNS. VERY TOXIC TO AQUATIC |
|
|
|
ORGANISMS, MAY CAUSE
LONG-TERM ADVERSE EFFECTS IN THE AQUATIC |
|
|
|
ENVIRONMENT. |
|
|
| HMIS
RATING |
|
|
|
HEALTH: 3 |
|
|
|
FLAMMABILITY: 0 |
|
|
|
REACTIVITY: 1 |
|
|
| NFPA
RATING |
|
|
|
HEALTH: 3 |
|
|
|
FLAMMABILITY: 0 |
|
|
|
REACTIVITY: 1 |
|
|
|
FOR
ADDITIONAL INFORMATION ON TOXICITY, PLEASE REFER TO SECTION 11. |
|
|
| SECTION
4. FIRST AID MEASURES |
|
|
| ORAL
EXPOSURE |
|
|
|
IF SWALLOWED, WASH OUT
MOUTH WITH WATER PROVIDED PERSON IS |
|
|
|
CONSCIOUS. CALL A
PHYSICIAN IMMEDIATELY. DO NOT INDUCE VOMITING. |
|
|
| INHALATION
EXPOSURE |
|
|
|
IF INHALED, REMOVE TO
FRESH AIR. IF NOT BREATHING GIVE |
|
|
|
ARTIFICIAL RESPIRATION.
IF BREATHING IS DIFFICULT, GIVE OXYGEN. |
|
|
| DERMAL
EXPOSURE |
|
|
|
IN CASE OF SKIN CONTACT,
FLUSH WITH COPIOUS AMOUNTS OF WATER FOR |
|
|
|
AT LEAST 15 MINUTES.
REMOVE CONTAMINATED CLOTHING AND SHOES. |
|
|
|
CALL A PHYSICIAN. |
|
|
| EYE
EXPOSURE |
|
|
|
IN CASE OF CONTACT WITH
EYES, FLUSH WITH COPIOUS AMOUNTS OF |
|
|
|
WATER FOR AT LEAST 15
MINUTES. ASSURE ADEQUATE FLUSHING BY |
|
|
|
SEPARATING THE EYELIDS
WITH FINGERS. CALL A PHYSICIAN. |
|
|
| SECTION
5. FIRE FIGHTING MEASURES |
|
|
|
FLASH POINT |
|
N/A |
|
|
|
AUTOIGNITION TEMP |
|
N/A |
|
|
|
FLAMMABILITY |
|
N/A |
|
|
| FIREFIGHTING |
|
|
| PROTECTIVE
EQUIPMENT: WEAR SELF-CONTAINED
BREATHING APPARATUS |
|
|
|
AND PROTECTIVE CLOTHING
TO PREVENT CONTACT WITH SKIN AND EYES. |
|
|
|
SPECIFIC HAZARD(S): EMITS TOXIC FUMES UNDER FIRE CONDITIONS. |
|
|
| SECTION
6. ACCIDENTAL RELEASE MEASURES |
|
|
|
PROCEDURE TO BE FOLLOWED
IN CASE OF LEAK OR SPILL |
|
|
|
EVACUATE AREA. |
|
|
| PROCEDURE(S)
OF PERSONAL PRECAUTION(S) |
|
|
|
WEAR SELF-CONTAINED
BREATHING APPARATUS, RUBBER BOOTS, AND HEAVY |
|
|
|
RUBBER GLOVES. |
|
|
| METHODS
FOR CLEANING UP |
|
|
|
SWEEP UP, PLACE IN A BAG
AND HOLD FOR WASTE DISPOSAL. VENTILATE |
|
|
|
AREA AND WASH SPILL SITE
AFTER MATERIAL PICKUP IS COMPLETE. |
|
|
| SECTION
7. HANDLING AND STORAGE |
|
|
| HANDLING |
|
|
|
USER EXPOSURE: DO NOT BREATHE DUST. DO NOT GET IN EYES,
ON SKIN, |
|
|
|
ON CLOTHING. AVOID
PROLONGED OR REPEATED EXPOSURE. |
|
|
| STORAGE |
|
|
|
SUITABLE: KEEP TIGHTLY CLOSED. STORE IN A COOL DRY
PLACE. HANDLE |
|
|
|
AND STORE UNDER NITROGEN. |
|
|
|
SPECIAL REQUIREMENTS |
|
|
|
VERY HYGROSCOPIC. |
|
|
| SECTION
8. EXPOSURE CONTROLS / PPE |
|
|
| ENGINEERING
CONTROLS |
|
|
|
SAFETY SHOWER AND EYE
BATH. USE ONLY IN A CHEMICAL FUME HOOD. |
|
|
| PERSONAL
PROTECTIVE EQUIPMENT |
|
|
|
RESPIRATORY: GOVERNMENT APPROVED RESPIRATOR. |
|
|
|
HAND: COMPATIBLE CHEMICAL-RESISTANT GLOVES. |
|
|
|
EYE: CHEMICAL SAFETY GOGGLES. |
|
|
| GENERAL
HYGIENE MEASURES |
|
|
|
WASH CONTAMINATED
CLOTHING BEFORE REUSE. DISCARD CONTAMINATED |
|
|
|
SHOES. WASH THOROUGHLY
AFTER HANDLING. |
|
|
| EXPOSURE
LIMITS, RTECS |
|
|
| COUNTRY
SOURCE TYPE VALUE |
|
|
|
USA MSHA STANDARD-AIR TWA
1 MG/M3 (FUME) |
|
|
|
USA OSHA. PEL 8H TWA 1
MG/M3, FUME |
|
|
|
NEW ZEALAND OEL |
|
|
|
REMARKS: CHECK ACGIH TLV |
|
|
|
USA NIOSH TWA 1 MG/M3 |
|
|
|
STEL 2 MG/M3 |
|
|
| EXPOSURE
LIMITS |
|
|
| COUNTRY
SOURCE TYPE VALUE |
|
|
|
POLAND NDS 1 MG/M3 |
|
|
|
POLAND NDSCH 2 MG/M3 |
|
|
|
POLAND NDSP - |
|
|
| SECTION
9. PHYSICAL/CHEMICAL PROPERTIES |
|
|
| APPEARANCE
PHYSICAL STATE: SOLID |
|
|
|
COLOR: WHITE |
|
|
|
FORM: CRYSTALLINE POWDER |
|
|
| PROPERTY
VALUE AT TEMPERATURE OR PRESSURE |
|
|
|
MOLECULAR WEIGHT 136.28 AMU |
|
|
|
PH N/A |
|
|
|
BP/BP RANGE N/A |
|
|
|
MP/MP RANGE 293 °C |
|
|
|
FREEZING POINT N/A |
|
|
|
VAPOR PRESSURE 1
MMHG 428 °C |
|
|
|
VAPOR DENSITY N/A |
|
|
|
SATURATED VAPOR
CONC. N/A |
|
|
|
SG/DENSITY 2.907 G/CM3 |
|
|
|
BULK DENSITY N/A |
|
|
|
ODOR THRESHOLD N/A |
|
|
|
VOLATILE% N/A |
|
|
|
VOC CONTENT N/A |
|
|
|
WATER CONTENT N/A |
|
|
|
SOLVENT CONTENT N/A |
|
|
|
EVAPORATION RATE N/A |
|
|
|
VISCOSITY N/A |
|
|
|
SURFACE TENSION N/A |
|
|
|
PARTITION
COEFFICIENT N/A |
|
|
|
DECOMPOSITION TEMP. N/A |
|
|
|
FLASH POINT N/A |
|
|
|
EXPLOSION LIMITS N/A |
|
|
|
FLAMMABILITY N/A |
|
|
|
AUTOIGNITION TEMP N/A |
|
|
|
REFRACTIVE INDEX N/A |
|
|
|
OPTICAL ROTATION N/A |
|
|
|
MISCELLANEOUS DATA N/A |
|
|
|
SOLUBILITY N/A |
|
|
|
N/A = NOT AVAILABLE |
|
|
| SECTION
10. STABILITY AND REACTIVITY |
|
|
| STABILITY |
|
|
|
STABLE: STABLE. |
|
|
|
CONDITIONS TO AVOID: MOISTURE. |
|
|
|
MATERIALS TO AVOID: STRONG OXIDIZING AGENTS. |
|
|
|
HAZARDOUS DECOMPOSITION
PRODUCTS |
|
|
|
HAZARDOUS DECOMPOSITION
PRODUCTS: HYDROGEN CHLORIDE GAS,
ZINC/ZINC |
|
|
|
OXIDES, ZINC OXIDE FUMES
MAY ALSO FORM. |
|
|
| HAZARDOUS
POLYMERIZATION |
|
|
|
HAZARDOUS
POLYMERIZATION: WILL NOT OCCUR |
|
|
| SECTION
11. TOXICOLOGICAL INFORMATION |
|
|
| ROUTE
OF EXPOSURE |
|
|
|
SKIN CONTACT: CAUSES BURNS. |
|
|
|
SKIN ABSORPTION: MAY BE HARMFUL IF ABSORBED THROUGH THE
SKIN. |
|
|
|
EYE CONTACT: CAUSES BURNS. |
|
|
|
INHALATION: MAY BE HARMFUL IF INHALED. MATERIAL IS
EXTREMELY |
|
|
|
DESTRUCTIVE TO THE TISSUE
OF THE MUCOUS MEMBRANES AND UPPER |
|
|
|
RESPIRATORY TRACT. |
|
|
|
INGESTION: HARMFUL IF SWALLOWED. |
|
|
| SIGNS
AND SYMPTOMS OF EXPOSURE |
|
|
|
INHALATION MAY RESULT IN
SPASM, INFLAMMATION AND EDEMA OF THE |
|
|
|
LARYNXAND BRONCHI,
CHEMICAL PNEUMONITIS, AND PULMONARY EDEMA. |
|
|
|
SYMPTOMS OF EXPOSURE MAY
INCLUDE BURNING SENSATION, COUGHING, |
|
|
|
WHEEZING, LARYNGITIS,
SHORTNESS OF BREATH, HEADACHE, NAUSEA, AND |
|
|
|
VOMITING. MATERIAL IS
EXTREMELY DESTRUCTIVE TO TISSUE OF THE |
|
|
|
MUCOUS MEMBRANES AND
UPPER RESPIRATORY TRACT, EYES, AND SKIN. TO |
|
|
|
THE BEST OF OUR
KNOWLEDGE, THE CHEMICAL, PHYSICAL, AND |
|
|
|
TOXICOLOGICAL PROPERTIES
HAVE NOT BEEN THOROUGHLY INVESTIGATED. |
|
|
| TOXICITY
DATA |
|
|
|
ORAL |
RAT |
|
350 MG/KG |
LD50 |
|
|
|
INTRAPERITONEAL |
RAT |
|
58 MG/KG |
LD50 |
|
|
|
REMARKS: SENSE ORGANS AND SPECIAL SENSES (NOSE,
EYE, EAR, AND |
|
|
|
TASTE): EYE:
MIOSIS (PUPILLIARY CONSTRICTION). VASCULAR: BP |
|
|
|
ELEVATION NOT
CHARACTERTIZED IN AUTONOMIC SECTION. NUTRITIONAL |
|
|
|
AND GROSS METABOLIC: WEIGHT LOSS OR DECREASED WEIGHT GAIN. |
|
|
|
INTRAVENOUS |
|
RAT |
|
3690 UG/KG |
LD50 |
|
|
|
ORAL |
|
MOUSE |
|
329 MG/KG |
LD50 |
|
|
|
INTRAPERITONEAL |
MOUSE |
24 MG/KG |
LD50 |
|
|
|
SUBCUTANEOUS |
MOUSE |
330 MG/KG |
LD50 |
|
|
|
INTRAVENOUS |
|
MOUSE |
|
9090 UG/KG |
LD50 |
|
|
|
ORAL |
|
GUINEA PIG |
200 MG/KG |
LD50 |
|
|
|
CHRONIC EXPOSURE -
CARCINOGEN |
|
|
|
SPECIES: HAMSTER |
|
|
|
ROUTE OF
APPLICATION: PARENTERAL |
|
|
|
DOSE: 17 MG/KG |
|
|
|
RESULT: TUMORIGENIC: EQUIVOCAL TUMORIGENIC AGENT BY RTECS |
|
|
|
CRITERIA.
GASTROINTESTINAL: COLON TUMORS. |
|
|
|
SPECIES: CHICKEN |
|
|
|
ROUTE OF
APPLICATION: PARENTERAL |
|
|
|
DOSE: 15 MG/KG |
|
|
|
RESULT: TUMORIGENIC: EQUIVOCAL TUMORIGENIC AGENT BY RTECS |
|
|
|
CRITERIA. TUMORIGENIC
EFFECTS: TESTICULAR TUMORS. |
|
|
|
CHRONIC EXPOSURE -
TERATOGEN |
|
|
|
SPECIES: MOUSE |
|
|
|
DOSE: 12500 UG/KG |
|
|
|
ROUTE OF
APPLICATION: INTRAPERITONEAL |
|
|
|
EXPOSURE TIME: (11D PREG) |
|
|
|
RESULT: SPECIFIC DEVELOPMENTAL
ABNORMALITIES: MUSCULOSKELETAL |
|
|
|
SYSTEM. |
|
|
|
CHRONIC EXPOSURE -
MUTAGEN |
|
|
|
SPECIES: HUMAN |
|
|
|
DOSE: 2 MMOL/L |
|
|
|
CELL TYPE: FIBROBLAST |
|
|
|
MUTATION TEST: DNA DAMAGE |
|
|
|
SPECIES: HUMAN |
|
|
|
DOSE: 180 UMOL/L |
|
|
|
CELL TYPE: LYMPHOCYTE |
|
|
|
MUTATION TEST: UNSCHEDULED DNA SYNTHESIS |
|
|
|
SPECIES: HUMAN |
|
|
|
DOSE: 360 UMOL/L |
|
|
|
CELL TYPE: LYMPHOCYTE |
|
|
|
MUTATION TEST: DNA INHIBITION |
|
|
|
SPECIES: HUMAN |
|
|
|
DOSE: 2 MG |
|
|
|
CELL TYPE: LYMPHOCYTE |
|
|
|
MUTATION TEST: OTHER MUTATION TEST SYSTEMS |
|
|
|
SPECIES: HUMAN |
|
|
|
DOSE: 300 UMOL/L |
|
|
|
CELL TYPE: LYMPHOCYTE |
|
|
|
MUTATION TEST: CYTOGENETIC ANALYSIS |
|
|
|
SPECIES: RAT |
|
|
|
DOSE: 700 MG/KG |
|
|
|
CELL TYPE: ASCITES TUMOR |
|
|
|
MUTATION TEST: CYTOGENETIC ANALYSIS |
|
|
|
SPECIES: MOUSE |
|
|
|
ROUTE: PARENTERAL |
|
|
|
DOSE: 16 MG/KG |
|
|
|
MUTATION TEST: DNA INHIBITION |
|
|
|
SPECIES: MOUSE |
|
|
|
ROUTE: ORAL |
|
|
|
DOSE: 18 GM/KG |
|
|
|
EXPOSURE TIME: 30D |
|
|
|
MUTATION TEST: CYTOGENETIC ANALYSIS |
|
|
|
SPECIES: MOUSE |
|
|
|
DOSE: 6 MG/KG |
|
|
|
CELL TYPE: S. TYPHIMURIUM |
|
|
|
MUTATION TEST: HOST-MEDIATED ASSAY |
|
|
|
SPECIES: HAMSTER |
|
|
|
DOSE: 180 UMOL/L |
|
|
|
CELL TYPE: EMBRYO |
|
|
|
MUTATION TEST: MORPHOLOGICAL TRANSFORMATION. |
|
|
|
CHRONIC EXPOSURE -
REPRODUCTIVE HAZARD |
|
|
|
SPECIES: RAT |
|
|
|
DOSE: 155 MG/KG |
|
|
|
ROUTE OF
APPLICATION: ORAL |
|
|
|
EXPOSURE TIME: (33D MALE) |
|
|
|
RESULT: PATERNAL EFFECTS: OTHER EFFECTS ON MALE. |
|
|
|
ENDOCRINE: CHANGE IN LH. ENDOCRINE: CHANGE IN GONADOTROPINS. |
|
|
|
SPECIES: RAT |
|
|
|
DOSE: 6 GM/KG |
|
|
|
ROUTE OF
APPLICATION: ORAL |
|
|
|
EXPOSURE TIME: (77D MALE/77D PRE-21D POST) |
|
|
|
RESULT: EFFECTS ON NEWBORN: BEHAVIORAL. EFFECTS ON NEWBORN: |
|
|
|
GROWTH STATISTICS (E.G.,
REDUCED WEIGHT GAIN). |
|
|
|
SPECIES: RAT |
|
|
|
DOSE: 30 GM/KG |
|
|
|
ROUTE OF
APPLICATION: INTRAPERITONEAL |
|
|
|
EXPOSURE TIME: (7-8D PREG) |
|
|
|
RESULT: EFFECTS ON FERTILITY: POST-IMPLANTATION MORTALITY (E.G., |
|
|
|
DEAD AND/OR RESORBED
IMPLANTS PER TOTAL NUMBER OF IMPLANTS). |
|
|
|
EFFECTS ON EMBRYO OR
FETUS: FETOTOXICITY (EXCEPT DEATH,
E.G., |
|
|
|
STUNTED FETUS). EFFECTS
ON EMBRYO OR FETUS: FETAL DEATH. |
|
|
|
SPECIES: RAT |
|
|
|
DOSE: 37500 UG/KG |
|
|
|
ROUTE OF
APPLICATION: PARENTERAL |
|
|
|
EXPOSURE TIME: (10D PREG) |
|
|
|
RESULT: EFFECTS ON NEWBORN: VIABILITY INDEX (E.G., # ALIVE AT |
|
|
|
DAY 4 PER # BORN ALIVE). |
|
|
|
SPECIES: MOUSE |
|
|
|
DOSE: 20500 UG/KG |
|
|
|
ROUTE OF
APPLICATION: INTRAPERITONEAL |
|
|
|
EXPOSURE TIME: (8D PREG) |
|
|
|
RESULT: EFFECTS ON FERTILITY: POST-IMPLANTATION MORTALITY (E.G., |
|
|
|
DEAD AND/OR RESORBED
IMPLANTS PER TOTAL NUMBER OF IMPLANTS). |
|
|
|
SPECIFIC DEVELOPMENTAL
ABNORMALITIES: MUSCULOSKELETAL
SYSTEM. |
|
|
|
SPECIES: RABBIT |
|
|
|
DOSE: 29184 UG/KG |
|
|
|
ROUTE OF
APPLICATION: INTRAVAGINAL |
|
|
|
EXPOSURE TIME: (1D PRE) |
|
|
|
RESULT: EFFECTS ON FERTILITY: FEMALE FERTILITY INDEX (E.G., # |
|
|
|
FEMALES PREGNANT PER #
SPERM POSITIVE FEMALES; # FEMALES |
|
|
|
PREGNANT PER # FEMALES
MATED ). |
|
|
| SECTION
12. ECOLOGICAL INFORMATION |
|
|
|
NO DATA AVAILABLE. |
|
|
| SECTION
13. DISPOSAL CONSIDERATIONS |
|
|
|
APPROPRIATE METHOD OF
DISPOSAL OF SUBSTANCE OR PREPARATION |
|
|
|
CONTACT A LICENSED
PROFESSIONAL WASTE DISPOSAL SERVICE TO DISPOSE |
|
|
|
OF THIS MATERIAL.
DISSOLVE OR MIX THE MATERIAL WITH A COMBUSTIBLE |
|
|
|
SOLVENT AND BURN IN A
CHEMICAL INCINERATOR EQUIPPED WITH AN |
|
|
|
AFTERBURNER AND SCRUBBER.
OBSERVE ALL FEDERAL, STATE, AND LOCAL |
|
|
|
ENVIRONMENTAL
REGULATIONS. |
|
|
| SECTION
14. TRANSPORT INFORMATION |
|
|
|
CONTACT PROFOLDIN FOR
TRANSPORTATION INFORMATION. |
|
|
| SECTION 15. REGULATORY INFORMATION |
|
|
| EU
DIRECTIVES CLASSIFICATION |
|
|
|
SYMBOL OF DANGER: C N |
|
|
|
INDICATION OF
DANGER: CORROSIVE. DANGEROUS FOR THE
ENVIRONMENT. |
|
|
|
R: 34 50/53 |
|
|
|
RISK STATEMENTS: CAUSES BURNS. VERY TOXIC TO AQUATIC
ORGANISMS, |
|
|
|
MAY CAUSE LONG-TERM
ADVERSE EFFECTS IN THE AQUATIC ENVIRONMENT. |
|
|
|
S: 7/8 28 45 60 61 |
|
|
|
SAFETY STATEMENTS: KEEP CONTAINER TIGHTLY CLOSED AND DRY.
AFTER |
|
|
|
CONTACT WITH SKIN, WASH
IMMEDIATELY WITH PLENTY OF SOAP-SUDS. IN |
|
|
|
CASE OF ACCIDENT OR IF
YOU FEEL UNWELL, SEEK MEDICAL ADVICE |
|
|
|
IMMEDIATELY (SHOW THE
LABEL WHERE POSSIBLE). THIS MATERIAL AND |
|
|
|
ITS CONTAINER MUST BE
DISPOSED OF AS HAZARDOUS WASTE. AVOID |
|
|
|
RELEASE TO THE
ENVIRONMENT. REFER TO SPECIAL INSTRUCTIONS/SAFETY |
|
|
|
DATA SHEETS. |
|
|
| US
CLASSIFICATION AND LABEL TEXT |
|
|
|
INDICATION OF
DANGER: CORROSIVE. |
|
|
|
RISK STATEMENTS: HARMFUL IF SWALLOWED. CAUSES BURNS. VERY
TOXIC |
|
|
|
TO AQUATIC ORGANISMS, MAY
CAUSE LONG-TERM ADVERSE EFFECTS IN THE |
|
|
|
AQUATIC ENVIRONMENT. |
|
|
|
SAFETY STATEMENTS: KEEP CONTAINER TIGHTLY CLOSED AND DRY.
AFTER |
|
|
|
CONTACT WITH SKIN, WASH
IMMEDIATELY WITH PLENTY OF WATER. IN |
|
|
|
CASE OF ACCIDENT OR IF
YOU FEEL UNWELL, SEEK MEDICAL ADVICE |
|
|
|
IMMEDIATELY (SHOW THE
LABEL WHERE POSSIBLE). THIS MATERIAL AND |
|
|
|
ITS CONTAINER MUST BE
DISPOSED OF AS HAZARDOUS WASTE. AVOID |
|
|
|
RELEASE TO THE
ENVIRONMENT. REFER TO SPECIAL INSTRUCTIONS/SAFETY |
|
|
|
DATA SHEETS. |
|
|
| UNITED
STATES REGULATORY INFORMATION |
|
|
|
SARA LISTED: YES |
|
|
|
DEMINIMIS: 1 % |
|
|
|
NOTES: THIS PRODUCT IS SUBJECT TO SARA SECTION
313 REPORTING |
|
|
|
REQUIREMENTS - ZINC
COMPOUNDS. |
|
|
|
TSCA INVENTORY ITEM: YES |
|
|
| CANADA
REGULATORY INFORMATION |
|
|
|
WHMIS
CLASSIFICATION: THIS PRODUCT HAS
BEEN CLASSIFIED IN |
|
|
|
ACCORDANCE WITH THE
HAZARD CRITERIA OF THE CPR, AND THE MSDS |
|
|
|
CONTAINS ALL THE
INFORMATION REQUIRED BY THE CPR. |
|
|
|
DSL: YES |
|
|
|
NDSL: NO |
|
|
| SECTION
16. OTHER INFORMATION |
|
|
|
THIS
PRODUCT IS FOR R&D USE ONLY. IT IS NOT FOR DRUG, HOUSEHOLD |
|
|
|
OR
OTHER USES. EMPLOYERS SHOULD USE THIS
INFORMATION ONLY AS A |
|
|
|
SUPPLEMENT
TO OTHER INFORMATION GATHERED BY THEM, AND SHOULD MAKE |
|
|
|
INDEPENDENT
JUDGEMENT OF SUITABILITY OF THIS INFORMATION TO ENSURE |
|
|
|
PROPER
USE AND PROTECT THE HEALTH AND SAFETY OF EMPLOYEES. THIS |
|
|
|
INFORMATION
IS FURNISHED WITHOUT WARRANTY, AND ANY USE OF THE |
|
|
|
PRODUCT
NOT IN CONFORMANCE WITH THIS MATERIAL SAFETY DATA SHEET, |
|
|
|
OR IN
COMBINATION WITH ANY OTHER PRODUCT OR PROCESS, IS THE |
|
|
|
RESPONSIBILITY
OF THE USER. THE ABOVE INFORMATION IS
BELIEVED |
|
|
|
TO
BE CORRECT BUT DOES NOT PURPORT TO BE ALL INCLUSIVE AND SHALL |
|
|
|
BE
USED ONLY AS A GUIDE. PROFOLDIN SHALL
NOT BE HELD LIABLE FOR |
|
|
|
ANY
DAMAG RESULTING FROM HANDLING OR FROM CONTACT WITH THE ABOVE |
|
|
|
PRODUCT. |
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| |
|
| SECTION 1. CHEMICAL IDENTIFICATION |
|
|
|
CATALOG #: SFC01-10, SFC01, SFC02, SFC03, SFC04,
SFC05, SFC06, SFC07, SFC08, SFC09, SFC10 |
|
|
|
|
PFC01, PFC02, PFC03,
PFC04, PFC05, PFC06, PFC07, PFC08, PFC09, PFC10 |
|
|
NAME:
SODIUM ACETATE |
|
|
| SECTION
2. COMPOSITION/INFORMATION ON
INGREDIENT |
|
|
|
SUBSTANCE NAME |
|
CAS # |
|
SARA |
|
|
|
SODIUM ACETATE TRIHYDRATE |
6131-90-4 |
NO |
|
|
|
FORMULA: C2H3O2NA.3H2O |
|
|
|
SYNONYMS SODIUM ACETATE
TRIHYDRATE |
|
|
|
RTECS NUMBER: AJ4580000 |
|
|
| SECTION
3. HAZARDS IDENTIFICATION |
|
|
| EMERGENCY
OVERVIEW |
|
|
|
CAUTION: AVOID CONTACT AND INHALATION. |
|
|
| HMIS
RATING |
|
|
|
HEALTH: 0 |
|
|
|
FLAMMABILITY: 0 |
|
|
|
REACTIVITY: 0 |
|
|
| NFPA
RATING |
|
|
|
HEALTH: 0 |
|
|
|
FLAMMABILITY: 0 |
|
|
|
REACTIVITY: 0 |
|
|
|
FOR
ADDITIONAL INFORMATION ON TOXICITY, PLEASE REFER TO SECTION 11. |
|
|
| SECTION
4. FIRST AID MEASURES |
|
|
| ORAL
EXPOSURE |
|
|
|
IF SWALLOWED, WASH OUT
MOUTH WITH WATER PROVIDED PERSON IS |
|
|
|
CONSCIOUS. CALL A
PHYSICIAN. |
|
|
| INHALATION
EXPOSURE |
|
|
|
IF INHALED, REMOVE TO
FRESH AIR. IF BREATHING BECOMES DIFFICULT, |
|
|
|
CALL A PHYSICIAN. |
|
|
| DERMAL
EXPOSURE |
|
|
|
IN CASE OF CONTACT,
IMMEDIATELY WASH SKIN WITH SOAP AND COPIOUS |
|
|
|
AMOUNTS OF WATER. |
|
|
| EYE
EXPOSURE |
|
|
|
IN CASE OF CONTACT WITH
EYES, FLUSH WITH COPIOUS AMOUNTS OF |
|
|
|
WATER FOR AT LEAST 15
MINUTES. ASSURE ADEQUATE FLUSHING BY |
|
|
|
SEPARATING THE EYELIDS
WITH FINGERS. CALL A PHYSICIAN. |
|
|
| SECTION
5. FIRE FIGHTING MEASURES |
|
|
|
FLASH POINT |
|
|
|
N/A |
|
|
|
AUTOIGNITION TEMP |
|
|
|
600 °C |
|
|
|
FLAMMABILITY |
|
|
|
N/A |
|
|
|
EXTINGUISHING MEDIA |
|
|
|
SUITABLE: WATER SPRAY. CARBON DIOXIDE, DRY CHEMICAL
POWDER, OR |
|
|
|
APPROPRIATE FOAM. |
|
|
| FIREFIGHTING |
|
|
| PROTECTIVE
EQUIPMENT: WEAR SELF-CONTAINED
BREATHING APPARATUS |
|
|
|
AND PROTECTIVE CLOTHING
TO PREVENT CONTACT WITH SKIN AND EYES. |
|
|
|
SPECIFIC HAZARD(S): EMITS TOXIC FUMES UNDER FIRE CONDITIONS. |
|
|
| SECTION
6. ACCIDENTAL RELEASE MEASURES |
|
|
| PROCEDURE(S)
OF PERSONAL PRECAUTION(S) |
|
|
|
EXERCISE APPROPRIATE
PRECAUTIONS TO MINIMIZE DIRECT CONTACT WITH |
|
|
|
SKIN OR EYES AND PREVENT
INHALATION OF DUST. |
|
|
| METHODS
FOR CLEANING UP |
|
|
|
SWEEP UP, PLACE IN A BAG
AND HOLD FOR WASTE DISPOSAL. AVOID |
|
|
|
RAISING DUST. VENTILATE
AREA AND WASH SPILL SITE AFTER MATERIAL |
|
|
|
PICKUP IS COMPLETE. |
|
|
| SECTION
7. HANDLING AND STORAGE |
|
|
| HANDLING |
|
|
|
USER EXPOSURE: AVOID INHALATION. AVOID CONTACT WITH
EYES, SKIN, |
|
|
|
AND CLOTHING. AVOID
PROLONGED OR REPEATED EXPOSURE. |
|
|
| STORAGE |
|
|
|
SUITABLE: KEEP TIGHTLY CLOSED. |
|
|
| SECTION
8. EXPOSURE CONTROLS / PPE |
|
|
| ENGINEERING
CONTROLS |
|
|
|
SAFETY SHOWER AND EYE
BATH. MECHANICAL EXHAUST REQUIRED. |
|
|
| PERSONAL
PROTECTIVE EQUIPMENT |
|
|
|
RESPIRATORY: WEAR DUST MASK. |
|
|
|
HAND: PROTECTIVE GLOVES. |
|
|
|
EYE: CHEMICAL SAFETY GOGGLES. |
|
|
| GENERAL
HYGIENE MEASURES |
|
|
|
WASH THOROUGHLY AFTER
HANDLING. |
|
|
| SECTION
9. PHYSICAL/CHEMICAL PROPERTIES |
|
|
| APPEARANCE
PHYSICAL STATE: SOLID |
|
|
|
COLOR: WHITE |
|
|
|
FORM: FINE CRYSTALS |
|
|
| PROPERTY
VALUE AT TEMPERATURE OR PRESSURE |
|
|
|
MOLECULAR WEIGHT 136.08 AMU |
|
|
|
PH 8.5 - 1 |
|
|
|
BP/BP RANGE N/A |
|
|
|
MP/MP RANGE N/A |
|
|
|
FREEZING POINT N/A |
|
|
|
VAPOR PRESSURE N/A |
|
|
|
VAPOR DENSITY N/A |
|
|
|
SATURATED VAPOR
CONC. N/A |
|
|
|
SG/DENSITY
N/A |
|
|
|
BULK DENSITY 800 KG/L |
|
|
|
ODOR THRESHOLD N/A |
|
|
|
VOLATILE% N/A |
|
|
|
VOC CONTENT N/A |
|
|
|
WATER CONTENT N/A |
|
|
|
SOLVENT CONTENT N/A |
|
|
|
EVAPORATION RATE N/A |
|
|
|
VISCOSITY N/A |
|
|
|
SURFACE TENSION N/A |
|
|
|
PARTITION
COEFFICIENT N/A |
|
|
|
DECOMPOSITION TEMP. N/A |
|
|
|
FLASH POINT N/A |
|
|
|
EXPLOSION LIMITS N/A |
|
|
|
FLAMMABILITY N/A |
|
|
|
AUTOIGNITION TEMP 600 °C |
|
|
|
REFRACTIVE INDEX N/A |
|
|
|
OPTICAL ROTATION N/A |
|
|
|
MISCELLANEOUS DATA N/A |
|
|
|
SOLUBILITY SOLUBILITY IN
WATER: 3 M IN H2O, 20°C |
|
|
|
COMPLETE, COLORLESS |
|
|
|
N/A = NOT AVAILABLE |
|
|
| SECTION
10. STABILITY AND REACTIVITY |
|
|
| STABILITY |
|
|
|
STABLE: STABLE. |
|
|
|
MATERIALS TO AVOID: STRONG OXIDIZING AGENTS. |
|
|
|
HAZARDOUS DECOMPOSITION
PRODUCTS |
|
|
|
HAZARDOUS DECOMPOSITION
PRODUCTS: CARBON MONOXIDE, CARBON
DIOXIDE, |
|
|
|
SODIUM/SODIUM OXIDES. |
|
|
| HAZARDOUS
POLYMERIZATION |
|
|
|
HAZARDOUS
POLYMERIZATION: WILL NOT OCCUR |
|
|
| SECTION
11. TOXICOLOGICAL INFORMATION |
|
|
| ROUTE
OF EXPOSURE |
|
|
|
SKIN CONTACT: MAY CAUSE SKIN IRRITATION. |
|
|
|
SKIN ABSORPTION: MAY BE HARMFUL IF ABSORBED THROUGH THE
SKIN. |
|
|
|
EYE CONTACT: MAY CAUSE EYE IRRITATION. |
|
|
|
INHALATION: MAY BE HARMFUL IF INHALED. MATERIAL MAY
BE |
|
|
|
IRRITATING TO MUCOUS
MEMBRANES AND UPPER RESPIRATORY TRACT. |
|
|
|
INGESTION: MAY BE HARMFUL IF SWALLOWED. |
|
|
| SIGNS
AND SYMPTOMS OF EXPOSURE |
|
|
|
TO THE BEST OF OUR
KNOWLEDGE, THE CHEMICAL, PHYSICAL, AND |
|
|
|
TOXICOLOGICAL PROPERTIES
HAVE NOT BEEN THOROUGHLY INVESTIGATED. |
|
|
|
CHRONIC EXPOSURE -
MUTAGEN |
|
|
|
SPECIES: RAT |
|
|
|
ROUTE: ORAL |
|
|
|
DOSE: 11 MMOL/KG |
|
|
|
MUTATION TEST: UNSCHEDULED DNA SYNTHESIS |
|
|
| SECTION
12. ECOLOGICAL INFORMATION |
|
|
|
NO DATA AVAILABLE. |
|
|
| SECTION
13. DISPOSAL CONSIDERATIONS |
|
|
|
APPROPRIATE METHOD OF
DISPOSAL OF SUBSTANCE OR PREPARATION |
|
|
|
CONTACT A LICENSED
PROFESSIONAL WASTE DISPOSAL SERVICE TO DISPOSE |
|
|
|
OF THIS MATERIAL.
DISSOLVE OR MIX THE MATERIAL WITH A COMBUSTIBLE |
|
|
|
SOLVENT AND BURN IN A
CHEMICAL INCINERATOR EQUIPPED WITH AN |
|
|
|
AFTERBURNER AND SCRUBBER.
OBSERVE ALL FEDERAL, STATE, AND LOCAL |
|
|
|
ENVIRONMENTAL
REGULATIONS. |
|
|
| SECTION
14. TRANSPORT INFORMATION |
|
|
|
CONTACT PROFOLDIN FOR
TRANSPORTATION INFORMATION. |
|
|
| SECTION 15. REGULATORY INFORMATION |
|
|
| US
CLASSIFICATION AND LABEL TEXT |
|
|
|
US STATEMENTS: CAUTION: AVOID CONTACT AND INHALATION. |
|
|
| UNITED
STATES REGULATORY INFORMATION |
|
|
|
SARA LISTED: NO |
|
|
| CANADA
REGULATORY INFORMATION |
|
|
|
WHMIS
CLASSIFICATION: THIS PRODUCT HAS
BEEN CLASSIFIED IN |
|
|
|
ACCORDANCE WITH THE
HAZARD CRITERIA OF THE CPR, AND THE MSDS |
|
|
|
CONTAINS ALL THE
INFORMATION REQUIRED BY THE CPR. |
|
|
|
DSL: NO |
|
|
|
NDSL: NO |
|
|
| SECTION
16. OTHER INFORMATION |
|
|
|
THIS
PRODUCT IS FOR R&D USE ONLY. IT IS NOT FOR DRUG, HOUSEHOLD |
|
|
|
OR
OTHER USES. EMPLOYERS SHOULD USE THIS
INFORMATION ONLY AS A |
|
|
|
SUPPLEMENT
TO OTHER INFORMATION GATHERED BY THEM, AND SHOULD MAKE |
|
|
|
INDEPENDENT
JUDGEMENT OF SUITABILITY OF THIS INFORMATION TO ENSURE |
|
|
|
PROPER
USE AND PROTECT THE HEALTH AND SAFETY OF EMPLOYEES. THIS |
|
|
|
INFORMATION
IS FURNISHED WITHOUT WARRANTY, AND ANY USE OF THE |
|
|
|
PRODUCT
NOT IN CONFORMANCE WITH THIS MATERIAL SAFETY DATA SHEET, |
|
|
|
OR IN
COMBINATION WITH ANY OTHER PRODUCT OR PROCESS, IS THE |
|
|
|
RESPONSIBILITY
OF THE USER. THE ABOVE INFORMATION IS
BELIEVED |
|
|
|
TO
BE CORRECT BUT DOES NOT PURPORT TO BE ALL INCLUSIVE AND SHALL |
|
|
|
BE
USED ONLY AS A GUIDE. PROFOLDIN SHALL
NOT BE HELD LIABLE FOR |
|
|
|
ANY
DAMAG RESULTING FROM HANDLING OR FROM CONTACT WITH THE ABOVE |
|
|
|
PRODUCT. |
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| |
|
| SECTION 1. CHEMICAL IDENTIFICATION |
|
|
|
CATALOG #: SFC01-10, SFC01, SFC02, SFC03, SFC04,
SFC05, SFC06, SFC07, SFC08, SFC09, SFC10 |
|
|
|
|
PFC01, PFC02, PFC03,
PFC04, PFC05, PFC06, PFC07, PFC08, PFC09, PFC10 |
|
|
NAME: SODIUM AZIDE |
|
|
| SECTION
2. COMPOSITION/INFORMATION ON
INGREDIENT |
|
|
|
SUBSTANCE NAME |
|
CAS # |
|
SARA |
|
|
|
SODIUM AZIDE |
|
26628-22-8 |
|
YES |
|
|
|
FORMULA: NAN3 |
|
|
|
SYNONYMS AZIDE, SODIUM *
AZOTURE DE SODIUM (FRENCH) * |
|
|
|
AZYDEK SODU (POLISH) *
KAZOE * NATRIUMAZID |
|
|
|
(GERMAN) * NATRIUMMAZIDE
(DUTCH) * NCI-C06462 * |
|
|
|
NEMAZYD * NSC 3072 * RCRA
WASTE NUMBER P105 * |
|
|
|
SMITE * SODIUM AZIDE
(ACGIH) * SODIUM, AZOTURE DE |
|
|
|
(FRENCH) * SODIUM,
AZOTURO DI (ITALIAN) * U-3886 |
|
|
|
RTECS NUMBER: VY8050000 |
|
|
| SECTION
3. HAZARDS IDENTIFICATION |
|
|
| EMERGENCY
OVERVIEW |
|
|
|
HIGHLY TOXIC (USA) VERY
TOXIC (EU). |
|
|
|
HEATING MAY CAUSE AN
EXPLOSION. VERY TOXIC BY INHALATION, IN |
|
|
|
CONTACT WITH SKIN AND IF
SWALLOWED. CONTACT WITH ACIDS LIBERATES |
|
|
|
VERY TOXIC GAS. VERY
TOXIC TO AQUATIC ORGANISMS, MAY CAUSE |
|
|
|
LONG-TERM ADVERSE EFFECTS
IN THE AQUATIC ENVIRONMENT. |
|
|
|
READILY ABSORBED THROUGH
SKIN. SODIUM AZIDE MAY REACT WITH LEAD |
|
|
|
AND COPPER PLUMBING TO
FORM HIGHLY EXPLOSIVE METAL AZIDES. TARGET |
|
|
|
ORGAN(S): NERVES. HEART. |
|
|
| HMIS
RATING |
|
|
|
HEALTH: 4* |
|
|
|
FLAMMABILITY: 0 |
|
|
|
REACTIVITY: 2 |
|
|
| NFPA
RATING |
|
|
|
HEALTH: 4 |
|
|
|
FLAMMABILITY: 0 |
|
|
|
REACTIVITY: 2 |
|
|
|
*ADDITIONAL CHRONIC
HAZARDS PRESENT. |
|
|
|
FOR
ADDITIONAL INFORMATION ON TOXICITY, PLEASE REFER TO SECTION 11. |
|
|
| SECTION
4. FIRST AID MEASURES |
|
|
| ORAL
EXPOSURE |
|
|
|
IF SWALLOWED, WASH OUT
MOUTH WITH WATER PROVIDED PERSON IS |
|
|
|
CONSCIOUS. CALL A
PHYSICIAN IMMEDIATELY. |
|
|
| INHALATION
EXPOSURE |
|
|
|
IF INHALED, REMOVE TO
FRESH AIR. IF NOT BREATHING GIVE |
|
|
|
ARTIFICIAL RESPIRATION.
IF BREATHING IS DIFFICULT, GIVE OXYGEN. |
|
|
| DERMAL
EXPOSURE |
|
|
|
IN CASE OF SKIN CONTACT,
FLUSH WITH COPIOUS AMOUNTS OF WATER FOR |
|
|
|
AT LEAST 15 MINUTES.
REMOVE CONTAMINATED CLOTHING AND SHOES. |
|
|
|
CALL A PHYSICIAN. |
|
|
| EYE
EXPOSURE |
|
|
|
IN CASE OF CONTACT WITH
EYES, FLUSH WITH COPIOUS AMOUNTS OF |
|
|
|
WATER FOR AT LEAST 15
MINUTES. ASSURE ADEQUATE FLUSHING BY |
|
|
|
SEPARATING THE EYELIDS
WITH FINGERS. CALL A PHYSICIAN. |
|
|
| SECTION
5. FIRE FIGHTING MEASURES |
|
|
|
EXPLOSION HAZARDS |
|
|
|
CONTAINER EXPLOSION MAY
OCCUR UNDER FIRE CONDITIONS. AZIDE |
|
|
|
REACTS WITH MANY HEAVY
METALS SUCH AS LEAD, COPPER, MERCURY, |
|
|
|
SILVER, GOLD TO FORM
EXPLOSIVE COMPOUNDS. COPPER AND LEAD AZIDES |
|
|
|
ARE MORE SENSITIVE THAN
NITROGLYCERINE. AZIDE REACTS WITH METAL |
|
|
|
HALIDES TO GIVE A RANGE
OF METAL AZIDE HALIDES, MANY OF WHICH |
|
|
|
ARE EXPLOSIVE.
INCOMPATIBLE WITH CHROMYL CHLORIDE, HYDRAZINE, |
|
|
|
BROMINE, CARBON
DISULFIDE, DIMETHYL SULFATE, DIBROMOMALONITRILE. |
|
|
|
AN EXPLOSION OCCURRED
WHEN A MIXTURE OF SODIUM AZIDE, METHYLENE |
|
|
|
CHLORIDE, DIMETHYL
SULFOXIDE, AND SULFURIC ACID WERE BEING |
|
|
|
CONCENTRATED ON A ROTARY
EVAPORATOR. |
|
|
|
FLASH POINT |
|
|
|
N/A |
|
|
|
AUTOIGNITION TEMP |
|
|
|
N/A |
|
|
|
FLAMMABILITY |
|
|
|
N/A |
|
|
|
EXTINGUISHING MEDIA |
|
|
|
SUITABLE: DRY CHEMICAL POWDER. |
|
|
|
UNSUITABLE: DO NOT USE WATER. |
|
|
| FIREFIGHTING |
|
|
| PROTECTIVE
EQUIPMENT: WEAR SELF-CONTAINED
BREATHING APPARATUS |
|
|
|
AND PROTECTIVE CLOTHING
TO PREVENT CONTACT WITH SKIN AND EYES. |
|
|
|
SPECIFIC HAZARD(S): EMITS TOXIC FUMES UNDER FIRE CONDITIONS. |
|
|
| SECTION
6. ACCIDENTAL RELEASE MEASURES |
|
|
|
PROCEDURE TO BE FOLLOWED
IN CASE OF LEAK OR SPILL |
|
|
|
EVACUATE AREA. |
|
|
| PROCEDURE(S)
OF PERSONAL PRECAUTION(S) |
|
|
|
WEAR SELF-CONTAINED
BREATHING APPARATUS, RUBBER BOOTS, AND HEAVY |
|
|
|
RUBBER GLOVES. |
|
|
| METHODS
FOR CLEANING UP |
|
|
|
SWEEP UP, PLACE IN A BAG
AND HOLD FOR WASTE DISPOSAL. AVOID |
|
|
|
RAISING DUST. VENTILATE
AREA AND WASH SPILL SITE AFTER MATERIAL |
|
|
|
PICKUP IS COMPLETE. |
|
|
| SECTION
7. HANDLING AND STORAGE |
|
|
| HANDLING |
|
|
|
USER EXPOSURE: DO NOT BREATHE DUST. DO NOT GET IN EYES,
ON SKIN, |
|
|
|
ON CLOTHING. AVOID
PROLONGED OR REPEATED EXPOSURE. |
|
|
| STORAGE |
|
|
|
SUITABLE: KEEP TIGHTLY CLOSED. STORE IN A COOL DRY
PLACE. |
|
|
|
INCOMPATIBLE
MATERIALS: AZIDE REACTS WITH MANY
HEAVY METALS SUCH |
|
|
|
AS LEAD, COPPER, MERCURY,
SILVER, GOLD TO FORM EXPLOSIVE |
|
|
|
COMPOUNDS. COPPER AND
LEAD AZIDES ARE MORE SENSITIVE THAN |
|
|
|
NITROGLYCERINE. AZIDE
REACTS WITH METAL HALIDES TO GIVE A RANGE |
|
|
|
OF METAL AZIDE HALIDES,
MANY OF WHICH ARE EXPLOSIVE. |
|
|
|
INCOMPATIBLE WITH CHROMYL
CHLORIDE, HYDRAZINE, BROMINE, CARBON |
|
|
|
DISULFIDE, DIMETHYL
SULFATE, DIBROMOMALONITRILE. |
|
|
|
SPECIAL REQUIREMENTS |
|
|
|
HEAT SENSITIVE. |
|
|
| SECTION
8. EXPOSURE CONTROLS / PPE |
|
|
| ENGINEERING
CONTROLS |
|
|
|
SAFETY SHOWER AND EYE
BATH. USE ONLY IN A CHEMICAL FUME HOOD. |
|
|
| PERSONAL
PROTECTIVE EQUIPMENT |
|
|
|
RESPIRATORY: GOVERNMENT APPROVED RESPIRATOR. |
|
|
|
HAND: COMPATIBLE CHEMICAL-RESISTANT GLOVES. |
|
|
|
EYE: CHEMICAL SAFETY GOGGLES. |
|
|
| GENERAL
HYGIENE MEASURES |
|
|
|
WASH CONTAMINATED
CLOTHING BEFORE REUSE. WASH THOROUGHLY AFTER |
|
|
| HANDLING. |
|
|
| EXPOSURE
LIMITS, RTECS |
|
|
| COUNTRY
SOURCE TYPE VALUE |
|
|
|
USA ACGIH CEILING CO0.29
MG/M3 (SODIUM AZIDE) |
|
|
|
NEW ZEALAND OEL |
|
|
|
REMARKS: CHECK ACGIH TLV |
|
|
|
USA NIOSH CEILING CO0.1
PPM (SK) |
|
|
| EXPOSURE
LIMITS |
|
|
| COUNTRY
SOURCE TYPE VALUE |
|
|
|
POLAND NDS 0.1 MG/M3 |
|
|
|
POLAND NDSCH 0.3 MG/M3 |
|
|
|
POLAND NDSP |
|
|
| SECTION
9. PHYSICAL/CHEMICAL PROPERTIES |
|
|
| APPEARANCE
PHYSICAL STATE: SOLID |
|
|
|
COLOR: WHITE |
|
|
|
FORM: FINE CRYSTALS |
|
|
| PROPERTY
VALUE AT TEMPERATURE OR PRESSURE |
|
|
|
MOLECULAR WEIGHT 65.01 AMU |
|
|
|
PH 10 |
|
|
|
BP/BP RANGE N/A |
|
|
|
MP/MP RANGE 275 °C |
|
|
|
FREEZING POINT N/A |
|
|
|
VAPOR PRESSURE N/A |
|
|
|
VAPOR DENSITY N/A |
|
|
|
SATURATED VAPOR
CONC. N/A |
|
|
|
SG/DENSITY 1.85 G/CM3 |
|
|
|
BULK DENSITY N/A |
|
|
|
ODOR THRESHOLD N/A |
|
|
|
VOLATILE% N/A |
|
|
|
VOC CONTENT N/A |
|
|
|
WATER CONTENT N/A |
|
|
|
SOLVENT CONTENT N/A |
|
|
|
EVAPORATION RATE N/A |
|
|
|
VISCOSITY N/A |
|
|
|
SURFACE TENSION N/A |
|
|
|
PARTITION
COEFFICIENT N/A |
|
|
|
DECOMPOSITION TEMP. N/A |
|
|
|
FLASH POINT N/A |
|
|
|
EXPLOSION LIMITS N/A |
|
|
|
FLAMMABILITY N/A |
|
|
|
AUTOIGNITION TEMP N/A |
|
|
|
REFRACTIVE INDEX N/A |
|
|
|
OPTICAL ROTATION N/A |
|
|
|
MISCELLANEOUS DATA N/A |
|
|
|
SOLUBILITY SOLUBILITY IN
WATER: 1 M IN H2O, 20°C |
|
|
|
COMPLETE, COLORLESS |
|
|
|
N/A = NOT AVAILABLE |
|
|
| SECTION
10. STABILITY AND REACTIVITY |
|
|
| STABILITY |
|
|
|
STABLE: STABLE. |
|
|
|
CONDITIONS OF
INSTABILITY: HEAT SENSITIVE. |
|
|
|
CONDITIONS TO AVOID: EXPLODES WHEN HEATED. |
|
|
|
MATERIALS TO AVOID: HALOGENATED SOLVENTS AVOID CONTACT WITH |
|
|
|
METALS. AVOID CONTACT
WITH ACID., ACID CHLORIDES |
|
|
|
HAZARDOUS DECOMPOSITION
PRODUCTS |
|
|
|
HAZARDOUS DECOMPOSITION
PRODUCTS: NITROGEN OXIDES REACTS
WITH |
|
|
|
PROTIC SOLVENTS (WATER,
ALCOHOLS, AMINES, ETC.) TO RELEASE TOXIC |
|
|
|
HYDRAZOIC ACID |
|
|
|
HAZARDOUS
DECOMPOSITION PRODUCTS FORMED UPON CONTACT WITH WATER: |
|
|
|
REACTS WITH PROTIC
SOLVENTS (WATER, ALCOHOLS, AMINES, ETC.) TO |
|
|
|
RELEASE TOXIC HYDRAZOIC
ACID |
|
|
| HAZARDOUS
POLYMERIZATION |
|
|
|
HAZARDOUS
POLYMERIZATION: WILL NOT OCCUR |
|
|
| SECTION
11. TOXICOLOGICAL INFORMATION |
|
|
| ROUTE
OF EXPOSURE |
|
|
|
SKIN CONTACT: MAY CAUSE SKIN IRRITATION. |
|
|
|
SKIN ABSORPTION: MAY BE FATAL IF ABSORBED THROUGH SKIN. |
|
|
|
EYE CONTACT: MAY CAUSE EYE IRRITATION. |
|
|
|
INHALATION: MAY BE FATAL IF INHALED. MATERIAL MAY BE
IRRITATING |
|
|
|
TO MUCOUS MEMBRANES AND
UPPER RESPIRATORY TRACT. |
|
|
|
INGESTION: MAY BE FATAL IF SWALLOWED. |
|
|
| TARGET
ORGAN(S) OR SYSTEM(S) |
|
|
|
NERVES. HEART. BRAIN. |
|
|
| SIGNS
AND SYMPTOMS OF EXPOSURE |
|
|
|
EXPOSURE CAN CAUSE: NAUSEA, HEADACHE, AND VOMITING.
LABORATORY |
|
|
|
EXPERIMENTS IN ANIMALS
HAVE SHOWN SODIUM AZIDE TO PRODUCE A |
|
|
|
PROFOUND HYPOTENSIVE
EFFECT, DEMYELINATION OF MYELINATED NERVE |
|
|
|
FIBERS IN THE CENTRAL
NERVOUS SYSTEM, TESTICULAR DAMAGE, |
|
|
|
BLINDNESS, ATTACKS OF
RIGIDITY, AND HEPATIC AND CEREBRAL EFFECTS. |
|
|
| TOXICITY
DATA |
|
|
|
ORAL |
|
|
|
WOMAN |
|
|
|
786 MG/KG |
|
|
|
LDLO |
|
|
|
REMARKS: BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE
THRESHOLD. |
|
|
|
BEHAVIORAL: COMA. CARDIAC: ARRYTHMIAS (INCLUDING CHANGES IT |
|
|
|
CONDUCTION). |
|
|
|
ORAL |
|
|
|
MAN |
|
|
|
29 MG/KG |
|
|
|
LDLO |
|
|
|
REMARKS: BRAIN AND COVERINGS: INCREASED INTRACRANIAL PRESSURE. |
|
|
|
CARDIAC: PULSE RATE. LUNGS, THORAX, OR
RESPIRATION: ACUTE |
|
|
|
PULMONARY EDEMA. |
|
|
|
ORAL |
|
|
|
MAN |
|
|
|
129 MG/KG |
|
|
|
LDLO |
|
|
|
REMARKS: BEHAVIORAL: COMA. CARDIAC: PULSE RATE. CARDIAC: OTHER |
|
|
|
CHANGES. |
|
|
|
ORAL |
|
|
|
WOMAN |
|
|
|
14 MG/KG |
|
|
|
LDLO |
|
|
|
REMARKS: BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE
THRESHOLD. |
|
|
|
CARDIAC: ARRYTHMIAS (INCLUDING CHANGES IT
CONDUCTION). |
|
|
|
CARDIAC: CHANGE IN FORCE OF CONTRACTION. |
|
|
|
ORAL |
|
|
|
MAN |
|
|
|
143 MG/KG |
|
|
|
LDLO |
|
|
|
REMARKS: SENSE ORGANS AND SPECIAL SENSES (NOSE,
EYE, EAR, AND |
|
|
|
TASTE): EYE:
MYDRIASIS (PUPILLIARY DILATION). |
|
|
|
BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY). |
|
|
|
BEHAVIORAL: IRRITABILITY. |
|
|
|
ORAL |
|
|
|
RAT |
|
|
|
27 MG/KG |
|
|
|
LD50 |
|
|
|
INHALATION |
|
|
|
RAT |
|
|
|
37 MG/M3 |
|
|
|
LC50 |
|
|
|
REMARKS: SENSE ORGANS AND SPECIAL SENSES (NOSE,
EYE, EAR, AND |
|
|
|
TASTE): EYE:
OTHER. BEHAVIORAL: CONVULSIONS
OR EFFECT ON SEIZURE |
|
|
|
THRESHOLD. LUNGS, THORAX,
OR RESPIRATION: STRUCTURAL OR |
|
|
|
FUNCTIONAL CHANGE IN
TRACHEA OR BRONCHI. |
|
|
|
SKIN |
|
|
|
RAT |
|
|
|
50 MG/KG |
|
|
|
LD50 |
|
|
|
SUBCUTANEOUS |
|
|
|
RAT |
|
|
|
45100 UG/KG |
|
|
|
LD50 |
|
|
|
REMARKS: PERIPHERAL NERVE AND SENSATION: SPASTIC PARALYSIS WITH |
|
|
|
OR WITHOUT SENSORY
CHANGE. LUNGS, THORAX, OR RESPIRATION:
OTHER |
|
|
|
CHANGES. |
|
|
|
INTRATRACHEAL |
|
|
|
RAT |
|
|
|
47500 UG/KG |
|
|
|
LD50 |
|
|
|
REMARKS: PERIPHERAL NERVE AND SENSATION: SPASTIC PARALYSIS WITH |
|
|
|
OR WITHOUT SENSORY
CHANGE. LUNGS, THORAX, OR RESPIRATION:
OTHER |
|
|
|
CHANGES. |
|
|
|
ORAL |
|
|
|
MOUSE |
|
|
|
27 MG/KG |
|
|
|
LD50 |
|
|
|
INHALATION |
|
|
|
MOUSE |
|
|
|
32.4 MG/M3 |
|
|
|
LC50 |
|
|
|
REMARKS: SENSE ORGANS AND SPECIAL SENSES (NOSE,
EYE, EAR, AND |
|
|
|
TASTE): EYE:
OTHER. BEHAVIORAL: CONVULSIONS
OR EFFECT ON SEIZURE |
|
|
|
THRESHOLD. LUNGS, THORAX,
OR RESPIRATION: STRUCTURAL OR |
|
|
|
FUNCTIONAL CHANGE IN
TRACHEA OR BRONCHI. |
|
|
|
INTRAPERITONEAL |
|
|
|
MOUSE |
|
|
|
28 MG/KG |
|
|
|
LD50 |
|
|
|
REMARKS: BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE
THRESHOLD. |
|
|
|
BEHAVIORAL: CHANGE IN MOTOR ACTIVITY (SPECIFIC ASSAY).
LUNGS, |
|
|
|
THORAX, OR
RESPIRATION: RESPIRATORY STIMULATION. |
|
|
|
SUBCUTANEOUS |
|
|
|
MOUSE |
|
|
|
23060 UG/KG |
|
|
|
LD50 |
|
|
|
REMARKS: PERIPHERAL NERVE AND SENSATION: SPASTIC PARALYSIS WITH |
|
|
|
OR WITHOUT SENSORY
CHANGE. LUNGS, THORAX, OR RESPIRATION:
OTHER |
|
|
|
CHANGES. |
|
|
|
INTRAVENOUS |
|
|
|
MOUSE |
|
|
|
19 MG/KG |
|
|
|
LD50 |
|
|
|
SKIN |
|
|
|
RABBIT |
|
|
|
20 MG/KG |
|
|
|
LD50 |
|
|
|
ORAL |
|
|
|
BIRD (WILD) |
|
|
|
23.7 MG/KG |
|
|
|
LD50 |
|
|
|
CHRONIC EXPOSURE -
CARCINOGEN |
|
|
|
SPECIES: RAT |
|
|
|
ROUTE OF
APPLICATION: ORAL |
|
|
|
DOSE: 2730 MG/KG |
|
|
|
EXPOSURE TIME: 78W |
|
|
|
FREQUENCY: C |
|
|
|
RESULT: TUMORIGENIC: EQUIVOCAL TUMORIGENIC AGENT BY RTECS |
|
|
|
CRITERIA. ENDOCRINE: TUMORS. SKIN AND APPENDAGES: OTHER:
TUMORS. |
|
|
|
SPECIES: RAT |
|
|
|
ROUTE OF
APPLICATION: ORAL |
|
|
|
DOSE: 5460 MG/KG |
|
|
|
EXPOSURE TIME: 78W |
|
|
|
FREQUENCY: C |
|
|
|
RESULT: TUMORIGENIC: EQUIVOCAL TUMORIGENIC AGENT BY RTECS |
|
|
|
CRITERIA. ENDOCRINE: TUMORS. SKIN AND APPENDAGES: OTHER:
TUMORS. |
|
|
|
NTP CARCINOGEN LIST |
|
|
|
RATING: NO EVIDENCE. |
|
|
|
SPECIES: RAT |
|
|
|
ROUTE: GAVAGE |
|
|
|
ACGIH CARCINOGEN LIST |
|
|
|
RATING: A4 |
|
|
|
CHRONIC EXPOSURE -
MUTAGEN |
|
|
|
RESULT: LABORATORY EXPERIMENTS HAVE SHOWN
MUTAGENIC EFFECTS. |
|
|
|
SPECIES: OTHER INSECTS |
|
|
|
ROUTE: ORAL |
|
|
|
DOSE: 100 MG/L |
|
|
|
MUTATION TEST: HERITABLE TRANSLOCATION TEST |
|
|
|
SPECIES: HUMAN |
|
|
|
DOSE: 30 MMOL/L |
|
|
|
CELL TYPE: HELA CELL |
|
|
|
MUTATION TEST: DNA INHIBITION |
|
|
|
SPECIES: HUMAN |
|
|
|
DOSE: 50 MG/L |
|
|
|
CELL TYPE: FIBROBLAST |
|
|
|
MUTATION TEST: DNA INHIBITION |
|
|
|
SPECIES: RAT |
|
|
|
DOSE: 1 MMOL/L |
|
|
|
CELL TYPE: LIVER |
|
|
|
MUTATION TEST: MUTATION IN MAMMALIAN SOMATIC CELLS. |
|
|
|
SPECIES: MOUSE |
|
|
|
DOSE: 500 MG/L |
|
|
|
EXPOSURE TIME: 2H |
|
|
|
CELL TYPE: LYMPHOCYTE |
|
|
|
MUTATION TEST: MUTATION IN MAMMALIAN SOMATIC CELLS. |
|
|
|
SPECIES: HAMSTER |
|
|
|
DOSE: 1 MMOL/L |
|
|
|
CELL TYPE: LUNG |
|
|
|
MUTATION TEST: MUTATION IN MAMMALIAN SOMATIC CELLS. |
|
|
| SECTION
12. ECOLOGICAL INFORMATION |
|
|
|
ACUTE ECOTOXICITY TESTS |
|
|
|
TEST TYPE: EC50 DAPHNIA |
|
|
|
SPECIES: DAPHNIA PULEX |
|
|
|
TIME: 48 H |
|
|
|
VALUE: 4.2 MG/L |
|
|
|
TEST TYPE: LC50 FISH |
|
|
|
SPECIES: PIMEPHALES PROMELAS (FATHEAD MINNOW) |
|
|
|
TIME: 96 H |
|
|
|
VALUE: 5.46 MG/L |
|
|
|
TEST TYPE: LC50 FISH |
|
|
|
SPECIES: ONCHORHYNCHUS MYKISS (RAINBOW TROUT) |
|
|
|
TIME: 96 H |
|
|
|
VALUE: 3.92 MG/L |
|
|
| SECTION
13. DISPOSAL CONSIDERATIONS |
|
|
|
APPROPRIATE METHOD OF
DISPOSAL OF SUBSTANCE OR PREPARATION |
|
|
|
CONTACT A LICENSED
PROFESSIONAL WASTE DISPOSAL SERVICE TO DISPOSE |
|
|
|
OF THIS MATERIAL. OBSERVE
ALL FEDERAL, STATE, AND LOCAL |
|
|
|
ENVIRONMENTAL
REGULATIONS. |
|
|
| SECTION
14. TRANSPORT INFORMATION |
|
|
|
CONTACT PROFOLDIN FOR
TRANSPORTATION INFORMATION. |
|
|
| SECTION 15. REGULATORY INFORMATION |
|
|
| EU
DIRECTIVES CLASSIFICATION |
|
|
|
SYMBOL OF DANGER: T+ N |
|
|
|
INDICATION OF
DANGER: VERY TOXIC. DANGEROUS FOR
THE ENVIRONMENT. |
|
|
|
R: 28 32 50/53 |
|
|
|
RISK STATEMENTS: VERY TOXIC IF SWALLOWED. CONTACT WITH
ACIDS |
|
|
|
LIBERATES VERY TOXIC GAS.
VERY TOXIC TO AQUATIC ORGANISMS, MAY |
|
|
|
CAUSE LONG-TERM ADVERSE
EFFECTS IN THE AQUATIC ENVIRONMENT. |
|
|
|
S: 28 45 60 61 |
|
|
|
SAFETY STATEMENTS: AFTER CONTACT WITH SKIN, WASH IMMEDIATELY |
|
|
|
WITH PLENTY OF SOAP-SUDS.
IN CASE OF ACCIDENT OR IF YOU FEEL |
|
|
|
UNWELL, SEEK MEDICAL
ADVICE IMMEDIATELY (SHOW THE LABEL WHERE |
|
|
|
POSSIBLE). THIS MATERIAL
AND ITS CONTAINER MUST BE DISPOSED OF |
|
|
|
AS HAZARDOUS WASTE. AVOID
RELEASE TO THE ENVIRONMENT. REFER TO |
|
|
|
SPECIAL
INSTRUCTIONS/SAFETY DATA SHEETS. |
|
|
| US
CLASSIFICATION AND LABEL TEXT |
|
|
|
INDICATION OF
DANGER: HIGHLY TOXIC (USA) VERY
TOXIC (EU). |
|
|
|
RISK STATEMENTS: HEATING MAY CAUSE AN EXPLOSION. VERY
TOXIC BY |
|
|
|
INHALATION, IN CONTACT
WITH SKIN AND IF SWALLOWED. CONTACT WITH |
|
|
|
ACIDS LIBERATES VERY
TOXIC GAS. VERY TOXIC TO AQUATIC ORGANISMS, |
|
|
|
MAY CAUSE LONG-TERM
ADVERSE EFFECTS IN THE AQUATIC ENVIRONMENT. |
|
|
|
SAFETY STATEMENTS: IN CASE OF ACCIDENT OR IF YOU FEEL
UNWELL, |
|
|
|
SEEK MEDICAL ADVICE
IMMEDIATELY (SHOW THE LABEL WHERE POSSIBLE). |
|
|
|
WEAR SUITABLE PROTECTIVE
CLOTHING, GLOVES, AND EYE/FACE |
|
|
|
PROTECTION. DO NOT
BREATHE DUST. |
|
|
|
US STATEMENTS: READILY ABSORBED THROUGH SKIN. SODIUM
AZIDE MAY |
|
|
|
REACT WITH LEAD AND
COPPER PLUMBING TO FORM HIGHLY EXPLOSIVE |
|
|
|
METAL AZIDES. TARGET
ORGAN(S): NERVES. HEART. |
|
|
| UNITED
STATES REGULATORY INFORMATION |
|
|
|
SARA LISTED: YES |
|
|
|
DEMINIMIS: 1 % |
|
|
|
NOTES: THIS PRODUCT IS SUBJECT TO SARA SECTION
313 REPORTING |
|
|
|
REQUIREMENTS. |
|
|
|
TSCA INVENTORY ITEM: YES |
|
|
| CANADA
REGULATORY INFORMATION |
|
|
|
WHMIS
CLASSIFICATION: THIS PRODUCT HAS
BEEN CLASSIFIED IN |
|
|
|
ACCORDANCE WITH THE
HAZARD CRITERIA OF THE CPR, AND THE MSDS |
|
|
|
CONTAINS ALL THE
INFORMATION REQUIRED BY THE CPR. |
|
|
|
DSL: YES |
|
|
|
NDSL: NO |
|
|
| SECTION
16. OTHER INFORMATION |
|
|
|
THIS
PRODUCT IS FOR R&D USE ONLY. IT IS NOT FOR DRUG, HOUSEHOLD |
|
|
|
OR
OTHER USES. EMPLOYERS SHOULD USE THIS
INFORMATION ONLY AS A |
|
|
|
SUPPLEMENT
TO OTHER INFORMATION GATHERED BY THEM, AND SHOULD MAKE |
|
|
|
INDEPENDENT
JUDGEMENT OF SUITABILITY OF THIS INFORMATION TO ENSURE |
|
|
|
PROPER
USE AND PROTECT THE HEALTH AND SAFETY OF EMPLOYEES. THIS |
|
|
|
INFORMATION
IS FURNISHED WITHOUT WARRANTY, AND ANY USE OF THE |
|
|
|
PRODUCT
NOT IN CONFORMANCE WITH THIS MATERIAL SAFETY DATA SHEET, |
|
|
|
OR IN
COMBINATION WITH ANY OTHER PRODUCT OR PROCESS, IS THE |
|
|
|
RESPONSIBILITY
OF THE USER. THE ABOVE INFORMATION IS
BELIEVED |
|
|
|
TO
BE CORRECT BUT DOES NOT PURPORT TO BE ALL INCLUSIVE AND SHALL |
|
|
|
BE
USED ONLY AS A GUIDE. PROFOLDIN SHALL
NOT BE HELD LIABLE FOR |
|
|
|
ANY
DAMAG RESULTING FROM HANDLING OR FROM CONTACT WITH THE ABOVE |
|
|
|
PRODUCT. |
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| |
|
| SECTION 1. CHEMICAL IDENTIFICATION |
|
|
|
CATALOG #: SFC01-10, SFC01, SFC02, SFC03, SFC04,
SFC05, SFC06, SFC07, SFC08, SFC09, SFC10 |
|
|
|
|
PFC01, PFC02, PFC03,
PFC04, PFC05, PFC06, PFC07, PFC08, PFC09, PFC10 |
|
|
NAME:
MAGNESIUM ACETATE |
|
|
| SECTION
2. COMPOSITION/INFORMATION ON
INGREDIENT |
|
|
|
SUBSTANCE NAME |
|
|
CAS # |
|
SARA |
|
|
|
MAGNESIUM ACETATE TETRAHYDRATE |
|
16674-78-5 |
|
NO |
|
|
|
FORMULA: (C2H3O2)2MG.4H2O |
|
|
| SECTION
3. HAZARDS IDENTIFICATION |
|
|
| EMERGENCY
OVERVIEW |
|
|
|
CAUTION: AVOID CONTACT AND INHALATION. TARGET
ORGAN(S): CENTRAL |
|
|
|
NERVOUS SYSTEM. G.I.
SYSTEM. |
|
|
| HMIS
RATING |
|
|
|
HEALTH: 1* |
|
|
|
FLAMMABILITY: 0 |
|
|
|
REACTIVITY: 1 |
|
|
| NFPA
RATING |
|
|
|
HEALTH: 1 |
|
|
|
FLAMMABILITY: 0 |
|
|
|
REACTIVITY: 1 |
|
|
|
*ADDITIONAL CHRONIC
HAZARDS PRESENT. |
|
|
|
FOR
ADDITIONAL INFORMATION ON TOXICITY, PLEASE REFER TO SECTION 11. |
|
|
| SECTION
4. FIRST AID MEASURES |
|
|
| ORAL
EXPOSURE |
|
|
|
IF SWALLOWED, WASH OUT
MOUTH WITH WATER PROVIDED PERSON IS |
|
|
|
CONSCIOUS. CALL A
PHYSICIAN. |
|
|
| INHALATION
EXPOSURE |
|
|
|
IF INHALED, REMOVE TO
FRESH AIR. IF BREATHING BECOMES DIFFICULT, |
|
|
|
CALL A PHYSICIAN. |
|
|
| DERMAL
EXPOSURE |
|
|
|
IN CASE OF CONTACT,
IMMEDIATELY WASH SKIN WITH SOAP AND COPIOUS |
|
|
|
AMOUNTS OF WATER. |
|
|
| EYE
EXPOSURE |
|
|
|
IN CASE OF CONTACT WITH
EYES, FLUSH WITH COPIOUS AMOUNTS OF |
|
|
|
WATER FOR AT LEAST 15
MINUTES. ASSURE ADEQUATE FLUSHING BY |
|
|
|
SEPARATING THE EYELIDS
WITH FINGERS. CALL A PHYSICIAN. |
|
|
| SECTION
5. FIRE FIGHTING MEASURES |
|
|
|
FLASH POINT |
|
|
|
N/A |
|
|
|
AUTOIGNITION TEMP |
|
|
|
N/A |
|
|
|
FLAMMABILITY |
|
|
|
N/A |
|
|
|
EXTINGUISHING MEDIA |
|
|
|
SUITABLE: WATER SPRAY. CARBON DIOXIDE, DRY CHEMICAL
POWDER, OR |
|
|
|
APPROPRIATE FOAM. |
|
|
| FIREFIGHTING |
|
|
| PROTECTIVE
EQUIPMENT: WEAR SELF-CONTAINED
BREATHING APPARATUS |
|
|
|
AND PROTECTIVE CLOTHING
TO PREVENT CONTACT WITH SKIN AND EYES. |
|
|
|
SPECIFIC HAZARD(S): EMITS TOXIC FUMES UNDER FIRE CONDITIONS. |
|
|
| SECTION
6. ACCIDENTAL RELEASE MEASURES |
|
|
| PROCEDURE(S)
OF PERSONAL PRECAUTION(S) |
|
|
|
EXERCISE APPROPRIATE
PRECAUTIONS TO MINIMIZE DIRECT CONTACT WITH |
|
|
|
SKIN OR EYES AND PREVENT
INHALATION OF DUST. |
|
|
| METHODS
FOR CLEANING UP |
|
|
|
SWEEP UP, PLACE IN A BAG
AND HOLD FOR WASTE DISPOSAL. AVOID |
|
|
|
RAISING DUST. VENTILATE
AREA AND WASH SPILL SITE AFTER MATERIAL |
|
|
|
PICKUP IS COMPLETE. |
|
|
| SECTION
7. HANDLING AND STORAGE |
|
|
| HANDLING |
|
|
|
USER EXPOSURE: AVOID INHALATION. AVOID CONTACT WITH
EYES, SKIN, |
|
|
|
AND CLOTHING. AVOID
PROLONGED OR REPEATED EXPOSURE. |
|
|
| STORAGE |
|
|
|
SUITABLE: KEEP TIGHTLY CLOSED. |
|
|
|
SPECIAL REQUIREMENTS |
|
|
|
MOISTURE SENSITIVE. |
|
|
| SECTION
8. EXPOSURE CONTROLS / PPE |
|
|
| ENGINEERING
CONTROLS |
|
|
|
SAFETY SHOWER AND EYE
BATH. MECHANICAL EXHAUST REQUIRED. |
|
|
| PERSONAL
PROTECTIVE EQUIPMENT |
|
|
|
RESPIRATORY: WEAR DUST MASK. |
|
|
|
HAND: PROTECTIVE GLOVES. |
|
|
|
EYE: CHEMICAL SAFETY GOGGLES. |
|
|
| GENERAL
HYGIENE MEASURES |
|
|
|
WASH THOROUGHLY AFTER
HANDLING. |
|
|
| SECTION
9. PHYSICAL/CHEMICAL PROPERTIES |
|
|
| APPEARANCE
PHYSICAL STATE: SOLID |
|
|
|
COLOR: WHITE |
|
|
|
FORM: FINE CRYSTALS |
|
|
| PROPERTY
VALUE AT TEMPERATURE OR PRESSURE |
|
|
|
MOLECULAR WEIGHT 214.46 AMU |
|
|
|
PH N/A |
|
|
|
BP/BP RANGE N/A |
|
|
|
MP/MP RANGE 80 °C |
|
|
|
FREEZING POINT N/A |
|
|
|
VAPOR PRESSURE N/A |
|
|
|
VAPOR DENSITY N/A |
|
|
|
SATURATED VAPOR
CONC. N/A |
|
|
|
SG/DENSITY 1.454 G/CM3 |
|
|
|
BULK DENSITY N/A |
|
|
|
ODOR THRESHOLD N/A |
|
|
|
VOLATILE% N/A |
|
|
|
VOC CONTENT N/A |
|
|
|
WATER CONTENT N/A |
|
|
|
SOLVENT CONTENT N/A |
|
|
|
EVAPORATION RATE N/A |
|
|
|
VISCOSITY N/A |
|
|
|
SURFACE TENSION N/A |
|
|
|
PARTITION
COEFFICIENT N/A |
|
|
|
DECOMPOSITION TEMP. N/A |
|
|
|
FLASH POINT N/A |
|
|
|
EXPLOSION LIMITS N/A |
|
|
|
FLAMMABILITY N/A |
|
|
|
AUTOIGNITION TEMP N/A |
|
|
|
REFRACTIVE INDEX N/A |
|
|
|
OPTICAL ROTATION N/A |
|
|
|
MISCELLANEOUS DATA N/A |
|
|
|
SOLUBILITY N/A |
|
|
|
N/A = NOT AVAILABLE |
|
|
| SECTION
10. STABILITY AND REACTIVITY |
|
|
| STABILITY |
|
|
|
STABLE: STABLE. |
|
|
|
CONDITIONS TO AVOID: MOISTURE. |
|
|
|
MATERIALS TO AVOID: STRONG OXIDIZING AGENTS. |
|
|
|
HAZARDOUS DECOMPOSITION
PRODUCTS |
|
|
|
HAZARDOUS DECOMPOSITION
PRODUCTS: CARBON MONOXIDE, CARBON
DIOXIDE, |
|
|
|
MAGNESIUM OXIDE. |
|
|
| HAZARDOUS
POLYMERIZATION |
|
|
|
HAZARDOUS
POLYMERIZATION: WILL NOT OCCUR |
|
|
| SECTION
11. TOXICOLOGICAL INFORMATION |
|
|
| ROUTE
OF EXPOSURE |
|
|
|
SKIN CONTACT: MAY CAUSE SKIN IRRITATION. |
|
|
|
SKIN ABSORPTION: MAY BE HARMFUL IF ABSORBED THROUGH THE
SKIN. |
|
|
|
EYE CONTACT: MAY CAUSE EYE IRRITATION. |
|
|
|
INHALATION: MAY BE HARMFUL IF INHALED. MATERIAL MAY
BE |
|
|
|
IRRITATING TO MUCOUS
MEMBRANES AND UPPER RESPIRATORY TRACT. |
|
|
|
INGESTION: MAY BE HARMFUL IF SWALLOWED. |
|
|
| TARGET
ORGAN(S) OR SYSTEM(S) |
|
|
|
CENTRAL NERVOUS SYSTEM.
G.I. SYSTEM. |
|
|
| SIGNS
AND SYMPTOMS OF EXPOSURE |
|
|
|
TO THE BEST OF OUR
KNOWLEDGE, THE CHEMICAL, PHYSICAL, AND |
|
|
|
TOXICOLOGICAL PROPERTIES
HAVE NOT BEEN THOROUGHLY INVESTIGATED. |
|
|
| TOXICITY
DATA |
|
|
|
INTRAVENOUS |
|
|
|
MOUSE |
|
|
|
111 MG/KG |
|
|
|
LD50 |
|
|
| SECTION
12. ECOLOGICAL INFORMATION |
|
|
|
NO DATA AVAILABLE. |
|
|
| SECTION
13. DISPOSAL CONSIDERATIONS |
|
|
|
APPROPRIATE METHOD OF
DISPOSAL OF SUBSTANCE OR PREPARATION |
|
|
|
CONTACT A LICENSED
PROFESSIONAL WASTE DISPOSAL SERVICE TO DISPOSE |
|
|
|
OF THIS MATERIAL.
DISSOLVE OR MIX THE MATERIAL WITH A COMBUSTIBLE |
|
|
|
SOLVENT AND BURN IN A
CHEMICAL INCINERATOR EQUIPPED WITH AN |
|
|
|
AFTERBURNER AND SCRUBBER.
OBSERVE ALL FEDERAL, STATE, AND LOCAL |
|
|
|
ENVIRONMENTAL
REGULATIONS. |
|
|
| SECTION
14. TRANSPORT INFORMATION |
|
|
|
CONTACT PROFOLDIN FOR
TRANSPORTATION INFORMATION. |
|
|
| SECTION 15. REGULATORY INFORMATION |
|
|
| EU
ADDITIONAL CLASSIFICATION |
|
|
|
S: 22 24/25 |
|
|
|
SAFETY STATEMENTS: DO NOT BREATHE DUST. AVOID CONTACT WITH
SKIN |
|
|
|
AND EYES. |
|
|
| US
CLASSIFICATION AND LABEL TEXT |
|
|
|
US STATEMENTS: CAUTION: AVOID CONTACT AND INHALATION. TARGET |
|
|
|
ORGAN(S): CENTRAL NERVOUS SYSTEM. G.I. SYSTEM. |
|
|
| UNITED
STATES REGULATORY INFORMATION |
|
|
|
SARA LISTED: NO |
|
|
|
TSCA INVENTORY ITEM: YES |
|
|
| CANADA
REGULATORY INFORMATION |
|
|
|
WHMIS
CLASSIFICATION: THIS PRODUCT HAS
BEEN CLASSIFIED IN |
|
|
|
ACCORDANCE WITH THE
HAZARD CRITERIA OF THE CPR, AND THE MSDS |
|
|
|
CONTAINS ALL THE
INFORMATION REQUIRED BY THE CPR. |
|
|
|
DSL: NO |
|
|
|
NDSL: NO |
|
|
| SECTION
16. OTHER INFORMATION |
|
|
|
THIS
PRODUCT IS FOR R&D USE ONLY. IT IS NOT FOR DRUG, HOUSEHOLD |
|
|
|
OR
OTHER USES. EMPLOYERS SHOULD USE THIS
INFORMATION ONLY AS A |
|
|
|
SUPPLEMENT
TO OTHER INFORMATION GATHERED BY THEM, AND SHOULD MAKE |
|
|
|
INDEPENDENT
JUDGEMENT OF SUITABILITY OF THIS INFORMATION TO ENSURE |
|
|
|
PROPER
USE AND PROTECT THE HEALTH AND SAFETY OF EMPLOYEES. THIS |
|
|
|
INFORMATION
IS FURNISHED WITHOUT WARRANTY, AND ANY USE OF THE |
|
|
|
PRODUCT
NOT IN CONFORMANCE WITH THIS MATERIAL SAFETY DATA SHEET, |
|
|
|
OR IN
COMBINATION WITH ANY OTHER PRODUCT OR PROCESS, IS THE |
|
|
|
RESPONSIBILITY
OF THE USER. THE ABOVE INFORMATION IS
BELIEVED |
|
|
|
TO
BE CORRECT BUT DOES NOT PURPORT TO BE ALL INCLUSIVE AND SHALL |
|
|
|
BE
USED ONLY AS A GUIDE. PROFOLDIN SHALL
NOT BE HELD LIABLE FOR |
|
|
|
ANY
DAMAG RESULTING FROM HANDLING OR FROM CONTACT WITH THE ABOVE |
|
|
|
PRODUCT. |
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| |
|
| SECTION 1. CHEMICAL IDENTIFICATION |
|
|
|
CATALOG #: SFC01-10, SFC01, SFC02, SFC03, SFC04,
SFC05, SFC06, SFC07, SFC08, SFC09, SFC10 |
|
|
|
|
PFC01, PFC02, PFC03,
PFC04, PFC05, PFC06, PFC07, PFC08, PFC09, PFC10 |
|
|
NAME: GLYCEROL |
|
|
|
APPROX 99% |
|
|
| SECTION
2. COMPOSITION/INFORMATION ON
INGREDIENT |
|
|
|
SUBSTANCE NAME |
|
CAS
# |
|
SARA |
|
|
|
GLYCEROL |
|
56-81-5 |
|
NO |
|
|
|
FORMULA: C3H8O3 |
|
|
|
SYNONYMS GLYCEROL *
CITIFLUOR AF 2 * GLYCERIN * GLYCERIN, |
|
|
|
ANHYDROUS * GLYCERINE *
GLYCERIN MIST |
|
|
|
(ACGIH,OSHA) * GLYCERIN,
SYNTHETIC * GLYCERITOL * |
|
|
|
GLYCYL ALCOHOL *
CLYZERIN, WASSERFREI (GERMAN) * |
|
|
|
GROCOLENE * MOON *
1,2,3-PROPANETRIOL * OSMOGLYN |
|
|
|
* STAR * SYNTHETIC
GLYCERIN * 90 TECHNICAL |
|
|
|
GLYCERINE *
TRIHYDROXYPROPANE * |
|
|
|
1,2,3-TRIHYDROXYPROPANE |
|
|
|
RTECS NUMBER: MA8050000 |
|
|
| SECTION
3. HAZARDS IDENTIFICATION |
|
|
| EMERGENCY
OVERVIEW |
|
|
|
CAUTION: AVOID CONTACT AND INHALATION. TARGET
ORGAN(S): KIDNEYS. |
|
|
| HMIS
RATING |
|
|
|
HEALTH: 1* |
|
|
|
FLAMMABILITY: 0 |
|
|
|
REACTIVITY: 1 |
|
|
| NFPA
RATING |
|
|
|
HEALTH: 1 |
|
|
|
FLAMMABILITY: 0 |
|
|
|
REACTIVITY: 1 |
|
|
|
*ADDITIONAL CHRONIC
HAZARDS PRESENT. |
|
|
|
FOR
ADDITIONAL INFORMATION ON TOXICITY, PLEASE REFER TO SECTION 11. |
|
|
| SECTION
4. FIRST AID MEASURES |
|
|
| ORAL
EXPOSURE |
|
|
|
IF SWALLOWED, WASH OUT
MOUTH WITH WATER PROVIDED PERSON IS |
|
|
|
CONSCIOUS. CALL A
PHYSICIAN. |
|
|
| INHALATION
EXPOSURE |
|
|
|
IF INHALED, REMOVE TO
FRESH AIR. IF BREATHING BECOMES DIFFICULT, |
|
|
|
CALL A PHYSICIAN. |
|
|
| DERMAL
EXPOSURE |
|
|
|
IN CASE OF CONTACT,
IMMEDIATELY WASH SKIN WITH SOAP AND COPIOUS |
|
|
|
AMOUNTS OF WATER. |
|
|
| EYE
EXPOSURE |
|
|
|
IN CASE OF CONTACT WITH
EYES, FLUSH WITH COPIOUS AMOUNTS OF |
|
|
|
WATER FOR AT LEAST 15
MINUTES. ASSURE ADEQUATE FLUSHING BY |
|
|
|
SEPARATING THE EYELIDS
WITH FINGERS. CALL A PHYSICIAN. |
|
|
| SECTION
5. FIRE FIGHTING MEASURES |
|
|
|
FLASH POINT |
|
|
|
320 °F 160 °C
METHOD: CLOSED CUP |
|
|
|
EXPLOSION LIMITS |
|
|
|
LOWER: 0.9 % |
|
|
|
AUTOIGNITION TEMP |
|
|
|
370 °C |
|
|
|
FLAMMABILITY |
|
|
|
N/A |
|
|
|
EXTINGUISHING MEDIA |
|
|
|
SUITABLE: WATER SPRAY. CARBON DIOXIDE, DRY CHEMICAL
POWDER, OR |
|
|
|
APPROPRIATE FOAM. |
|
|
| FIREFIGHTING |
|
|
| PROTECTIVE
EQUIPMENT: WEAR SELF-CONTAINED
BREATHING APPARATUS |
|
|
|
AND PROTECTIVE CLOTHING
TO PREVENT CONTACT WITH SKIN AND EYES. |
|
|
|
SPECIFIC HAZARD(S): EMITS TOXIC FUMES UNDER FIRE CONDITIONS. |
|
|
| SECTION
6. ACCIDENTAL RELEASE MEASURES |
|
|
| PROCEDURE(S)
OF PERSONAL PRECAUTION(S) |
|
|
|
EXERCISE APPROPRIATE
PRECAUTIONS TO MINIMIZE DIRECT CONTACT WITH |
|
|
|
SKIN OR EYES AND PREVENT
INHALATION OF VAPORS. |
|
|
| METHODS
FOR CLEANING UP |
|
|
|
ABSORB ON SAND OR
VERMICULITE AND PLACE IN CLOSED CONTAINERS FOR |
|
|
|
DISPOSAL. VENTILATE AREA
AND WASH SPILL SITE AFTER MATERIAL |
|
|
|
PICKUP IS COMPLETE. |
|
|
| SECTION
7. HANDLING AND STORAGE |
|
|
| HANDLING |
|
|
|
USER EXPOSURE: AVOID INHALATION. AVOID CONTACT WITH
EYES, SKIN, |
|
|
|
AND CLOTHING. AVOID
PROLONGED OR REPEATED EXPOSURE. |
|
|
| STORAGE |
|
|
|
SUITABLE: KEEP TIGHTLY CLOSED. |
|
|
|
SPECIAL REQUIREMENTS |
|
|
|
HYGROSCOPIC. |
|
|
| SECTION
8. EXPOSURE CONTROLS / PPE |
|
|
| ENGINEERING
CONTROLS |
|
|
|
SAFETY SHOWER AND EYE
BATH. MECHANICAL EXHAUST REQUIRED. |
|
|
| PERSONAL
PROTECTIVE EQUIPMENT |
|
|
|
HAND: PROTECTIVE GLOVES. |
|
|
|
EYE: CHEMICAL SAFETY GOGGLES. |
|
|
| GENERAL
HYGIENE MEASURES |
|
|
|
WASH THOROUGHLY AFTER
HANDLING. |
|
|
| EXPOSURE
LIMITS, RTECS |
|
|
| COUNTRY
SOURCE TYPE VALUE |
|
|
|
USA USA ACGIH ACGIH TWA
TWA 10 MG/M3 10 MG/M3 |
|
|
|
REMARKS: INHALABLE PARTICULATE |
|
|
|
USA USA MSHA STANDARD
MSHA |
|
|
|
REMARKS: NUISANCE PARTICULATES (MIST). NUISANCE |
|
|
|
USA USA OSHA. OSHA. PEL
PEL 8H TWA 15 MG/M3, TOTAL DUST 8H |
|
|
|
NEW ZEALAND OEL OEL |
|
|
|
REMARKS: CHECK ACGIH TLV CHECK ACGIH TLV |
|
|
| EXPOSURE
LIMITS |
|
|
| COUNTRY
SOURCE TYPE VALUE |
|
|
|
POLAND NDS 10 MG/M3 |
|
|
|
POLAND NDSCH - |
|
|
|
POLAND NDSP |
|
|
|
REMARKS: {OELS ARE VALID FOR AEROSOLS} AEROZOLE |
|
|
| SECTION
9. PHYSICAL/CHEMICAL PROPERTIES |
|
|
| APPEARANCE
PHYSICAL STATE: LIQUID |
|
|
| PROPERTY
VALUE AT TEMPERATURE OR PRESSURE |
|
|
|
MOLECULAR WEIGHT 92.09 AMU |
|
|
|
PH 5.5 - 8 |
|
|
|
BP/BP RANGE 182 °C 20
MMHG |
|
|
|
MP/MP RANGE 20 °C |
|
|
|
FREEZING POINT N/A |
|
|
|
VAPOR PRESSURE < 1
MMHG 20 °C |
|
|
|
VAPOR DENSITY 3.1 G/L |
|
|
|
SATURATED VAPOR
CONC. N/A |
|
|
|
SG/DENSITY 1.262 G/CM3 |
|
|
|
BULK DENSITY N/A |
|
|
|
ODOR THRESHOLD N/A |
|
|
|
VOLATILE% N/A |
|
|
|
VOC CONTENT N/A |
|
|
|
WATER CONTENT < 0.1 % |
|
|
|
SOLVENT CONTENT N/A |
|
|
|
EVAPORATION RATE N/A |
|
|
|
VISCOSITY N/A |
|
|
|
SURFACE TENSION N/A |
|
|
|
PARTITION
COEFFICIENT N/A |
|
|
|
DECOMPOSITION TEMP. N/A |
|
|
|
FLASH POINT 320 °F 160 °C
METHOD: CLOSED CUP |
|
|
|
EXPLOSION LIMITS
LOWER: 0.9 % |
|
|
|
FLAMMABILITY N/A |
|
|
|
AUTOIGNITION TEMP 370 °C |
|
|
|
REFRACTIVE INDEX 1.474 |
|
|
|
OPTICAL ROTATION N/A |
|
|
|
MISCELLANEOUS DATA N/A |
|
|
|
SOLUBILITY SOLUBILITY IN
WATER: 5 M IN H2O, 20°C |
|
|
|
COMPLETE, COLORLESS |
|
|
|
N/A = NOT AVAILABLE |
|
|
| SECTION
10. STABILITY AND REACTIVITY |
|
|
| STABILITY |
|
|
|
STABLE: STABLE. |
|
|
|
CONDITIONS TO AVOID: MOISTURE. |
|
|
|
MATERIALS TO AVOID: STRONG BASES, STRONG OXIDIZING AGENTS. |
|
|
|
HAZARDOUS DECOMPOSITION
PRODUCTS |
|
|
|
HAZARDOUS DECOMPOSITION
PRODUCTS: CARBON MONOXIDE, CARBON
DIOXIDE. |
|
|
| HAZARDOUS
POLYMERIZATION |
|
|
|
HAZARDOUS
POLYMERIZATION: WILL NOT OCCUR |
|
|
| SECTION
11. TOXICOLOGICAL INFORMATION |
|
|
| ROUTE
OF EXPOSURE |
|
|
|
SKIN CONTACT: MAY CAUSE SKIN IRRITATION. |
|
|
|
SKIN ABSORPTION: MAY BE HARMFUL IF ABSORBED THROUGH THE
SKIN. |
|
|
|
EYE CONTACT: MAY CAUSE EYE IRRITATION. |
|
|
|
INHALATION: MAY BE HARMFUL IF INHALED. MATERIAL MAY
BE |
|
|
|
IRRITATING TO MUCOUS
MEMBRANES AND UPPER RESPIRATORY TRACT. |
|
|
|
INGESTION: MAY BE HARMFUL IF SWALLOWED. |
|
|
| TARGET
ORGAN(S) OR SYSTEM(S) |
|
|
|
KIDNEYS. |
|
|
| SIGNS
AND SYMPTOMS OF EXPOSURE |
|
|
|
PROLONGED EXPOSURE CAN
CAUSE: NAUSEA, HEADACHE, AND
VOMITING. |
|
|
| TOXICITY
DATA |
|
|
|
SKIN |
|
|
|
RABBIT |
|
|
|
> 10,000 MG/KG |
|
|
|
LD50 |
|
|
|
ORAL |
|
|
|
RAT |
|
|
|
* |
|
|
|
LD50 |
|
|
|
INHALATION |
|
|
|
RAT |
|
|
|
> 4 MG/KG |
|
|
|
LC50 |
|
|
|
ORAL |
|
|
|
RAT |
|
|
|
12600 MG/KG |
|
|
|
LD50 |
|
|
|
REMARKS: BEHAVIORAL: GENERAL ANESTHETIC. BEHAVIORAL: MUSCLE |
|
|
|
WEAKNESS. LIVER: OTHER CHANGES. |
|
|
|
INHALATION |
|
|
|
RAT |
|
|
|
> 570 MG/M3 |
|
|
|
LC50 |
|
|
|
INTRAPERITONEAL |
|
|
|
RAT |
|
|
|
4420 MG/KG |
|
|
|
LD50 |
|
|
|
REMARKS: BEHAVIORAL: TOXIC PSYCHOSIS. CARDIAC: OTHER CHANGES. |
|
|
|
KIDNEY, URETER,
BLADDER: OTHER CHANGES. |
|
|
|
SUBCUTANEOUS |
|
|
|
RAT |
|
|
|
100 MG/KG |
|
|
|
LD50 |
|
|
|
INTRAVENOUS |
|
|
|
RAT |
|
|
|
5566 MG/KG |
|
|
|
LD50 |
|
|
|
ORAL |
|
|
|
MOUSE |
|
|
|
4090 MG/KG |
|
|
|
LD50 |
|
|
|
INTRAPERITONEAL |
|
|
|
MOUSE |
|
|
|
8700 MG/KG |
|
|
|
LD50 |
|
|
|
REMARKS: BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN |
|
|
|
RIGHTING REFLEX). |
|
|
|
SUBCUTANEOUS |
|
|
|
MOUSE |
|
|
|
91 MG/KG |
|
|
|
LD50 |
|
|
|
INTRAVENOUS |
|
|
|
MOUSE |
|
|
|
4250 MG/KG |
|
|
|
LD50 |
|
|
|
ORAL |
|
|
|
RABBIT |
|
|
|
27000 MG/KG |
|
|
|
LD50 |
|
|
|
SKIN |
|
|
|
RABBIT |
|
|
|
> 10000 MG/KG |
|
|
|
LD50 |
|
|
|
INTRAVENOUS |
|
|
|
RABBIT |
|
|
|
53 GM/KG |
|
|
|
LD50 |
|
|
|
ORAL |
|
|
|
GUINEA PIG |
|
|
|
7750 MG/KG |
|
|
|
LD50 |
|
|
|
IRRITATION DATA |
|
|
|
SKIN |
|
|
|
RABBIT |
|
|
|
500 MG |
|
|
|
24H |
|
|
|
REMARKS: MILD IRRITATION EFFECT |
|
|
|
EYES |
|
|
|
RABBIT |
|
|
|
126 MG |
|
|
|
REMARKS: MILD IRRITATION EFFECT |
|
|
|
EYES |
|
|
|
RABBIT |
|
|
|
500 MG |
|
|
|
24H |
|
|
|
REMARKS: MILD IRRITATION EFFECT |
|
|
|
CHRONIC EXPOSURE -
MUTAGEN |
|
|
|
SPECIES: HUMAN |
|
|
|
DOSE: 200 MMOL/L |
|
|
|
CELL TYPE: LYMPHOCYTE |
|
|
|
MUTATION TEST: DNA INHIBITION |
|
|
|
SPECIES: RAT |
|
|
|
ROUTE: ORAL |
|
|
|
DOSE: 1 GM/KG |
|
|
|
MUTATION TEST: CYTOGENETIC ANALYSIS |
|
|
|
CHRONIC EXPOSURE -
REPRODUCTIVE HAZARD |
|
|
|
SPECIES: RAT |
|
|
|
DOSE: 100 MG/KG |
|
|
|
ROUTE OF
APPLICATION: ORAL |
|
|
|
EXPOSURE TIME: (1D MALE) |
|
|
|
RESULT: EFFECTS ON FERTILITY: POST-IMPLANTATION MORTALITY (E.G., |
|
|
|
DEAD AND/OR RESORBED
IMPLANTS PER TOTAL NUMBER OF IMPLANTS). |
|
|
|
SPECIES: RAT |
|
|
|
DOSE: 280 MG/KG |
|
|
|
ROUTE OF
APPLICATION: INTRATESTICULAR |
|
|
|
EXPOSURE TIME: (2D MALE) |
|
|
|
RESULT: PATERNAL EFFECTS: SPERMATOGENESIS (INCLUDING GENETIC |
|
|
|
MATERIAL, SPERM
MORPHOLOGY,MOTILITY, AND COUNT). PATERNAL |
|
|
|
EFFECTS: TESTES, EPIDIDYMIS, SPERM DUCT. |
|
|
|
SPECIES: RAT |
|
|
|
DOSE: 1600 MG/KG |
|
|
|
ROUTE OF
APPLICATION: INTRATESTICULAR |
|
|
|
EXPOSURE TIME: (1D MALE) |
|
|
|
RESULT: EFFECTS ON FERTILITY: MALE FERTILITY INDEX (E.G., # |
|
|
|
MALES IMPREGNATING
FEMALES PER # MALES EXPOSED TO FERTILE |
|
|
|
NONPREGNANT FEMALES). |
|
|
|
SPECIES: RAT |
|
|
|
DOSE: 862 MG/KG |
|
|
|
ROUTE OF
APPLICATION: INTRATESTICULAR |
|
|
|
EXPOSURE TIME: (1D MALE) |
|
|
|
RESULT: PATERNAL EFFECTS: SPERMATOGENESIS (INCLUDING GENETIC |
|
|
|
MATERIAL, SPERM
MORPHOLOGY,MOTILITY, AND COUNT). |
|
|
|
SPECIES: MONKEY |
|
|
|
DOSE: 119 MG/KG |
|
|
|
ROUTE OF
APPLICATION: INTRATESTICULAR |
|
|
|
EXPOSURE TIME: (1D MALE) |
|
|
|
RESULT: PATERNAL EFFECTS: SPERMATOGENESIS (INCLUDING GENETIC |
|
|
|
MATERIAL, SPERM
MORPHOLOGY,MOTILITY, AND COUNT). PATERNAL |
|
|
|
EFFECTS: TESTES, EPIDIDYMIS, SPERM DUCT. |
|
|
| SECTION
12. ECOLOGICAL INFORMATION |
|
|
|
NO DATA AVAILABLE. |
|
|
|
ACUTE ECOTOXICITY TESTS |
|
|
|
TEST TYPE: LC50 FISH |
|
|
|
SPECIES: OTHER FISH |
|
|
|
VALUE: > 100,100
MG/L |
|
|
|
TEST TYPE: LC50 FISH |
|
|
|
SPECIES: PIMEPHALES PROMELAS (FATHEAD MINNOW) |
|
|
|
VALUE: 44,000 MG/L |
|
|
|
TEST TYPE: LC50 FISH |
|
|
|
SPECIES: CARASSIUS AURATUS (GOLDFISH) |
|
|
|
VALUE: > 5,000
MG/L |
|
|
| SECTION
13. DISPOSAL CONSIDERATIONS |
|
|
|
APPROPRIATE METHOD OF
DISPOSAL OF SUBSTANCE OR PREPARATION |
|
|
|
CONTACT A LICENSED
PROFESSIONAL WASTE DISPOSAL SERVICE TO DISPOSE |
|
|
|
OF THIS MATERIAL.
DISSOLVE OR MIX THE MATERIAL WITH A COMBUSTIBLE |
|
|
|
SOLVENT AND BURN IN A
CHEMICAL INCINERATOR EQUIPPED WITH AN |
|
|
|
AFTERBURNER AND SCRUBBER.
OBSERVE ALL FEDERAL, STATE, AND LOCAL |
|
|
|
ENVIRONMENTAL
REGULATIONS. |
|
|
| SECTION
14. TRANSPORT INFORMATION |
|
|
|
CONTACT PROFOLDIN FOR
TRANSPORTATION INFORMATION. |
|
|
| SECTION 15. REGULATORY INFORMATION |
|
|
| EU
ADDITIONAL CLASSIFICATION |
|
|
|
S: 23 24/25 |
|
|
|
SAFETY STATEMENTS: DO NOT BREATHE VAPOR. AVOID CONTACT WITH
SKIN |
|
|
|
AND EYES. |
|
|
| US
CLASSIFICATION AND LABEL TEXT |
|
|
|
US STATEMENTS: CAUTION: AVOID CONTACT AND INHALATION. TARGET |
|
|
|
ORGAN(S): KIDNEYS. |
|
|
| UNITED
STATES REGULATORY INFORMATION |
|
|
|
SARA LISTED: NO |
|
|
|
TSCA INVENTORY ITEM: YES YES |
|
|
| CANADA
REGULATORY INFORMATION |
|
|
|
WHMIS
CLASSIFICATION: THIS PRODUCT HAS
BEEN CLASSIFIED IN |
|
|
|
ACCORDANCE WITH THE
HAZARD CRITERIA OF THE CPR, AND THE MSDS |
|
|
|
CONTAINS ALL THE
INFORMATION REQUIRED BY THE CPR. |
|
|
|
DSL: YES |
|
|
|
NDSL: NO |
|
|
| SECTION
16. OTHER INFORMATION |
|
|
|
THIS
PRODUCT IS FOR R&D USE ONLY. IT IS NOT FOR DRUG, HOUSEHOLD |
|
|
|
OR
OTHER USES. EMPLOYERS SHOULD USE THIS
INFORMATION ONLY AS A |
|
|
|
SUPPLEMENT
TO OTHER INFORMATION GATHERED BY THEM, AND SHOULD MAKE |
|
|
|
INDEPENDENT
JUDGEMENT OF SUITABILITY OF THIS INFORMATION TO ENSURE |
|
|
|
PROPER
USE AND PROTECT THE HEALTH AND SAFETY OF EMPLOYEES. THIS |
|
|
|
INFORMATION
IS FURNISHED WITHOUT WARRANTY, AND ANY USE OF THE |
|
|
|
PRODUCT
NOT IN CONFORMANCE WITH THIS MATERIAL SAFETY DATA SHEET, |
|
|
|
OR IN
COMBINATION WITH ANY OTHER PRODUCT OR PROCESS, IS THE |
|
|
|
RESPONSIBILITY
OF THE USER. THE ABOVE INFORMATION IS
BELIEVED |
|
|
|
TO
BE CORRECT BUT DOES NOT PURPORT TO BE ALL INCLUSIVE AND SHALL |
|
|
|
BE
USED ONLY AS A GUIDE. PROFOLDIN SHALL
NOT BE HELD LIABLE FOR |
|
|
|
ANY
DAMAG RESULTING FROM HANDLING OR FROM CONTACT WITH THE ABOVE |
|
|
|
PRODUCT. |
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| |
|
| SECTION 1. CHEMICAL IDENTIFICATION |
|
|
|
CATALOG #: SFC01-10, SFC01, SFC02, SFC03, SFC04,
SFC05, SFC06, SFC07, SFC08, SFC09, SFC10 |
|
|
|
|
PFC01, PFC02, PFC03,
PFC04, PFC05, PFC06, PFC07, PFC08, PFC09, PFC10 |
|
|
NAME: SEPHADEX |
|
|
| SECTION
2. COMPOSITION/INFORMATION ON
INGREDIENT |
|
|
|
SUBSTANCE NAME |
|
CAS # |
|
SARA |
|
|
|
PDX G.F. 25 (100-300) |
|
9041-35-4 |
|
NO |
|
|
| SECTION
3. HAZARDS IDENTIFICATION |
|
|
| HMIS
RATING |
|
|
|
HEALTH: 0 |
|
|
|
FLAMMABILITY: 0 |
|
|
|
REACTIVITY: 0 |
|
|
| NFPA
RATING |
|
|
|
HEALTH: 0 |
|
|
|
FLAMMABILITY: 0 |
|
|
|
REACTIVITY: 0 |
|
|
|
FOR
ADDITIONAL INFORMATION ON TOXICITY, PLEASE REFER TO SECTION 11. |
|
|
| SECTION
4. FIRST AID MEASURES |
|
|
| ORAL
EXPOSURE |
|
|
|
IF SWALLOWED, WASH OUT
MOUTH WITH WATER PROVIDED PERSON IS |
|
|
|
CONSCIOUS. CALL A
PHYSICIAN. |
|
|
| INHALATION
EXPOSURE |
|
|
|
IF INHALED, REMOVE TO
FRESH AIR. IF NOT BREATHING GIVE |
|
|
|
ARTIFICIAL RESPIRATION.
IF BREATHING IS DIFFICULT, GIVE OXYGEN. |
|
|
| DERMAL
EXPOSURE |
|
|
|
IN CASE OF CONTACT,
IMMEDIATELY WASH SKIN WITH SOAP AND COPIOUS |
|
|
|
AMOUNTS OF WATER. |
|
|
| EYE
EXPOSURE |
|
|
|
IN CASE OF CONTACT,
IMMEDIATELY FLUSH EYES WITH COPIOUS AMOUNTS |
|
|
|
OF WATER FOR AT LEAST 15
MINUTES. |
|
|
| SECTION
5. FIRE FIGHTING MEASURES |
|
|
|
FLASH POINT |
|
|
|
N/A |
|
|
|
AUTOIGNITION TEMP |
|
|
|
N/A |
|
|
|
FLAMMABILITY |
|
|
|
N/A |
|
|
|
EXTINGUISHING MEDIA |
|
|
|
SUITABLE: WATER SPRAY. CARBON DIOXIDE, DRY CHEMICAL
POWDER, OR |
|
|
|
APPROPRIATE FOAM. |
|
|
| FIREFIGHTING |
|
|
| PROTECTIVE
EQUIPMENT: WEAR SELF-CONTAINED
BREATHING APPARATUS |
|
|
|
AND PROTECTIVE CLOTHING
TO PREVENT CONTACT WITH SKIN AND EYES. |
|
|
|
SPECIFIC HAZARD(S): EMITS TOXIC FUMES UNDER FIRE CONDITIONS. |
|
|
| SECTION
6. ACCIDENTAL RELEASE MEASURES |
|
|
| PROCEDURE(S)
OF PERSONAL PRECAUTION(S) |
|
|
|
EXERCISE APPROPRIATE
PRECAUTIONS TO MINIMIZE DIRECT CONTACT WITH |
|
|
|
SKIN OR EYES AND PREVENT
INHALATION OF DUST. |
|
|
| METHODS
FOR CLEANING UP |
|
|
|
SWEEP UP, PLACE IN A BAG
AND HOLD FOR WASTE DISPOSAL. AVOID |
|
|
|
RAISING DUST. VENTILATE
AREA AND WASH SPILL SITE AFTER MATERIAL |
|
|
|
PICKUP IS COMPLETE. |
|
|
| SECTION
7. HANDLING AND STORAGE |
|
|
| HANDLING |
|
|
|
USER EXPOSURE: AVOID INHALATION. AVOID CONTACT WITH
EYES, SKIN, |
|
|
|
AND CLOTHING. AVOID
PROLONGED OR REPEATED EXPOSURE. |
|
|
| STORAGE |
|
|
|
SUITABLE: KEEP TIGHTLY CLOSED. STORE IN A COOL DRY
PLACE. |
|
|
|
SPECIAL REQUIREMENTS |
|
|
|
MOISTURE SENSITIVE. |
|
|
| SECTION
8. EXPOSURE CONTROLS / PPE |
|
|
| ENGINEERING
CONTROLS |
|
|
|
SAFETY SHOWER AND EYE
BATH. MECHANICAL EXHAUST REQUIRED. |
|
|
| PERSONAL
PROTECTIVE EQUIPMENT |
|
|
|
RESPIRATORY: GOVERNMENT APPROVED RESPIRATOR. |
|
|
|
HAND: COMPATIBLE CHEMICAL-RESISTANT GLOVES. |
|
|
|
EYE: CHEMICAL SAFETY GOGGLES. |
|
|
| GENERAL
HYGIENE MEASURES |
|
|
|
WASH THOROUGHLY AFTER
HANDLING. WASH CONTAMINATED CLOTHING BEFORE |
|
|
|
REUSE. |
|
|
| SECTION
9. PHYSICAL/CHEMICAL PROPERTIES |
|
|
| APPEARANCE
COLOR: WHITE |
|
|
|
FORM: POWDER |
|
|
| PROPERTY
VALUE AT TEMPERATURE OR PRESSURE |
|
|
|
MOLECULAR WEIGHT N/A |
|
|
|
PH N/A |
|
|
|
BP/BP RANGE N/A |
|
|
|
MP/MP RANGE N/A |
|
|
|
FREEZING POINT N/A |
|
|
|
VAPOR PRESSURE N/A |
|
|
|
VAPOR DENSITY N/A |
|
|
|
SATURATED VAPOR
CONC. N/A |
|
|
|
SG/DENSITY
N/A |
|
|
|
BULK DENSITY N/A |
|
|
|
ODOR THRESHOLD N/A |
|
|
|
VOLATILE% N/A |
|
|
|
VOC CONTENT N/A |
|
|
|
WATER CONTENT N/A |
|
|
|
SOLVENT CONTENT N/A |
|
|
|
EVAPORATION RATE N/A |
|
|
|
VISCOSITY N/A |
|
|
|
SURFACE TENSION N/A |
|
|
|
PARTITION
COEFFICIENT N/A |
|
|
|
DECOMPOSITION TEMP. N/A |
|
|
|
FLASH POINT N/A |
|
|
|
EXPLOSION LIMITS N/A |
|
|
|
FLAMMABILITY N/A |
|
|
|
AUTOIGNITION TEMP N/A |
|
|
|
REFRACTIVE INDEX N/A |
|
|
|
OPTICAL ROTATION N/A |
|
|
|
MISCELLANEOUS DATA N/A |
|
|
|
SOLUBILITY N/A |
|
|
|
N/A = NOT AVAILABLE |
|
|
| SECTION
10. STABILITY AND REACTIVITY |
|
|
| STABILITY |
|
|
|
CONDITIONS TO AVOID: MOISTURE. |
|
|
|
MATERIALS TO AVOID: STRONG OXIDIZING AGENTS. |
|
|
|
HAZARDOUS DECOMPOSITION
PRODUCTS |
|
|
|
HAZARDOUS DECOMPOSITION
PRODUCTS: CARBON MONOXIDE, CARBON
DIOXIDE. |
|
|
| HAZARDOUS
POLYMERIZATION |
|
|
|
HAZARDOUS
POLYMERIZATION: WILL NOT OCCUR |
|
|
| SECTION
11. TOXICOLOGICAL INFORMATION |
|
|
| ROUTE
OF EXPOSURE |
|
|
|
SKIN CONTACT: MAY CAUSE SKIN IRRITATION. |
|
|
|
SKIN ABSORPTION: MAY BE HARMFUL IF ABSORBED THROUGH THE
SKIN. |
|
|
|
EYE CONTACT: MAY CAUSE EYE IRRITATION. |
|
|
|
INHALATION: MAY BE HARMFUL IF INHALED. MATERIAL MAY
BE |
|
|
|
IRRITATING TO MUCOUS
MEMBRANES AND UPPER RESPIRATORY TRACT. |
|
|
|
INGESTION: MAY BE HARMFUL IF SWALLOWED. |
|
|
| SIGNS
AND SYMPTOMS OF EXPOSURE |
|
|
|
TO THE BEST OF OUR
KNOWLEDGE, THE CHEMICAL, PHYSICAL, AND |
|
|
|
TOXICOLOGICAL PROPERTIES
HAVE NOT BEEN THOROUGHLY INVESTIGATED. |
|
|
| SECTION
12. ECOLOGICAL INFORMATION |
|
|
|
NO DATA AVAILABLE. |
|
|
| SECTION
13. DISPOSAL CONSIDERATIONS |
|
|
|
APPROPRIATE METHOD OF
DISPOSAL OF SUBSTANCE OR PREPARATION |
|
|
|
DISSOLVE OR MIX THE
MATERIAL WITH A COMBUSTIBLE SOLVENT AND BURN |
|
|
|
IN A CHEMICAL INCINERATOR
EQUIPPED WITH AN AFTERBURNER AND |
|
|
|
SCRUBBER. OBSERVE ALL
FEDERAL, STATE, AND LOCAL ENVIRONMENTAL |
|
|
|
REGULATIONS. |
|
|
| SECTION
14. TRANSPORT INFORMATION |
|
|
|
CONTACT PROFOLDIN FOR
TRANSPORTATION INFORMATION. |
|
|
| SECTION 15. REGULATORY INFORMATION |
|
|
| EU
ADDITIONAL CLASSIFICATION |
|
|
|
S: 22 |
|
|
|
SAFETY STATEMENTS: DO NOT BREATHE DUST. |
|
|
| UNITED
STATES REGULATORY INFORMATION |
|
|
|
SARA LISTED: NO |
|
|
| CANADA
REGULATORY INFORMATION |
|
|
|
WHMIS
CLASSIFICATION: THIS PRODUCT HAS
BEEN CLASSIFIED IN |
|
|
|
ACCORDANCE WITH THE
HAZARD CRITERIA OF THE CPR, AND THE MSDS |
|
|
|
CONTAINS ALL THE
INFORMATION REQUIRED BY THE CPR. |
|
|
|
DSL: NO |
|
|
|
NDSL: NO |
|
|
| SECTION
16. OTHER INFORMATION |
|
|
|
THIS
PRODUCT IS FOR R&D USE ONLY. IT IS NOT FOR DRUG, HOUSEHOLD |
|
|
|
OR
OTHER USES. EMPLOYERS SHOULD USE THIS
INFORMATION ONLY AS A |
|
|
|
SUPPLEMENT
TO OTHER INFORMATION GATHERED BY THEM, AND SHOULD MAKE |
|
|
|
INDEPENDENT
JUDGEMENT OF SUITABILITY OF THIS INFORMATION TO ENSURE |
|
|
|
PROPER
USE AND PROTECT THE HEALTH AND SAFETY OF EMPLOYEES. THIS |
|
|
|
INFORMATION
IS FURNISHED WITHOUT WARRANTY, AND ANY USE OF THE |
|
|
|
PRODUCT
NOT IN CONFORMANCE WITH THIS MATERIAL SAFETY DATA SHEET, |
|
|
|
OR IN
COMBINATION WITH ANY OTHER PRODUCT OR PROCESS, IS THE |
|
|
|
RESPONSIBILITY
OF THE USER. THE ABOVE INFORMATION IS
BELIEVED |
|
|
|
TO
BE CORRECT BUT DOES NOT PURPORT TO BE ALL INCLUSIVE AND SHALL |
|
|
|
BE
USED ONLY AS A GUIDE. PROFOLDIN SHALL
NOT BE HELD LIABLE FOR |
|
|
|
ANY
DAMAG RESULTING FROM HANDLING OR FROM CONTACT WITH THE ABOVE |
|
|
|
PRODUCT. |
|
|
|
|
| SECTION 1. CHEMICAL IDENTIFICATION |
|
|
|
CATALOG #: SFC01-10, SFC01, SFC02, SFC03, SFC04,
SFC05, SFC06, SFC07, SFC08, SFC09, SFC10 |
|
|
|
|
PFC01, PFC02, PFC03,
PFC04, PFC05, PFC06, PFC07, PFC08, PFC09, PFC10 |
|
|
NAME: DIMETHYL SULFOXIDE |
|
|
|
REAGENT |
|
|
| SECTION
2. COMPOSITION/INFORMATION ON
INGREDIENT |
|
|
|
SUBSTANCE NAME |
|
CAS
# |
|
SARA |
|
|
|
DIMETHYL SULFOXIDE |
|
67-68-5 |
|
NO |
|
|
|
FORMULA: C2H6OS |
|
|
|
SYNONYMS A 10846 * DELTAN
* DEMESO * DEMASORB * DEMAVET * |
|
|
|
DEMSODROX * DERMASORB *
DIMETHYL SULFOXIDE * |
|
|
|
DIMETHYL SULPHOXIDE *
DIMEXIDE * |
|
|
|
DIPIRARTRIL-TROPICO *
DMS-70 * DMS-90 * DMSO * |
|
|
|
DOLICUR * DOMOSO *
DROMISOL * DURASORB * GAMASOL |
|
|
|
90 * HYADUR * INFILTRINA
* M 176 * METHANE, |
|
|
|
SULFINYLBIS- *
METHYLSULFINYLMETHANE * NSC-763 * |
|
|
|
RIMSO-50 * SOMIPRONT * SQ
9453 * |
|
|
|
SULFINYLBIS(METHANE) *
SYNTEXAN * TOPSYM |
|
|
|
RTECS NUMBER: PV6210000 |
|
|
| SECTION
3. HAZARDS IDENTIFICATION |
|
|
| EMERGENCY
OVERVIEW |
|
|
|
COMBUSTIBLE. READILY
ABSORBED THROUGH SKIN. TARGET ORGAN(S):
EYES. |
|
|
|
SKIN. |
|
|
| HMIS
RATING |
|
|
|
HEALTH: 0* |
|
|
|
FLAMMABILITY: 2 |
|
|
|
REACTIVITY: 1 |
|
|
| NFPA
RATING |
|
|
|
HEALTH: 0 |
|
|
|
FLAMMABILITY: 2 |
|
|
|
REACTIVITY: 1 |
|
|
|
*ADDITIONAL CHRONIC
HAZARDS PRESENT. |
|
|
|
FOR
ADDITIONAL INFORMATION ON TOXICITY, PLEASE REFER TO SECTION 11. |
|
|
| SECTION
4. FIRST AID MEASURES |
|
|
| ORAL
EXPOSURE |
|
|
|
IF SWALLOWED, WASH OUT
MOUTH WITH WATER PROVIDED PERSON IS |
|
|
|
CONSCIOUS. CALL A
PHYSICIAN. |
|
|
| INHALATION
EXPOSURE |
|
|
|
IF INHALED, REMOVE TO
FRESH AIR. IF NOT BREATHING GIVE |
|
|
|
ARTIFICIAL RESPIRATION.
IF BREATHING IS DIFFICULT, GIVE OXYGEN. |
|
|
| DERMAL
EXPOSURE |
|
|
|
IN CASE OF CONTACT,
IMMEDIATELY WASH SKIN WITH SOAP AND COPIOUS |
|
|
|
AMOUNTS OF WATER. |
|
|
| EYE
EXPOSURE |
|
|
|
IN CASE OF CONTACT,
IMMEDIATELY FLUSH EYES WITH COPIOUS AMOUNTS |
|
|
|
OF WATER FOR AT LEAST 15
MINUTES. |
|
|
| SECTION
5. FIRE FIGHTING MEASURES |
|
|
|
FLASH POINT |
|
|
|
188.6 °F 87 °C
METHOD: CLOSED CUP |
|
|
|
EXPLOSION LIMITS |
|
|
|
LOWER: 3.5 % UPPER: 42 % |
|
|
|
AUTOIGNITION TEMP |
|
|
|
301 °C |
|
|
|
FLAMMABILITY |
|
|
|
N/A |
|
|
|
EXTINGUISHING MEDIA |
|
|
|
SUITABLE: WATER SPRAY. CARBON DIOXIDE, DRY CHEMICAL
POWDER, OR |
|
|
|
APPROPRIATE FOAM. |
|
|
| FIREFIGHTING |
|
|
| PROTECTIVE
EQUIPMENT: WEAR SELF-CONTAINED
BREATHING APPARATUS |
|
|
|
AND PROTECTIVE CLOTHING
TO PREVENT CONTACT WITH SKIN AND EYES. |
|
|
|
SPECIFIC HAZARD(S): COMBUSTIBLE LIQUID. EMITS TOXIC FUMES
UNDER |
|
|
|
FIRE CONDITIONS. |
|
|
| SECTION
6. ACCIDENTAL RELEASE MEASURES |
|
|
|
PROCEDURE TO BE FOLLOWED
IN CASE OF LEAK OR SPILL |
|
|
|
EVACUATE AREA. |
|
|
| PROCEDURE(S)
OF PERSONAL PRECAUTION(S) |
|
|
|
WEAR RESPIRATOR, CHEMICAL
SAFETY GOGGLES, RUBBER BOOTS, AND |
|
|
|
HEAVY RUBBER GLOVES. |
|
|
| METHODS
FOR CLEANING UP |
|
|
|
COVER WITH DRY-LIME,
SAND, OR SODA ASH. PLACE IN COVERED |
|
|
|
CONTAINERS USING
NON-SPARKING TOOLS AND TRANSPORT OUTDOORS. |
|
|
|
VENTILATE AREA AND WASH
SPILL SITE AFTER MATERIAL PICKUP IS |
|
|
|
COMPLETE. |
|
|
|
ENVIRONMENTAL
PRECAUTION(S) |
|
|
|
AVOID CONTAMINATING
SEWERS AND WATERWAYS WITH THIS MATERIAL. |
|
|
| SECTION
7. HANDLING AND STORAGE |
|
|
| HANDLING |
|
|
|
USER EXPOSURE: DO NOT BREATHE VAPOR. AVOID CONTACT WITH
DMSO |
|
|
|
SOLUTIONS CONTAINING
TOXIC MATERIALS OR MATERIALS WITH UNKNOWN |
|
|
|
TOXICOLOGICAL PROPERTIES.
DIMETHYL SULFOXIDE IS READILY ABSORBED |
|
|
|
THROUGH SKIN AND MAY
CARRY SUCH MATERIALS INTO THE BODY. AVOID |
|
|
|
PROLONGED OR REPEATED
EXPOSURE. |
|
|
| STORAGE |
|
|
|
SUITABLE: STORE UNDER INERT GAS. KEEP TIGHTLY
CLOSED. KEEP AWAY |
|
|
|
FROM HEAT AND OPEN FLAME.
STORE IN A COOL DRY PLACE. |
|
|
|
SPECIAL REQUIREMENTS |
|
|
|
STORE UNDER INERT GAS.
HYGROSCOPIC. |
|
|
| SECTION
8. EXPOSURE CONTROLS / PPE |
|
|
| ENGINEERING
CONTROLS |
|
|
|
SAFETY SHOWER AND EYE
BATH. MECHANICAL EXHAUST REQUIRED. |
|
|
| PERSONAL
PROTECTIVE EQUIPMENT |
|
|
|
RESPIRATORY: GOVERNMENT APPROVED RESPIRATOR. |
|
|
|
HAND: COMPATIBLE CHEMICAL-RESISTANT GLOVES. |
|
|
|
EYE: CHEMICAL SAFETY GOGGLES. |
|
|
|
SKIN-SPECIFIC: CHEMICAL RESISTANT APRON. |
|
|
| GENERAL
HYGIENE MEASURES |
|
|
|
WASH CONTAMINATED
CLOTHING BEFORE REUSE. WASH THOROUGHLY AFTER |
|
|
| HANDLING. |
|
|
| SECTION
9. PHYSICAL/CHEMICAL PROPERTIES |
|
|
| APPEARANCE
PHYSICAL STATE: CLEAR LIQUID |
|
|
|
COLOR: COLORLESS |
|
|
| PROPERTY
VALUE AT TEMPERATURE OR PRESSURE |
|
|
|
MOLECULAR WEIGHT 78.13 AMU |
|
|
|
PH N/A |
|
|
|
BP/BP RANGE 189 °C |
|
|
|
MP/MP RANGE 18.4
°C |
|
|
|
FREEZING POINT N/A |
|
|
|
VAPOR PRESSURE 0.42 MMHG
20 °C |
|
|
|
VAPOR DENSITY 2.7 G/L |
|
|
|
SATURATED VAPOR
CONC. N/A |
|
|
|
SG/DENSITY 1.1 G/CM3 |
|
|
|
BULK DENSITY N/A |
|
|
|
ODOR THRESHOLD N/A |
|
|
|
VOLATILE% N/A |
|
|
|
VOC CONTENT N/A |
|
|
|
WATER CONTENT N/A |
|
|
|
SOLVENT CONTENT N/A |
|
|
|
EVAPORATION RATE N/A |
|
|
|
VISCOSITY 0.002 PAS 20 °C |
|
|
|
SURFACE TENSION N/A |
|
|
|
PARTITION COEFFICIENT LOG
KOW: -2.03 |
|
|
|
DECOMPOSITION TEMP. >
190 °C |
|
|
|
FLASH POINT 188.6 °F 87
°C METHOD: CLOSED CUP |
|
|
|
EXPLOSION LIMITS
LOWER: 3.5 % |
|
|
|
UPPER: 42 % |
|
|
|
FLAMMABILITY N/A |
|
|
|
AUTOIGNITION TEMP 301 °C |
|
|
|
REFRACTIVE INDEX 1.479 |
|
|
|
OPTICAL ROTATION N/A |
|
|
|
MISCELLANEOUS DATA N/A |
|
|
|
SOLUBILITY SOLUBILITY IN
WATER: MISCIBLE. |
|
|
|
OTHER SOLVENTS: ALCOHOLS, ETHYL ETHERS |
|
|
|
N/A = NOT AVAILABLE |
|
|
| SECTION
10. STABILITY AND REACTIVITY |
|
|
| STABILITY |
|
|
|
STABLE: STABLE. |
|
|
|
CONDITIONS TO AVOID: MOISTURE. |
|
|
|
MATERIALS TO AVOID: ACID CHLORIDES, PHOSPHORUS HALIDES,
STRONG |
|
|
|
ACIDS, STRONG OXIDIZING
AGENTS, STRONG REDUCING AGENTS. |
|
|
|
HAZARDOUS DECOMPOSITION
PRODUCTS |
|
|
|
HAZARDOUS DECOMPOSITION
PRODUCTS: CARBON MONOXIDE, CARBON
DIOXIDE, |
|
|
|
SULFUR OXIDES. |
|
|
|
HAZARDOUS EXOTHERMIC
REACTIONS |
|
|
|
HAZARDOUS EXOTHERMIC
REACTIONS: METHYL SULFOXIDE (DMSO)
UNDERGOES |
|
|
|
A VIOLENT EXOTHERMIC
REACTION ON MIXING WITH COPPER WOOL AND |
|
|
|
TRICHLOROACETIC ACID. ON
MIXING WITH POTASSIUM PERMANGANATE IT |
|
|
|
WILL FLASH
INSTANTANEOUSLY. IT REACTS VIOLENTLY WITH:
ACID |
|
|
|
HALIDES, CYANURIC
CHLORIDE, SILICON TETRACHLORIDE, PHOSPHORUS |
|
|
|
TRICHLORIDE AND TRIOXIDE,
THIONYL CHLORIDE, MAGNESIUM PERCHLORATE, |
|
|
|
SILVER FLUORIDE, METHYL
BROMIDE, IODINE PENTAFLUORIDE, NITROGEN |
|
|
|
PERIODATE, DIBORANE,
SODIUM HYDRIDE, AND PERCHLORIC AND PERIODIC |
|
|
|
ACIDS. WHEN HEATED ABOVE
ITS BOILING POINT METHYL SULFOXIDE |
|
|
|
DEGRADES GIVING OFF
FORMALDEHYDE, METHYL MERCAPTAN, AND SULFUR |
|
|
|
DIOXIDE. |
|
|
| HAZARDOUS
POLYMERIZATION |
|
|
|
HAZARDOUS
POLYMERIZATION: WILL NOT OCCUR |
|
|
| SECTION
11. TOXICOLOGICAL INFORMATION |
|
|
| ROUTE
OF EXPOSURE |
|
|
|
SKIN CONTACT: MAY CAUSE SKIN IRRITATION. |
|
|
|
SKIN ABSORPTION: MAY BE HARMFUL IF ABSORBED THROUGH THE
SKIN. |
|
|
|
READILY ABSORBED THROUGH
SKIN. |
|
|
|
EYE CONTACT: MAY CAUSE EYE IRRITATION. |
|
|
|
INHALATION: MATERIAL MAY BE IRRITATING TO MUCOUS
MEMBRANES AND |
|
|
|
UPPER RESPIRATORY TRACT.
MAY BE HARMFUL IF INHALED. |
|
|
|
INGESTION: MAY BE HARMFUL IF SWALLOWED. |
|
|
| TARGET
ORGAN(S) OR SYSTEM(S) |
|
|
|
EYES. SKIN. |
|
|
|
CONDITIONS AGGRAVATED BY
EXPOSURE |
|
|
|
AVOID CONTACT WITH DMSO
SOLUTIONS CONTAINING TOXIC MATERIALS OR |
|
|
|
MATERIALS WITH UNKNOWN
TOXICOLOGICAL PROPERTIES. DIMETHYL |
|
|
|
SULFOXIDE IS READILY
ABSORBED THROUGH SKIN AND MAY CARRY SUCH |
|
|
|
MATERIALS INTO THE BODY. |
|
|
| TOXICITY
DATA |
|
|
|
INHALATION |
|
|
|
RAT |
|
|
|
40,250 PPM |
|
|
|
LC50 |
|
|
|
ORAL |
|
|
|
RAT |
|
|
|
3,300 MG/KG |
|
|
|
LD50 |
|
|
|
SKIN |
|
|
|
RABBIT |
|
|
|
> 5,000 MG/KG |
|
|
|
LD50 |
|
|
|
ORAL |
|
|
|
RAT |
|
|
|
14500 MG/KG |
|
|
|
LD50 |
|
|
|
REMARKS: SENSE ORGANS AND SPECIAL SENSES (NOSE,
EYE, EAR, AND |
|
|
|
TASTE): EYE:
HEMORRHAGE. SENSE ORGANS AND SPECIAL SENSES (NOSE, |
|
|
|
EYE, EAR, AND
TASTE): EYE: CONJUNCTIVE IRRITATION. |
|
|
|
SKIN |
|
|
|
RAT |
|
|
|
40000 MG/KG |
|
|
|
LD50 |
|
|
|
INTRAPERITONEAL |
|
|
|
RAT |
|
|
|
8200 MG/KG |
|
|
|
LD50 |
|
|
|
SUBCUTANEOUS |
|
|
|
RAT |
|
|
|
12 GM/KG |
|
|
|
LD50 |
|
|
|
REMARKS: BEHAVIORAL: CHANGE IN MOTOR ACTIVITY (SPECIFIC ASSAY). |
|
|
|
LUNGS, THORAX, OR
RESPIRATION: DYSPNEA. |
|
|
|
INTRAVENOUS |
|
|
|
RAT |
|
|
|
5360 MG/KG |
|
|
|
LD50 |
|
|
|
REMARKS: BEHAVIORAL: TREMOR. BEHAVIORAL: MUSCLE WEAKNESS. LUNGS, |
|
|
|
THORAX, OR
RESPIRATION: DYSPNEA. |
|
|
|
ORAL |
|
|
|
MOUSE |
|
|
|
7920 MG/KG |
|
|
|
LD50 |
|
|
|
SKIN |
|
|
|
MOUSE |
|
|
|
50000 MG/KG |
|
|
|
LD50 |
|
|
|
INTRAPERITONEAL |
|
|
|
MOUSE |
|
|
|
2500 MG/KG |
|
|
|
LD50 |
|
|
|
SUBCUTANEOUS |
|
|
|
MOUSE |
|
|
|
14 GM/KG |
|
|
|
LD50 |
|
|
|
REMARKS: BEHAVIORAL: CHANGE IN MOTOR ACTIVITY (SPECIFIC ASSAY). |
|
|
|
LUNGS, THORAX, OR
RESPIRATION: OTHER CHANGES. KIDNEY,
URETER, |
|
|
|
BLADDER: HEMATURIA. |
|
|
|
INTRAVENOUS |
|
|
|
MOUSE |
|
|
|
3100 MG/KG |
|
|
|
LD50 |
|
|
|
REMARKS: SENSE ORGANS AND SPECIAL SENSES (NOSE,
EYE, EAR, AND |
|
|
|
TASTE): EYE:
HEMORRHAGE. SENSE ORGANS AND SPECIAL SENSES (NOSE, |
|
|
|
EYE, EAR, AND
TASTE): EYE: CONJUNCTIVE IRRITATION. |
|
|
|
ORAL |
|
|
|
DOG |
|
|
|
> 10000 MG/KG |
|
|
|
LD50 |
|
|
|
INTRAVENOUS |
|
|
|
DOG |
|
|
|
2500 MG/KG |
|
|
|
LD50 |
|
|
|
REMARKS: CARDIAC:
OTHER CHANGES. KIDNEY, URETER, |
|
|
|
BLADDER: HEMATURIA. KIDNEY, URETER, BLADDER: OTHER CHANGES. |
|
|
|
ORAL |
|
|
|
CHICKEN |
|
|
|
12000 MG/KG |
|
|
|
LD50 |
|
|
|
ORAL |
|
|
|
MAMMAL |
|
|
|
21400 MG/KG |
|
|
|
LD50 |
|
|
|
ORAL |
|
|
|
BIRD (WILD) |
|
|
|
100 MG/KG |
|
|
|
LD50 |
|
|
|
IRRITATION DATA |
|
|
|
SKIN |
|
|
|
RABBIT |
|
|
|
4 HOURS |
|
|
|
REMARKS: NO IRRITATION EFFECT |
|
|
|
EYES |
|
|
|
RABBIT |
|
|
|
REMARKS: MILD IRRITATION EFFECT |
|
|
|
SKIN |
|
|
|
RABBIT |
|
|
|
10 MG |
|
|
|
24H |
|
|
|
REMARKS: OPEN IRRITATION TEST |
|
|
|
SKIN |
|
|
|
RABBIT |
|
|
|
500 MG |
|
|
|
24H |
|
|
|
REMARKS: MILD IRRITATION EFFECT |
|
|
|
EYES |
|
|
|
RABBIT |
|
|
|
100 MG |
|
|
|
EYES |
|
|
|
RABBIT |
|
|
|
500 MG |
|
|
|
24H |
|
|
|
REMARKS: MILD IRRITATION EFFECT |
|
|
|
CHRONIC EXPOSURE -
CARCINOGEN |
|
|
|
SPECIES: RAT |
|
|
|
ROUTE OF
APPLICATION: ORAL |
|
|
|
DOSE: 59 GM/KG |
|
|
|
EXPOSURE TIME: 81W |
|
|
|
FREQUENCY: I |
|
|
|
RESULT: TUMORIGENIC: EQUIVOCAL TUMORIGENIC AGENT BY RTECS |
|
|
|
CRITERIA. SKIN AND
APPENDAGES: OTHER: TUMORS. |
|
|
|
SPECIES: RAT |
|
|
|
ROUTE OF
APPLICATION: SUBCUTANEOUS |
|
|
|
DOSE: 220 GM/KG |
|
|
|
EXPOSURE TIME: 82W |
|
|
|
FREQUENCY: I |
|
|
|
RESULT: TUMORIGENIC: EQUIVOCAL TUMORIGENIC AGENT BY RTECS |
|
|
|
CRITERIA. SKIN AND
APPENDAGES: OTHER: TUMORS. |
|
|
|
SPECIES: MOUSE |
|
|
|
ROUTE OF
APPLICATION: ORAL |
|
|
|
DOSE: 65340 MG/KG |
|
|
|
EXPOSURE TIME: 66W |
|
|
|
FREQUENCY: I |
|
|
|
RESULT: TUMORIGENIC: EQUIVOCAL TUMORIGENIC AGENT BY RTECS |
|
|
|
CRITERIA. BLOOD: LEUKEMIA SKIN AND APPENDAGES: OTHER:
TUMORS. |
|
|
|
SPECIES: MOUSE |
|
|
|
ROUTE OF
APPLICATION: SUBCUTANEOUS |
|
|
|
DOSE: 66 GM/KG |
|
|
|
EXPOSURE TIME: 66W |
|
|
|
FREQUENCY: I |
|
|
|
RESULT: TUMORIGENIC: EQUIVOCAL TUMORIGENIC AGENT BY RTECS |
|
|
|
CRITERIA. LUNGS, THORAX,
OR RESPIRATION: TUMORS. SKIN AND |
|
|
|
APPENDAGES: OTHER:
TUMORS. |
|
|
|
CHRONIC EXPOSURE -
TERATOGEN |
|
|
|
SPECIES: MOUSE |
|
|
|
DOSE: 210 GM/KG |
|
|
|
ROUTE OF
APPLICATION: INTRAPERITONEAL |
|
|
|
EXPOSURE TIME: (6-12D PREG) |
|
|
|
RESULT: SPECIFIC DEVELOPMENTAL
ABNORMALITIES: CENTRAL NERVOUS |
|
|
|
SYSTEM. SPECIFIC
DEVELOPMENTAL ABNORMALITIES:
MUSCULOSKELETAL |
|
|
|
SYSTEM. |
|
|
|
SPECIES: MOUSE |
|
|
|
DOSE: 5500 MG/KG |
|
|
|
ROUTE OF
APPLICATION: INTRAPERITONEAL |
|
|
|
EXPOSURE TIME: (10D PREG) |
|
|
|
RESULT: EFFECTS ON EMBRYO OR FETUS: FETOTOXICITY (EXCEPT DEATH, |
|
|
|
E.G.,
STUNTED FETUS). SPECIFIC DEVELOPMENTAL ABNORMALITIES: |
|
|
|
MUSCULOSKELETAL SYSTEM. |
|
|
|
SPECIES: HAMSTER |
|
|
|
DOSE: 11 GM/KG |
|
|
|
ROUTE OF
APPLICATION: ORAL |
|
|
|
EXPOSURE TIME: (7D PREG) |
|
|
|
RESULT: SPECIFIC DEVELOPMENTAL
ABNORMALITIES: CENTRAL NERVOUS |
|
|
|
SYSTEM. SPECIFIC
DEVELOPMENTAL ABNORMALITIES:
MUSCULOSKELETAL |
|
|
|
SYSTEM. |
|
|
|
SPECIES: HAMSTER |
|
|
|
DOSE: 5500 MG/KG |
|
|
|
ROUTE OF
APPLICATION: INTRAPERITONEAL |
|
|
|
EXPOSURE TIME: (8D PREG) |
|
|
|
RESULT: SPECIFIC DEVELOPMENTAL
ABNORMALITIES: MUSCULOSKELETAL |
|
|
|
SYSTEM. SPECIFIC
DEVELOPMENTAL ABNORMALITIES: CENTRAL
NERVOUS |
|
|
|
SYSTEM. SPECIFIC
DEVELOPMENTAL ABNORMALITIES:
CRANIOFACIAL |
|
|
|
(INCLUDING NOSE AND
TONGUE). |
|
|
|
SPECIES: HAMSTER |
|
|
|
DOSE: 4400 MG/KG |
|
|
|
ROUTE OF
APPLICATION: INTRAPERITONEAL |
|
|
|
EXPOSURE TIME: (8D PREG) |
|
|
|
RESULT: EFFECTS ON EMBRYO OR FETUS: FETAL DEATH. SPECIFIC |
|
|
|
DEVELOPMENTAL
ABNORMALITIES: CENTRAL NERVOUS
SYSTEM. |
|
|
|
SPECIES: HAMSTER |
|
|
|
DOSE: 2500 MG/KG |
|
|
|
ROUTE OF
APPLICATION: INTRAVENOUS |
|
|
|
EXPOSURE TIME: (8D PREG) |
|
|
|
RESULT: SPECIFIC DEVELOPMENTAL
ABNORMALITIES: CENTRAL NERVOUS |
|
|
|
SYSTEM. SPECIFIC
DEVELOPMENTAL ABNORMALITIES:
CRANIOFACIAL |
|
|
|
(INCLUDING NOSE AND
TONGUE). SPECIFIC DEVELOPMENTAL |
|
|
|
ABNORMALITIES: MUSCULOSKELETAL SYSTEM. |
|
|
|
SPECIES: HAMSTER |
|
|
|
DOSE: 2500 MG/KG |
|
|
|
ROUTE OF
APPLICATION: INTRAVENOUS |
|
|
|
EXPOSURE TIME: (8D PREG) |
|
|
|
RESULT: SPECIFIC DEVELOPMENTAL
ABNORMALITIES: OTHER |
|
|
|
DEVELOPMENTAL
ABNORMALITIES. |
|
|
|
CHRONIC EXPOSURE -
MUTAGEN |
|
|
|
SPECIES: HUMAN |
|
|
|
DOSE: 140 MMOL/L |
|
|
|
CELL TYPE: LYMPHOCYTE |
|
|
|
MUTATION TEST: OTHER MUTATION TEST SYSTEMS |
|
|
|
SPECIES: RAT |
|
|
|
ROUTE: INTRAPERITONEAL |
|
|
|
DOSE: 25 GM/KG |
|
|
|
EXPOSURE TIME: 5D |
|
|
|
MUTATION TEST: CYTOGENETIC ANALYSIS |
|
|
|
SPECIES: MOUSE |
|
|
|
ROUTE: INTRAPERITONEAL |
|
|
|
DOSE: 75 MMOL/KG |
|
|
|
MUTATION TEST: DNA DAMAGE |
|
|
|
SPECIES: MOUSE |
|
|
|
DOSE: 93 GM/L |
|
|
|
CELL TYPE: LYMPHOCYTE |
|
|
|
MUTATION TEST: CYTOGENETIC ANALYSIS |
|
|
|
SPECIES: MOUSE |
|
|
|
DOSE: 1 MOL/L |
|
|
|
CELL TYPE: LYMPHOCYTE |
|
|
|
MUTATION TEST: MUTATION IN MAMMALIAN SOMATIC CELLS. |
|
|
|
SPECIES: HAMSTER |
|
|
|
DOSE: 19 PPH |
|
|
|
CELL TYPE: OVARY |
|
|
|
MUTATION TEST: CYTOGENETIC ANALYSIS |
|
|
|
SPECIES: HAMSTER |
|
|
|
DOSE: 1 PPH |
|
|
|
CELL TYPE: LUNG |
|
|
|
MUTATION TEST: CYTOGENETIC ANALYSIS |
|
|
|
CHRONIC EXPOSURE -
REPRODUCTIVE HAZARD |
|
|
|
SPECIES: RAT |
|
|
|
DOSE: 56 GM/KG |
|
|
|
ROUTE OF
APPLICATION: INTRAPERITONEAL |
|
|
|
EXPOSURE TIME: (6-12D PREG) |
|
|
|
RESULT: EFFECTS ON FERTILITY: ABORTION. |
|
|
|
SPECIES: RAT |
|
|
|
DOSE: 6600 MG/KG |
|
|
|
ROUTE OF
APPLICATION: INTRAPERITONEAL |
|
|
|
EXPOSURE TIME: (7-15D PREG) |
|
|
|
RESULT: EFFECTS ON FERTILITY: POST-IMPLANTATION MORTALITY (E.G., |
|
|
|
DEAD AND/OR RESORBED
IMPLANTS PER TOTAL NUMBER OF IMPLANTS). |
|
|
|
SPECIES: RAT |
|
|
|
DOSE: 30750 MG/KG |
|
|
|
ROUTE OF
APPLICATION: SUBCUTANEOUS |
|
|
|
EXPOSURE TIME: (8-10D PREG) |
|
|
|
RESULT: EFFECTS ON FERTILITY: POST-IMPLANTATION MORTALITY (E.G., |
|
|
|
DEAD AND/OR RESORBED
IMPLANTS PER TOTAL NUMBER OF IMPLANTS). |
|
|
|
EFFECTS ON
FERTILITY: LITTER SIZE (E.G.; #
FETUSES PER LITTER; |
|
|
|
MEASURED BEFORE BIRTH). |
|
|
|
SPECIES: MOUSE |
|
|
|
DOSE: 16 MG/KG |
|
|
|
ROUTE OF
APPLICATION: ORAL |
|
|
|
EXPOSURE TIME: (5-9D PREG) |
|
|
|
RESULT: EFFECTS ON FERTILITY: PRE-IMPLANTATION MORTALITY (E.G., |
|
|
|
REDUCTION IN NUMBER OF
IMPLANTS PER FEMALE; TOTAL NUMBER OF |
|
|
|
IMPLANTS
PER CORPORA LUTEA). EFFECTS ON EMBRYO OR FETUS: |
|
|
|
FETOTOXICITY (EXCEPT
DEATH, E.G., STUNTED FETUS). SPECIFIC |
|
|
|
DEVELOPMENTAL
ABNORMALITIES: MUSCULOSKELETAL
SYSTEM. |
|
|
|
SPECIES: MOUSE |
|
|
|
DOSE: 8250 MG/KG |
|
|
|
ROUTE OF
APPLICATION: INTRAPERITONEAL |
|
|
|
EXPOSURE TIME: (10D PREG) |
|
|
|
RESULT: EFFECTS ON FERTILITY: POST-IMPLANTATION MORTALITY (E.G., |
|
|
|
DEAD AND/OR RESORBED
IMPLANTS PER TOTAL NUMBER OF IMPLANTS). |
|
|
|
SPECIES: MOUSE |
|
|
|
DOSE: 240 GM/KG |
|
|
|
ROUTE OF
APPLICATION: INTRAVENOUS |
|
|
|
EXPOSURE TIME: (1-20D PREG) |
|
|
|
RESULT: EFFECTS ON FERTILITY: POST-IMPLANTATION MORTALITY (E.G., |
|
|
|
DEAD AND/OR RESORBED
IMPLANTS PER TOTAL NUMBER OF IMPLANTS). |
|
|
| SECTION
12. ECOLOGICAL INFORMATION |
|
|
|
ACUTE ECOTOXICITY TESTS |
|
|
|
TEST TYPE: LC50 FISH |
|
|
|
SPECIES: ONCHORHYNCHUS MYKISS (RAINBOW TROUT) |
|
|
|
TIME: 96 H |
|
|
|
VALUE: 35,000 MG/L |
|
|
|
TEST TYPE: EC50 DAPHNIA |
|
|
|
SPECIES: DAPHNIA PULEX |
|
|
|
VALUE: 27,500 MG/L |
|
|
|
TEST TYPE: EC50 ALGAE |
|
|
|
SPECIES: LEPOMIS MACROCHIRUS (BLUEGILL) |
|
|
|
TIME: 96 H |
|
|
|
VALUE: > 400,000
MG/L |
|
|
|
TEST TYPE: LC50 FISH |
|
|
|
SPECIES: PIMEPHALES PROMELAS (FATHEAD MINNOW) |
|
|
|
TIME: 96 H |
|
|
|
VALUE: 34,000 MG/L |
|
|
| SECTION
13. DISPOSAL CONSIDERATIONS |
|
|
|
APPROPRIATE METHOD OF
DISPOSAL OF SUBSTANCE OR PREPARATION |
|
|
|
CONTACT A LICENSED
PROFESSIONAL WASTE DISPOSAL SERVICE TO DISPOSE |
|
|
|
OF THIS MATERIAL. THIS
COMBUSTIBLE MATERIAL MAY BE BURNED IN A |
|
|
|
CHEMICAL INCINERATOR
EQUIPPED WITH AN AFTERBURNER AND SCRUBBER. |
|
|
|
OBSERVE ALL FEDERAL,
STATE, AND LOCAL ENVIRONMENTAL REGULATIONS. |
|
|
| SECTION
14. TRANSPORT INFORMATION |
|
|
|
CONTACT PROFOLDIN FOR
TRANSPORTATION INFORMATION. |
|
|
| SECTION 15. REGULATORY INFORMATION |
|
|
| US
CLASSIFICATION AND LABEL TEXT |
|
|
|
US STATEMENTS: COMBUSTIBLE. READILY ABSORBED THROUGH
SKIN. |
|
|
| TARGET
ORGAN(S): EYES. SKIN. |
|
|
| UNITED
STATES REGULATORY INFORMATION |
|
|
|
SARA LISTED: NO |
|
|
|
TSCA INVENTORY ITEM: YES |
|
|
| CANADA
REGULATORY INFORMATION |
|
|
|
WHMIS
CLASSIFICATION: THIS PRODUCT HAS
BEEN CLASSIFIED IN |
|
|
|
ACCORDANCE WITH THE
HAZARD CRITERIA OF THE CPR, AND THE MSDS |
|
|
|
CONTAINS ALL THE
INFORMATION REQUIRED BY THE CPR. |
|
|
|
DSL: YES |
|
|
|
NDSL: NO |
|
|
| SECTION
16. OTHER INFORMATION |
|
|
|
THIS
PRODUCT IS FOR R&D USE ONLY. IT IS NOT FOR DRUG, HOUSEHOLD |
|
|
|
OR
OTHER USES. EMPLOYERS SHOULD USE THIS
INFORMATION ONLY AS A |
|
|
|
SUPPLEMENT
TO OTHER INFORMATION GATHERED BY THEM, AND SHOULD MAKE |
|
|
|
INDEPENDENT
JUDGEMENT OF SUITABILITY OF THIS INFORMATION TO ENSURE |
|
|
|
PROPER
USE AND PROTECT THE HEALTH AND SAFETY OF EMPLOYEES. THIS |
|
|
|
INFORMATION
IS FURNISHED WITHOUT WARRANTY, AND ANY USE OF THE |
|
|
|
PRODUCT
NOT IN CONFORMANCE WITH THIS MATERIAL SAFETY DATA SHEET, |
|
|
|
OR IN
COMBINATION WITH ANY OTHER PRODUCT OR PROCESS, IS THE |
|
|
|
RESPONSIBILITY
OF THE USER. THE ABOVE INFORMATION IS
BELIEVED |
|
|
|
TO
BE CORRECT BUT DOES NOT PURPORT TO BE ALL INCLUSIVE AND SHALL |
|
|
|
BE
USED ONLY AS A GUIDE. PROFOLDIN SHALL
NOT BE HELD LIABLE FOR |
|
|
|
ANY
DAMAG RESULTING FROM HANDLING OR FROM CONTACT WITH THE ABOVE |
|
|
|
PRODUCT. |
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| |
|
| SECTION 1. CHEMICAL IDENTIFICATION |
|
|
|
CATALOG #: SFC01-10, SFC01, SFC02, SFC03, SFC04,
SFC05, SFC06, SFC07, SFC08, SFC09, SFC10 |
|
|
|
|
PFC01, PFC02, PFC03,
PFC04, PFC05, PFC06, PFC07, PFC08, PFC09, PFC10 |
|
|
NAME: L-CYSTINE FREE |
|
|
|
PERFORMANCE CERTIFIED |
|
|
| SECTION
2. COMPOSITION/INFORMATION ON
INGREDIENT |
|
|
|
SUBSTANCE NAME |
|
CAS # |
|
SARA |
|
|
|
L-CYSTINE |
|
56-89-3 |
|
NO |
|
|
|
FORMULA: C6H12N2O4S2 |
|
|
|
SYNONYMS L-ALANINE,
3,3’-DITHIOBIS- * |
|
|
|
BIS(BETA-AMINO-BETA-CARBOXYETHYL)DISULFIDE
* |
|
|
|
CYSTEINE DISULFIDE *
L-CYSTEINE DISULFIDE * |
|
|
|
CYSTIN * L-CYSTIN *
CYSTINE ACID * (-)-CYSTINE * |
|
|
|
L-CYSTINE (9CI) *
1-CYSTINE * L-(-)-CYSTINE * |
|
|
|
BETA,BETA’-DIAMINO-BETA,BETA’-DICARBOXYDIETHYL |
|
|
|
DISULFIDE * DICYSTEINE * |
|
|
|
3,3’-DITHIOBIS(2-AMINOPROPANOIC
ACID) * |
|
|
|
(R-(R*,R*))-3,3’-DITHIOBIS(2-AMINOPROPANOIC
ACID) |
|
|
|
*
BETA,BETA’-DITHIODIALANINE * OXIDIZED |
|
|
|
L-CYSTEINE * PROPANOIC
ACID, |
|
|
|
3,3’-DITHIOBIS(2-AMINO-,
(R-(R*,R*))- |
|
|
|
RTECS NUMBER: HA2690000 |
|
|
| SECTION
3. HAZARDS IDENTIFICATION |
|
|
| HMIS
RATING |
|
|
|
HEALTH: 0 |
|
|
|
FLAMMABILITY: 0 |
|
|
|
REACTIVITY: 0 |
|
|
| NFPA
RATING |
|
|
|
HEALTH: 0 |
|
|
|
FLAMMABILITY: 0 |
|
|
|
REACTIVITY: 0 |
|
|
|
FOR
ADDITIONAL INFORMATION ON TOXICITY, PLEASE REFER TO SECTION 11. |
|
|
| SECTION
4. FIRST AID MEASURES |
|
|
| ORAL
EXPOSURE |
|
|
|
IF SWALLOWED, WASH OUT
MOUTH WITH WATER PROVIDED PERSON IS |
|
|
|
CONSCIOUS. CALL A
PHYSICIAN. |
|
|
| INHALATION
EXPOSURE |
|
|
|
IF INHALED, REMOVE TO
FRESH AIR. IF BREATHING BECOMES DIFFICULT, |
|
|
|
CALL A PHYSICIAN. |
|
|
| DERMAL
EXPOSURE |
|
|
|
IN CASE OF CONTACT,
IMMEDIATELY WASH SKIN WITH SOAP AND COPIOUS |
|
|
|
AMOUNTS OF WATER. |
|
|
| EYE
EXPOSURE |
|
|
|
IN CASE OF CONTACT WITH
EYES, FLUSH WITH COPIOUS AMOUNTS OF |
|
|
|
WATER FOR AT LEAST 15
MINUTES. ASSURE ADEQUATE FLUSHING BY |
|
|
|
SEPARATING THE EYELIDS
WITH FINGERS. CALL A PHYSICIAN. |
|
|
| SECTION
5. FIRE FIGHTING MEASURES |
|
|
|
FLASH POINT |
|
|
|
N/A |
|
|
|
AUTOIGNITION TEMP |
|
|
|
N/A |
|
|
|
FLAMMABILITY |
|
|
|
N/A |
|
|
|
EXTINGUISHING MEDIA |
|
|
|
SUITABLE: WATER SPRAY. CARBON DIOXIDE, DRY CHEMICAL
POWDER, OR |
|
|
|
APPROPRIATE FOAM. |
|
|
| FIREFIGHTING |
|
|
| PROTECTIVE
EQUIPMENT: WEAR SELF-CONTAINED
BREATHING APPARATUS |
|
|
|
AND PROTECTIVE CLOTHING
TO PREVENT CONTACT WITH SKIN AND EYES. |
|
|
|
SPECIFIC HAZARD(S): EMITS TOXIC FUMES UNDER FIRE CONDITIONS. |
|
|
| SECTION
6. ACCIDENTAL RELEASE MEASURES |
|
|
| PROCEDURE(S)
OF PERSONAL PRECAUTION(S) |
|
|
|
EXERCISE APPROPRIATE
PRECAUTIONS TO MINIMIZE DIRECT CONTACT WITH |
|
|
|
SKIN OR EYES AND PREVENT
INHALATION OF DUST. |
|
|
| METHODS
FOR CLEANING UP |
|
|
|
SWEEP UP, PLACE IN A BAG
AND HOLD FOR WASTE DISPOSAL. AVOID |
|
|
|
RAISING DUST. VENTILATE
AREA AND WASH SPILL SITE AFTER MATERIAL |
|
|
|
PICKUP IS COMPLETE. |
|
|
| SECTION
7. HANDLING AND STORAGE |
|
|
| HANDLING |
|
|
|
USER EXPOSURE: AVOID INHALATION. AVOID CONTACT WITH
EYES, SKIN, |
|
|
|
AND CLOTHING. AVOID
PROLONGED OR REPEATED EXPOSURE. |
|
|
| STORAGE |
|
|
|
SUITABLE: KEEP TIGHTLY CLOSED. |
|
|
| SECTION
8. EXPOSURE CONTROLS / PPE |
|
|
| ENGINEERING
CONTROLS |
|
|
|
SAFETY SHOWER AND EYE
BATH. MECHANICAL EXHAUST REQUIRED. |
|
|
| PERSONAL
PROTECTIVE EQUIPMENT |
|
|
|
RESPIRATORY: WEAR DUST MASK. |
|
|
|
HAND: PROTECTIVE GLOVES. |
|
|
|
EYE: CHEMICAL SAFETY GOGGLES. |
|
|
| GENERAL
HYGIENE MEASURES |
|
|
|
WASH THOROUGHLY AFTER
HANDLING. |
|
|
| SECTION
9. PHYSICAL/CHEMICAL PROPERTIES |
|
|
| APPEARANCE
PHYSICAL STATE: SOLID |
|
|
|
COLOR: WHITE |
|
|
|
FORM: POWDER |
|
|
| PROPERTY
VALUE AT TEMPERATURE OR PRESSURE |
|
|
|
MOLECULAR WEIGHT 240.3 AMU |
|
|
|
PH N/A |
|
|
|
BP/BP RANGE N/A |
|
|
|
MP/MP RANGE 240 °C |
|
|
|
FREEZING POINT N/A |
|
|
|
VAPOR PRESSURE N/A |
|
|
|
VAPOR DENSITY N/A |
|
|
|
SATURATED VAPOR
CONC. N/A |
|
|
|
SG/DENSITY
N/A |
|
|
|
BULK DENSITY N/A |
|
|
|
ODOR THRESHOLD N/A |
|
|
|
VOLATILE% N/A |
|
|
|
VOC CONTENT N/A |
|
|
|
WATER CONTENT N/A |
|
|
|
SOLVENT CONTENT N/A |
|
|
|
EVAPORATION RATE N/A |
|
|
|
VISCOSITY N/A |
|
|
|
SURFACE TENSION N/A |
|
|
|
PARTITION
COEFFICIENT N/A |
|
|
|
DECOMPOSITION TEMP. N/A |
|
|
|
FLASH POINT N/A |
|
|
|
EXPLOSION LIMITS N/A |
|
|
|
FLAMMABILITY N/A |
|
|
|
AUTOIGNITION TEMP N/A |
|
|
|
REFRACTIVE INDEX N/A |
|
|
|
OPTICAL ROTATION DEGREE
OF ROTATION: 10 G/L SOLVENT: 1 M HCL |
|
|
|
-259 219 (+/-5) |
|
|
|
MISCELLANEOUS DATA N/A |
|
|
|
SOLUBILITY SOLVENT: 0.2 M IN HCL 1.0 M, 20°C COMPLETE, |
|
|
|
COLORLESS |
|
|
|
N/A = NOT AVAILABLE |
|
|
| SECTION
10. STABILITY AND REACTIVITY |
|
|
| STABILITY |
|
|
|
STABLE: STABLE. |
|
|
|
MATERIALS TO AVOID: STRONG OXIDIZING AGENTS. |
|
|
|
HAZARDOUS DECOMPOSITION
PRODUCTS |
|
|
|
HAZARDOUS DECOMPOSITION
PRODUCTS: CARBON MONOXIDE, CARBON
DIOXIDE, |
|
|
|
NITROGEN OXIDES, SULFUR
OXIDES. |
|
|
| HAZARDOUS
POLYMERIZATION |
|
|
|
HAZARDOUS
POLYMERIZATION: WILL NOT OCCUR |
|
|
| ROUTE
OF EXPOSURE |
|
|
|
SKIN CONTACT: MAY CAUSE SKIN IRRITATION. |
|
|
|
SKIN ABSORPTION: MAY BE HARMFUL IF ABSORBED THROUGH THE
SKIN. |
|
|
|
EYE CONTACT: MAY CAUSE EYE IRRITATION. |
|
|
|
INHALATION: MAY BE HARMFUL IF INHALED. MATERIAL MAY
BE |
|
|
|
IRRITATING TO MUCOUS
MEMBRANES AND UPPER RESPIRATORY TRACT. |
|
|
|
INGESTION: MAY BE HARMFUL IF SWALLOWED. |
|
|
| SIGNS
AND SYMPTOMS OF EXPOSURE |
|
|
|
TO THE BEST OF OUR
KNOWLEDGE, THE CHEMICAL, PHYSICAL, AND |
|
|
|
TOXICOLOGICAL PROPERTIES
HAVE NOT BEEN THOROUGHLY INVESTIGATED. |
|
|
| TOXICITY
DATA |
|
|
|
INTRAPERITONEAL |
|
|
|
MOUSE |
|
|
|
>961 MG/KG |
|
|
|
LD50 |
|
|
| SECTION
12. ECOLOGICAL INFORMATION |
|
|
|
NO DATA AVAILABLE. |
|
|
| SECTION
13. DISPOSAL CONSIDERATIONS |
|
|
|
APPROPRIATE METHOD OF
DISPOSAL OF SUBSTANCE OR PREPARATION |
|
|
|
CONTACT A LICENSED
PROFESSIONAL WASTE DISPOSAL SERVICE TO DISPOSE |
|
|
|
OF THIS MATERIAL.
DISSOLVE OR MIX THE MATERIAL WITH A COMBUSTIBLE |
|
|
|
SOLVENT AND BURN IN A
CHEMICAL INCINERATOR EQUIPPED WITH AN |
|
|
|
AFTERBURNER AND SCRUBBER.
OBSERVE ALL FEDERAL, STATE, AND LOCAL |
|
|
|
ENVIRONMENTAL
REGULATIONS. |
|
|
| SECTION
14. TRANSPORT INFORMATION |
|
|
|
CONTACT PROFOLDIN FOR
TRANSPORTATION INFORMATION. |
|
|
| SECTION 15. REGULATORY INFORMATION |
|
|
| UNITED
STATES REGULATORY INFORMATION |
|
|
|
SARA LISTED: NO |
|
|
|
TSCA INVENTORY ITEM: YES |
|
|
| CANADA
REGULATORY INFORMATION |
|
|
|
WHMIS
CLASSIFICATION: THIS PRODUCT HAS
BEEN CLASSIFIED IN |
|
|
|
ACCORDANCE WITH THE
HAZARD CRITERIA OF THE CPR, AND THE MSDS |
|
|
|
CONTAINS ALL THE
INFORMATION REQUIRED BY THE CPR. |
|
|
|
DSL: YES |
|
|
|
NDSL: NO |
|
|
| SECTION
16. OTHER INFORMATION |
|
|
|
THIS
PRODUCT IS FOR R&D USE ONLY. IT IS NOT FOR DRUG, HOUSEHOLD |
|
|
|
OR
OTHER USES. EMPLOYERS SHOULD USE THIS
INFORMATION ONLY AS A |
|
|
|
SUPPLEMENT
TO OTHER INFORMATION GATHERED BY THEM, AND SHOULD MAKE |
|
|
|
INDEPENDENT
JUDGEMENT OF SUITABILITY OF THIS INFORMATION TO ENSURE |
|
|
|
PROPER
USE AND PROTECT THE HEALTH AND SAFETY OF EMPLOYEES. THIS |
|
|
|
INFORMATION
IS FURNISHED WITHOUT WARRANTY, AND ANY USE OF THE |
|
|
|
PRODUCT
NOT IN CONFORMANCE WITH THIS MATERIAL SAFETY DATA SHEET, |
|
|
|
OR IN
COMBINATION WITH ANY OTHER PRODUCT OR PROCESS, IS THE |
|
|
|
RESPONSIBILITY
OF THE USER. THE ABOVE INFORMATION IS
BELIEVED |
|
|
|
TO
BE CORRECT BUT DOES NOT PURPORT TO BE ALL INCLUSIVE AND SHALL |
|
|
|
BE
USED ONLY AS A GUIDE. PROFOLDIN SHALL
NOT BE HELD LIABLE FOR |
|
|
|
ANY
DAMAG RESULTING FROM HANDLING OR FROM CONTACT WITH THE ABOVE |
|
|
|
PRODUCT. |
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| |
|
| SECTION 1. CHEMICAL IDENTIFICATION |
|
|
|
CATALOG #: SFC01-10, SFC01, SFC02, SFC03, SFC04,
SFC05, SFC06, SFC07, SFC08, SFC09, SFC10 |
|
|
|
|
PFC01, PFC02, PFC03,
PFC04, PFC05, PFC06, PFC07, PFC08, PFC09, PFC10 |
|
|
NAME: L-CYSTEINE |
|
|
| SECTION
2. COMPOSITION/INFORMATION ON
INGREDIENT |
|
|
|
SUBSTANCE NAME |
|
CAS
# |
|
SARA |
|
|
|
L(+)-CYSTEINE |
|
52-90-4 |
|
NO |
|
|
|
FORMULA: C3H7NO2S |
|
|
|
SYNONYMS L-ALANINE,
3-MERCAPTO- * |
|
|
|
2-AMINO-3-MERCAPTOPROPIONIC
ACID * CYSTEIN * |
|
|
|
CYSTEINE * L-CYSTEINE
(9CI) * L-(+)-CYSTEINE * |
|
|
|
HALF-CYSTEINE *
BETA-MERCAPTOALANINE * NSC-8746 * |
|
|
|
THIOSERINE |
|
|
|
RTECS NUMBER: HA1600000 |
|
|
| SECTION
3. HAZARDS IDENTIFICATION |
|
|
| EMERGENCY
OVERVIEW |
|
|
|
HARMFUL. |
|
|
|
HARMFUL IF SWALLOWED. |
|
|
| HMIS
RATING |
|
|
|
HEALTH: 1 |
|
|
|
FLAMMABILITY: 0 |
|
|
|
REACTIVITY: 0 |
|
|
| NFPA
RATING |
|
|
|
HEALTH: 1 |
|
|
|
FLAMMABILITY: 0 |
|
|
|
REACTIVITY: 0 |
|
|
|
FOR
ADDITIONAL INFORMATION ON TOXICITY, PLEASE REFER TO SECTION 11. |
|
|
| SECTION
4. FIRST AID MEASURES |
|
|
| ORAL
EXPOSURE |
|
|
|
IF SWALLOWED, WASH OUT
MOUTH WITH WATER PROVIDED PERSON IS |
|
|
|
CONSCIOUS. CALL A
PHYSICIAN. |
|
|
| INHALATION
EXPOSURE |
|
|
|
IF INHALED, REMOVE TO
FRESH AIR. IF NOT BREATHING GIVE |
|
|
|
ARTIFICIAL RESPIRATION.
IF BREATHING IS DIFFICULT, GIVE OXYGEN. |
|
|
| DERMAL
EXPOSURE |
|
|
|
IN CASE OF SKIN CONTACT,
FLUSH WITH COPIOUS AMOUNTS OF WATER FOR |
|
|
|
AT LEAST 15 MINUTES.
REMOVE CONTAMINATED CLOTHING AND SHOES. |
|
|
|
CALL A PHYSICIAN. |
|
|
| EYE
EXPOSURE |
|
|
|
IN CASE OF CONTACT WITH
EYES, FLUSH WITH COPIOUS AMOUNTS OF |
|
|
|
WATER FOR AT LEAST 15
MINUTES. ASSURE ADEQUATE FLUSHING BY |
|
|
|
SEPARATING THE EYELIDS
WITH FINGERS. CALL A PHYSICIAN. |
|
|
| SECTION
5. FIRE FIGHTING MEASURES |
|
|
|
FLASH POINT |
|
|
|
N/A |
|
|
|
AUTOIGNITION TEMP |
|
|
|
N/A |
|
|
|
FLAMMABILITY |
|
|
|
N/A |
|
|
|
EXTINGUISHING MEDIA |
|
|
|
SUITABLE: WATER SPRAY. CARBON DIOXIDE, DRY CHEMICAL
POWDER, OR |
|
|
|
APPROPRIATE FOAM. |
|
|
| FIREFIGHTING |
|
|
| PROTECTIVE
EQUIPMENT: WEAR SELF-CONTAINED
BREATHING APPARATUS |
|
|
|
AND PROTECTIVE CLOTHING
TO PREVENT CONTACT WITH SKIN AND EYES. |
|
|
|
SPECIFIC HAZARD(S): EMITS TOXIC FUMES UNDER FIRE CONDITIONS. |
|
|
| SECTION
6. ACCIDENTAL RELEASE MEASURES |
|
|
|
PROCEDURE TO BE FOLLOWED
IN CASE OF LEAK OR SPILL |
|
|
|
EVACUATE AREA. |
|
|
| PROCEDURE(S)
OF PERSONAL PRECAUTION(S) |
|
|
|
WEAR SELF-CONTAINED
BREATHING APPARATUS, RUBBER BOOTS, AND HEAVY |
|
|
|
RUBBER GLOVES. |
|
|
| METHODS
FOR CLEANING UP |
|
|
|
SWEEP UP, PLACE IN A BAG
AND HOLD FOR WASTE DISPOSAL. AVOID |
|
|
|
RAISING DUST. VENTILATE
AREA AND WASH SPILL SITE AFTER MATERIAL |
|
|
|
PICKUP IS COMPLETE. |
|
|
| SECTION
7. HANDLING AND STORAGE |
|
|
| HANDLING |
|
|
|
USER EXPOSURE: DO NOT BREATHE DUST. AVOID CONTACT WITH
EYES, |
|
|
|
SKIN, AND CLOTHING. AVOID
PROLONGED OR REPEATED EXPOSURE. |
|
|
| STORAGE |
|
|
|
SUITABLE: KEEP TIGHTLY CLOSED. |
|
|
| SECTION
8. EXPOSURE CONTROLS / PPE |
|
|
| ENGINEERING
CONTROLS |
|
|
|
SAFETY SHOWER AND EYE
BATH. MECHANICAL EXHAUST REQUIRED. |
|
|
| PERSONAL
PROTECTIVE EQUIPMENT |
|
|
|
RESPIRATORY: GOVERNMENT APPROVED RESPIRATOR. |
|
|
|
HAND: COMPATIBLE CHEMICAL-RESISTANT GLOVES. |
|
|
|
EYE: CHEMICAL SAFETY GOGGLES. |
|
|
| GENERAL
HYGIENE MEASURES |
|
|
|
WASH THOROUGHLY AFTER
HANDLING. |
|
|
| SECTION
9. PHYSICAL/CHEMICAL PROPERTIES |
|
|
| APPEARANCE
PHYSICAL STATE: SOLID |
|
|
|
COLOR: COLORLESS |
|
|
|
FORM: FINE CRYSTALS |
|
|
| PROPERTY
VALUE AT TEMPERATURE OR PRESSURE |
|
|
|
MOLECULAR WEIGHT 121.16 AMU |
|
|
|
PH N/A |
|
|
|
BP/BP RANGE N/A |
|
|
|
MP/MP RANGE 220 °C |
|
|
|
FREEZING POINT N/A |
|
|
|
VAPOR PRESSURE N/A |
|
|
|
VAPOR DENSITY N/A |
|
|
|
SATURATED VAPOR
CONC. N/A |
|
|
|
SG/DENSITY
N/A |
|
|
|
BULK DENSITY N/A |
|
|
|
ODOR THRESHOLD N/A |
|
|
|
VOLATILE% N/A |
|
|
|
VOC CONTENT N/A |
|
|
|
WATER CONTENT N/A |
|
|
|
SOLVENT CONTENT N/A |
|
|
|
EVAPORATION RATE N/A |
|
|
|
VISCOSITY N/A |
|
|
|
SURFACE TENSION N/A |
|
|
|
PARTITION
COEFFICIENT N/A |
|
|
|
DECOMPOSITION TEMP. N/A |
|
|
|
FLASH POINT N/A |
|
|
|
EXPLOSION LIMITS N/A |
|
|
|
FLAMMABILITY N/A |
|
|
|
AUTOIGNITION TEMP N/A |
|
|
|
REFRACTIVE INDEX N/A |
|
|
|
OPTICAL ROTATION DEGREE
OF ROTATION: 50 G/L SOLVENT: 5 M HCL |
|
|
|
+9.8 - +7.6 (+/-0.5) |
|
|
|
MISCELLANEOUS DATA N/A |
|
|
|
SOLUBILITY SOLVENT: 1 M IN HCL 1 M, 20°C COMPLETE, |
|
|
|
COLORLESS |
|
|
|
N/A = NOT AVAILABLE |
|
|
| SECTION
10. STABILITY AND REACTIVITY |
|
|
| STABILITY |
|
|
|
STABLE: STABLE. |
|
|
|
MATERIALS TO AVOID: STRONG OXIDIZING AGENTS. |
|
|
|
HAZARDOUS DECOMPOSITION
PRODUCTS |
|
|
|
HAZARDOUS DECOMPOSITION
PRODUCTS: CARBON MONOXIDE, CARBON
DIOXIDE, |
|
|
|
NITROGEN OXIDES, SULFUR
OXIDES. |
|
|
| HAZARDOUS
POLYMERIZATION |
|
|
|
HAZARDOUS
POLYMERIZATION: WILL NOT OCCUR |
|
|
| SECTION
11. TOXICOLOGICAL INFORMATION |
|
|
| ROUTE
OF EXPOSURE |
|
|
|
SKIN CONTACT: MAY CAUSE SKIN IRRITATION. |
|
|
|
SKIN ABSORPTION: MAY BE HARMFUL IF ABSORBED THROUGH THE
SKIN. |
|
|
|
EYE CONTACT: MAY CAUSE EYE IRRITATION. |
|
|
|
INHALATION: MAY BE HARMFUL IF INHALED. MATERIAL MAY
BE |
|
|
|
IRRITATING TO MUCOUS
MEMBRANES AND UPPER RESPIRATORY TRACT. |
|
|
|
INGESTION: HARMFUL IF SWALLOWED. |
|
|
| SIGNS
AND SYMPTOMS OF EXPOSURE |
|
|
|
TO THE BEST OF OUR
KNOWLEDGE, THE CHEMICAL, PHYSICAL, AND |
|
|
|
TOXICOLOGICAL PROPERTIES
HAVE NOT BEEN THOROUGHLY INVESTIGATED. |
|
|
| TOXICITY
DATA |
|
|
|
ORAL |
|
|
|
RAT |
|
|
|
1890 MG/KG |
|
|
|
LD50 |
|
|
|
REMARKS: BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY). |
|
|
|
LUNGS, THORAX, OR
RESPIRATION: DYSPNEA. KIDNEY, URETER, |
|
|
|
BLADDER: OTHER CHANGES IN URINE COMPOSITION. |
|
|
|
INTRAPERITONEAL |
|
|
|
RAT |
|
|
|
1620 MG/KG |
|
|
|
LD50 |
|
|
|
REMARKS: BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY). |
|
|
|
BEHAVIORAL: ATAXIA. LUNGS, THORAX, OR
RESPIRATION: RESPIRATORY |
|
|
|
DEPRESSION. |
|
|
|
SUBCUTANEOUS |
|
|
|
RAT |
|
|
|
1550 MG/KG |
|
|
|
LD50 |
|
|
|
REMARKS: BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY). |
|
|
|
BEHAVIORAL: ATAXIA. LUNGS, THORAX, OR
RESPIRATION: RESPIRATORY |
|
|
|
DEPRESSION. |
|
|
|
INTRAVENOUS |
|
|
|
RAT |
|
|
|
1140 MG/KG |
|
|
|
LD50 |
|
|
|
ORAL |
|
|
|
MOUSE |
|
|
|
660 MG/KG |
|
|
|
LD50 |
|
|
|
INTRAPERITONEAL |
|
|
|
MOUSE |
|
|
|
1400 MG/KG |
|
|
|
LD50 |
|
|
|
REMARKS: BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY). |
|
|
|
BEHAVIORAL: ATAXIA. LUNGS, THORAX, OR
RESPIRATION: RESPIRATORY |
|
|
|
DEPRESSION. |
|
|
|
SUBCUTANEOUS |
|
|
|
MOUSE |
|
|
|
1360 MG/KG |
|
|
|
LD50 |
|
|
|
REMARKS: BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY). |
|
|
|
BEHAVIORAL: ATAXIA. LUNGS, THORAX, OR
RESPIRATION: RESPIRATORY |
|
|
|
DEPRESSION. |
|
|
|
INTRAVENOUS |
|
|
|
MOUSE |
|
|
|
1250 MG/KG |
|
|
|
LD50 |
|
|
|
CHRONIC EXPOSURE -
MUTAGEN |
|
|
|
SPECIES: HUMAN |
|
|
|
DOSE: 1 MMOL/L |
|
|
|
CELL TYPE: FIBROBLAST |
|
|
|
MUTATION TEST: UNSCHEDULED DNA SYNTHESIS |
|
|
|
SPECIES: HUMAN |
|
|
|
DOSE: 10 MG/L |
|
|
|
CELL TYPE: LYMPHOCYTE |
|
|
|
MUTATION TEST: SISTER CHROMATID EXCHANGE |
|
|
|
SPECIES: RAT |
|
|
|
DOSE: 1 MMOL/L |
|
|
|
CELL TYPE: LIVER |
|
|
|
MUTATION TEST: DNA INHIBITION |
|
|
|
SPECIES: HAMSTER |
|
|
|
DOSE: 1 MMOL/L |
|
|
|
CELL TYPE: OVARY |
|
|
|
MUTATION TEST: CYTOGENETIC ANALYSIS |
|
|
|
SPECIES: HAMSTER |
|
|
|
DOSE: 100 UMOL/L |
|
|
|
CELL TYPE: OVARY |
|
|
|
MUTATION TEST: SISTER CHROMATID EXCHANGE |
|
|
|
CHRONIC EXPOSURE -
REPRODUCTIVE HAZARD |
|
|
|
SPECIES: RAT |
|
|
|
DOSE: 100 MG/KG |
|
|
|
ROUTE OF
APPLICATION: INTRAPERITONEAL |
|
|
|
EXPOSURE TIME: (12D PREG) |
|
|
|
RESULT: EFFECTS ON FERTILITY: LITTER SIZE (E.G.; # FETUSES PER |
|
|
|
LITTER; MEASURED BEFORE
BIRTH). |
|
|
|
SPECIES: MOUSE |
|
|
|
DOSE: 3600 MG/KG |
|
|
|
ROUTE OF
APPLICATION: ORAL |
|
|
|
EXPOSURE TIME: (7-12D PREG) |
|
|
|
RESULT: EFFECTS ON NEWBORN: PHYSICAL. |
|
|
|
SPECIES: MOUSE |
|
|
|
DOSE: 27600 MG/KG |
|
|
|
ROUTE OF
APPLICATION: ORAL |
|
|
|
EXPOSURE TIME: (23D PRE) |
|
|
|
RESULT: MATERNAL EFFECTS: MENSTRUAL CYCLE CHANGES OR DISORDERS. |
|
|
|
SPECIES: MOUSE |
|
|
|
DOSE: 6 GM/KG |
|
|
|
ROUTE OF
APPLICATION: ORAL |
|
|
|
EXPOSURE TIME: (30D MALE) |
|
|
|
RESULT: PATERNAL EFFECTS: PROSTATE, SEMINAL VESSICLE, COWPER’S |
|
|
|
GLAND, ACCESSORY GLANDS. |
|
|
| SECTION
12. ECOLOGICAL INFORMATION |
|
|
|
NO DATA AVAILABLE. |
|
|
| SECTION
13. DISPOSAL CONSIDERATIONS |
|
|
|
APPROPRIATE METHOD OF
DISPOSAL OF SUBSTANCE OR PREPARATION |
|
|
|
CONTACT A LICENSED
PROFESSIONAL WASTE DISPOSAL SERVICE TO DISPOSE |
|
|
|
OF THIS MATERIAL.
DISSOLVE OR MIX THE MATERIAL WITH A COMBUSTIBLE |
|
|
|
SOLVENT AND BURN IN A
CHEMICAL INCINERATOR EQUIPPED WITH AN |
|
|
|
AFTERBURNER AND SCRUBBER.
OBSERVE ALL FEDERAL, STATE, AND LOCAL |
|
|
|
ENVIRONMENTAL
REGULATIONS. |
|
|
| SECTION
14. TRANSPORT INFORMATION |
|
|
|
CONTACT PROFOLDIN FOR
TRANSPORTATION INFORMATION. |
|
|
| SECTION 15. REGULATORY INFORMATION |
|
|
| EU
ADDITIONAL CLASSIFICATION |
|
|
|
SYMBOL OF DANGER: XN |
|
|
|
INDICATION OF
DANGER: HARMFUL. |
|
|
|
R: 22 |
|
|
|
RISK STATEMENTS: HARMFUL IF SWALLOWED. |
|
|
| US
CLASSIFICATION AND LABEL TEXT |
|
|
|
INDICATION OF
DANGER: HARMFUL. |
|
|
|
RISK STATEMENTS: HARMFUL IF SWALLOWED. |
|
|
| UNITED
STATES REGULATORY INFORMATION |
|
|
|
SARA LISTED: NO |
|
|
|
TSCA INVENTORY ITEM: YES |
|
|
| CANADA
REGULATORY INFORMATION |
|
|
|
WHMIS
CLASSIFICATION: THIS PRODUCT HAS
BEEN CLASSIFIED IN |
|
|
|
ACCORDANCE WITH THE
HAZARD CRITERIA OF THE CPR, AND THE MSDS |
|
|
|
CONTAINS ALL THE
INFORMATION REQUIRED BY THE CPR. |
|
|
|
DSL: YES |
|
|
|
NDSL: NO |
|
|
| SECTION
16. OTHER INFORMATION |
|
|
|
THIS
PRODUCT IS FOR R&D USE ONLY. IT IS NOT FOR DRUG, HOUSEHOLD |
|
|
|
OR
OTHER USES. EMPLOYERS SHOULD USE THIS
INFORMATION ONLY AS A |
|
|
|
SUPPLEMENT
TO OTHER INFORMATION GATHERED BY THEM, AND SHOULD MAKE |
|
|
|
INDEPENDENT
JUDGEMENT OF SUITABILITY OF THIS INFORMATION TO ENSURE |
|
|
|
PROPER
USE AND PROTECT THE HEALTH AND SAFETY OF EMPLOYEES. THIS |
|
|
|
INFORMATION
IS FURNISHED WITHOUT WARRANTY, AND ANY USE OF THE |
|
|
|
PRODUCT
NOT IN CONFORMANCE WITH THIS MATERIAL SAFETY DATA SHEET, |
|
|
|
OR IN
COMBINATION WITH ANY OTHER PRODUCT OR PROCESS, IS THE |
|
|
|
RESPONSIBILITY
OF THE USER. THE ABOVE INFORMATION IS
BELIEVED |
|
|
|
TO
BE CORRECT BUT DOES NOT PURPORT TO BE ALL INCLUSIVE AND SHALL |
|
|
|
BE
USED ONLY AS A GUIDE. PROFOLDIN SHALL
NOT BE HELD LIABLE FOR |
|
|
|
ANY
DAMAG RESULTING FROM HANDLING OR FROM CONTACT WITH THE ABOVE |
|
|
|
PRODUCT. |
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| |
|
| SECTION 1. CHEMICAL IDENTIFICATION |
|
|
|
CATALOG #: SFC01-10, SFC01, SFC02, SFC03, SFC04,
SFC05, SFC06, SFC07, SFC08, SFC09, SFC10 |
|
|
|
|
PFC01, PFC02, PFC03,
PFC04, PFC05, PFC06, PFC07, PFC08, PFC09, PFC10 |
|
|
NAME: POLYOXYETHYLENE 23 LAURYL ETHER |
|
|
| SECTION
2. COMPOSITION/INFORMATION ON
INGREDIENT |
|
|
|
SUBSTANCE NAME |
|
|
|
CAS
# |
SARA |
|
|
|
POLYOXYETHYLENE LAURYL ETHER |
|
9002-92-0 |
NO |
|
|
|
FORMULA: (C2H4O)NC12H26O |
|
|
|
SYNONYMS ALDOSPERSE L 9 *
ASK-010 * ATLAS G-2133 * ATLAS |
|
|
|
G-3705 * BASE LP 12 * BL
9 * BL 9EX * BRIJ 23 * |
|
|
|
BRIJ 30 * BRIJ 35 * BRIJ
30SP * CHIMIPAL AE 3 * |
|
|
|
CIMAGEL * DEHYDOL LS 4 *
DEPEG * DO 9 * |
|
|
|
DODECANOL, ETHOXYLATE *
DODECANOL-ETHYLENE OXIDE |
|
|
|
(9.5 MOLES) CONDENSATE *
DODECANOL, |
|
|
|
POLYETHOXYLATED * DODECYL
ALCOHOL, ETHOXYLATED * |
|
|
|
ALPHA-DODECYL-OMEGA-HYDROXY-POLYOXYETHYLENE
* |
|
|
|
DODECYL-POLYAETHYLENOXYD-AETHER
(GERMAN) * |
|
|
|
DODECYL
POLY(OXYETHYLENE)ETHER * DU PONT WK * |
|
|
|
EMAL 108 * EMALEX 715 *
EMULGEN 100 * EMULGEN 105 |
|
|
|
* EMULGEN 108 * EMULGEN
109 * EMULGEN 120 * |
|
|
|
EMULGEN 147 * EMULMIN L
500 * ETHAL LA-X * |
|
|
|
ETHOSPERSE LA-4 *
ETHOSPERSE LA 12 * ETHOSPERSE |
|
|
|
LA 23 * ETHOXYLATED
LAURYL ALCOHOL * G 3707 * G |
|
|
|
3711 * G-2130A *
HYDROXYPOLYETHOXYDODECANE * LA 7 |
|
|
|
* LA (ALCOHOL) * LANETTES
* LAURETH * LAURETH 9 * |
|
|
|
LAURETH 12 * LAURETH 23 *
LAUROMACROGOL * |
|
|
|
LAUROMACROGOL 400 *
LAURYL ALCOHOL, ETHOXYLATED * |
|
|
|
LAURYL POLYETHYLENE
GLYCOL ETHER * LAURYL |
|
|
|
POLY(OXYETHYLENE) ETHER *
LIPAL 4LA * LIPOCOL L-4 |
|
|
|
* LIPOCOL L 12 * LIPOCOL
L-23 * LUBROL 12A9 * |
|
|
|
LUBROL PX * MARLIPAL 1217
* MERGITAL LM 11 * |
|
|
|
NCI-C54875 * NEWCOL 1203
* NIKKOL BL * NIKKOL BL |
|
|
| SECTION
3. HAZARDS IDENTIFICATION |
|
|
| EMERGENCY
OVERVIEW |
|
|
|
HARMFUL. |
|
|
|
HARMFUL IF SWALLOWED.
IRRITATING TO SKIN. RISK OF SERIOUS DAMAGE |
|
|
|
TO EYES. |
|
|
| HMIS
RATING |
|
|
|
HEALTH: 2 |
|
|
|
FLAMMABILITY: 0 |
|
|
|
REACTIVITY: 0 |
|
|
| NFPA
RATING |
|
|
|
HEALTH: 2 |
|
|
|
FLAMMABILITY: 0 |
|
|
|
REACTIVITY: 0 |
|
|
|
FOR
ADDITIONAL INFORMATION ON TOXICITY, PLEASE REFER TO SECTION 11. |
|
|
| SECTION
4. FIRST AID MEASURES |
|
|
| ORAL
EXPOSURE |
|
|
|
IF SWALLOWED, WASH OUT
MOUTH WITH WATER PROVIDED PERSON IS |
|
|
|
CONSCIOUS. CALL A
PHYSICIAN. |
|
|
| INHALATION
EXPOSURE |
|
|
|
IF INHALED, REMOVE TO
FRESH AIR. IF NOT BREATHING GIVE |
|
|
|
ARTIFICIAL RESPIRATION.
IF BREATHING IS DIFFICULT, GIVE OXYGEN. |
|
|
| DERMAL
EXPOSURE |
|
|
|
IN CASE OF CONTACT,
IMMEDIATELY WASH SKIN WITH SOAP AND COPIOUS |
|
|
|
AMOUNTS OF WATER. |
|
|
| EYE
EXPOSURE |
|
|
|
IN CASE OF CONTACT,
IMMEDIATELY FLUSH EYES WITH COPIOUS AMOUNTS |
|
|
|
OF WATER FOR AT LEAST 15
MINUTES. |
|
|
| SECTION
5. FIRE FIGHTING MEASURES |
|
|
|
FLASH POINT |
|
|
|
235 °F 113 °C
METHOD: CLOSED CUP |
|
|
|
AUTOIGNITION TEMP |
|
|
|
N/A |
|
|
|
FLAMMABILITY |
|
|
|
N/A |
|
|
|
EXTINGUISHING MEDIA |
|
|
|
SUITABLE: WATER SPRAY. CARBON DIOXIDE, DRY CHEMICAL
POWDER, OR |
|
|
|
APPROPRIATE FOAM. |
|
|
| FIREFIGHTING |
|
|
| PROTECTIVE
EQUIPMENT: WEAR SELF-CONTAINED
BREATHING APPARATUS |
|
|
|
AND PROTECTIVE CLOTHING
TO PREVENT CONTACT WITH SKIN AND EYES. |
|
|
|
SPECIFIC HAZARD(S): EMITS TOXIC FUMES UNDER FIRE CONDITIONS. |
|
|
| SECTION
6. ACCIDENTAL RELEASE MEASURES |
|
|
| PROCEDURE(S)
OF PERSONAL PRECAUTION(S) |
|
|
|
WEAR RESPIRATOR, CHEMICAL
SAFETY GOGGLES, RUBBER BOOTS, AND |
|
|
|
HEAVY RUBBER GLOVES. |
|
|
| METHODS
FOR CLEANING UP |
|
|
|
ABSORB ON SAND OR
VERMICULITE AND PLACE IN CLOSED CONTAINERS FOR |
|
|
|
DISPOSAL. VENTILATE AREA
AND WASH SPILL SITE AFTER MATERIAL |
|
|
|
PICKUP IS COMPLETE. |
|
|
| SECTION
7. HANDLING AND STORAGE |
|
|
| HANDLING |
|
|
|
USER EXPOSURE: DO NOT BREATHE VAPOR. AVOID CONTACT WITH
EYES, |
|
|
|
SKIN, AND CLOTHING. AVOID
PROLONGED OR REPEATED EXPOSURE. |
|
|
| STORAGE |
|
|
|
SUITABLE: KEEP TIGHTLY CLOSED. |
|
|
| SECTION
8. EXPOSURE CONTROLS / PPE |
|
|
| ENGINEERING
CONTROLS |
|
|
|
MECHANICAL EXHAUST
REQUIRED. SAFETY SHOWER AND EYE BATH. |
|
|
| PERSONAL
PROTECTIVE EQUIPMENT |
|
|
|
RESPIRATORY: GOVERNMENT APPROVED RESPIRATOR. |
|
|
|
HAND: COMPATIBLE CHEMICAL-RESISTANT GLOVES. |
|
|
|
EYE: CHEMICAL SAFETY GOGGLES. |
|
|
| GENERAL
HYGIENE MEASURES |
|
|
|
WASH THOROUGHLY AFTER
HANDLING. |
|
|
| SECTION
9. PHYSICAL/CHEMICAL PROPERTIES |
|
|
| APPEARANCE
PHYSICAL STATE: SEMI-SOLID MELTING
TO A |
|
|
|
CLEAR COLORLESS LIQUID |
|
|
| PROPERTY
VALUE AT TEMPERATURE OR PRESSURE |
|
|
|
MOLECULAR WEIGHT N/A |
|
|
|
PH 5.5 - 7.5
CONCENTRATION: 100 G/L |
|
|
|
BP/BP RANGE 100 °C 760
MMHG |
|
|
|
MP/MP RANGE 41 - 45 °C |
|
|
|
FREEZING POINT N/A |
|
|
|
VAPOR PRESSURE < 1
MMHG 20 °C |
|
|
|
VAPOR DENSITY N/A |
|
|
|
SATURATED VAPOR
CONC. N/A |
|
|
|
SG/DENSITY
N/A |
|
|
|
BULK DENSITY N/A |
|
|
|
ODOR THRESHOLD N/A |
|
|
|
VOLATILE% N/A |
|
|
|
VOC CONTENT N/A |
|
|
|
WATER CONTENT N/A |
|
|
|
SOLVENT CONTENT N/A |
|
|
|
EVAPORATION RATE N/A |
|
|
|
VISCOSITY N/A |
|
|
|
SURFACE TENSION N/A |
|
|
|
PARTITION
COEFFICIENT N/A |
|
|
|
DECOMPOSITION TEMP. N/A |
|
|
|
FLASH POINT 235 °F 113 °C
METHOD: CLOSED CUP |
|
|
|
EXPLOSION LIMITS N/A |
|
|
|
FLAMMABILITY N/A |
|
|
|
AUTOIGNITION TEMP N/A |
|
|
|
REFRACTIVE INDEX N/A |
|
|
|
OPTICAL ROTATION N/A |
|
|
|
MISCELLANEOUS DATA N/A |
|
|
|
SOLUBILITY SOLUBILITY IN
WATER: SOLUBLE. |
|
|
|
N/A = NOT AVAILABLE |
|
|
| SECTION
10. STABILITY AND REACTIVITY |
|
|
| STABILITY |
|
|
|
STABLE: STABLE. |
|
|
|
MATERIALS TO AVOID: STRONG OXIDIZING AGENTS. |
|
|
|
HAZARDOUS DECOMPOSITION
PRODUCTS |
|
|
|
HAZARDOUS DECOMPOSITION
PRODUCTS: NATURE OF DECOMPOSITION
PRODUCTS |
|
|
|
NOT KNOWN. |
|
|
| HAZARDOUS
POLYMERIZATION |
|
|
|
HAZARDOUS
POLYMERIZATION: WILL NOT OCCUR |
|
|
| SECTION
11. TOXICOLOGICAL INFORMATION |
|
|
| ROUTE
OF EXPOSURE |
|
|
|
SKIN CONTACT: CAUSES SKIN IRRITATION. |
|
|
|
SKIN ABSORPTION: MAY BE HARMFUL IF ABSORBED THROUGH THE
SKIN. |
|
|
|
EYE CONTACT: CAUSES SEVERE EYE IRRITATION. |
|
|
|
INHALATION: MAY BE HARMFUL IF INHALED. MATERIAL MAY
BE |
|
|
|
IRRITATING TO MUCOUS
MEMBRANES AND UPPER RESPIRATORY TRACT. |
|
|
|
INGESTION: HARMFUL IF SWALLOWED. |
|
|
| SIGNS
AND SYMPTOMS OF EXPOSURE |
|
|
|
TO THE BEST OF OUR
KNOWLEDGE, THE CHEMICAL, PHYSICAL, AND |
|
|
|
TOXICOLOGICAL PROPERTIES
HAVE NOT BEEN THOROUGHLY INVESTIGATED. |
|
|
| TOXICITY
DATA |
|
|
|
ORAL |
|
|
|
RAT |
|
|
|
1000 MG/KG |
|
|
|
LD50 |
|
|
|
REMARKS: GASTROINTESTINAL: ULCERATION OR BLEEDING FROM STOMACH. |
|
|
|
GASTROINTESTINAL: OTHER CHANGES. LIVER: FATTY LIVER DEGENERATION. |
|
|
|
INTRAPERITONEAL |
|
|
|
RAT |
|
|
|
125 MG/KG |
|
|
|
LD50 |
|
|
|
REMARKS: GASTROINTESTINAL: OTHER CHANGES. |
|
|
|
SUBCUTANEOUS |
|
|
|
RAT |
|
|
|
953 MG/KG |
|
|
|
LD50 |
|
|
|
INTRAVENOUS |
|
|
|
RAT |
|
|
|
27 MG/KG |
|
|
|
LD50 |
|
|
|
ORAL |
|
|
|
MOUSE |
|
|
|
1170 MG/KG |
|
|
|
LD50 |
|
|
|
REMARKS: PERIPHERAL NERVE AND SENSATION: FLACCID PARALYSIS |
|
|
|
WITHOUT ANESTHESIA
(USUALLY NEUROMUSCULAR BLOCKAGE). |
|
|
|
BEHAVIORAL: CHANGE IN MOTOR ACTIVITY (SPECIFIC ASSAY).
LUNGS, |
|
|
|
THORAX, OR
RESPIRATION: OTHER CHANGES. |
|
|
|
INTRAPERITONEAL |
|
|
|
MOUSE |
|
|
|
160 MG/KG |
|
|
|
LD50 |
|
|
|
SUBCUTANEOUS |
|
|
|
MOUSE |
|
|
|
792300 UG/KG |
|
|
|
LD50 |
|
|
|
INTRAVENOUS |
|
|
|
MOUSE |
|
|
|
100 MG/KG |
|
|
|
LD50 |
|
|
|
INTRAVENOUS |
|
|
|
RABBIT |
|
|
|
36 MG/KG |
|
|
|
LD50 |
|
|
|
REMARKS: BEHAVIORAL: CHANGE IN MOTOR ACTIVITY (SPECIFIC ASSAY). |
|
|
|
LUNGS, THORAX, OR
RESPIRATION: OTHER CHANGES. KIDNEY,
URETER, |
|
|
|
BLADDER: HEMATURIA. |
|
|
|
PARENTERAL |
|
|
|
RABBIT |
|
|
|
>75 MG/KG |
|
|
|
LD50 |
|
|
|
INTRATRACHEAL |
|
|
|
RABBIT |
|
|
|
>15 MG/KG |
|
|
|
LD50 |
|
|
|
ORAL |
|
|
|
GUINEA PIG |
|
|
|
384 MG/KG |
|
|
|
LD50 |
|
|
|
REMARKS: PERIPHERAL NERVE AND SENSATION: FLACCID PARALYSIS |
|
|
|
WITHOUT ANESTHESIA
(USUALLY NEUROMUSCULAR BLOCKAGE). |
|
|
|
BEHAVIORAL: CHANGE IN MOTOR ACTIVITY (SPECIFIC ASSAY).
LUNGS, |
|
|
|
THORAX, OR
RESPIRATION: OTHER CHANGES. |
|
|
|
INTRAVENOUS |
|
|
|
GUINEA PIG |
|
|
|
38 MG/KG |
|
|
|
LD50 |
|
|
|
REMARKS: BEHAVIORAL: CHANGE IN MOTOR ACTIVITY (SPECIFIC ASSAY). |
|
|
|
LUNGS, THORAX, OR
RESPIRATION: OTHER CHANGES. KIDNEY,
URETER, |
|
|
|
BLADDER: HEMATURIA. |
|
|
|
IRRITATION DATA |
|
|
|
SKIN |
|
|
|
HUMAN |
|
|
|
6 MG |
|
|
|
3D |
|
|
|
I |
|
|
|
REMARKS: MODERATE IRRITATION EFFECT |
|
|
|
SKIN |
|
|
|
RABBIT |
|
|
|
500 MG |
|
|
|
24H |
|
|
|
REMARKS: MILD IRRITATION EFFECT |
|
|
|
SKIN |
|
|
|
RABBIT |
|
|
|
75 MG |
|
|
|
24H |
|
|
|
REMARKS: MILD IRRITATION EFFECT |
|
|
|
SKIN |
|
|
|
RABBIT |
|
|
|
500 MG |
|
|
|
24H |
|
|
|
REMARKS: MODERATE IRRITATION EFFECT |
|
|
|
EYES |
|
|
|
RABBIT |
|
|
|
100 MG |
|
|
|
EYES |
|
|
|
RABBIT |
|
|
|
0.75 MG |
|
|
|
24H |
|
|
|
REMARKS: SEVERE IRRITATION EFFECT |
|
|
| SECTION
12. ECOLOGICAL INFORMATION |
|
|
|
ACUTE ECOTOXICITY TESTS |
|
|
|
TEST TYPE: EC50 ALGAE |
|
|
|
SPECIES: SELENASTRUM CAPRICORNUTUM RESP. |
|
|
|
VALUE: 2 - 4 MG/L |
|
|
|
TEST TYPE: EC50 DAPHNIA |
|
|
|
SPECIES: DAPHNIA MAGNA |
|
|
|
TIME: 48 H |
|
|
|
VALUE: 4.78 - 7.580 MG/L |
|
|
|
TEST TYPE: LC50 FISH |
|
|
|
SPECIES: CYPRINUS CARPIO |
|
|
|
TIME: 96 H |
|
|
|
VALUE: 1.4 MG/L |
|
|
|
TEST TYPE: LC50 FISH |
|
|
|
SPECIES: OTHER FISH |
|
|
|
TIME: 96 H |
|
|
|
VALUE: 1.5 MG/L |
|
|
| SECTION
13. DISPOSAL CONSIDERATIONS |
|
|
|
APPROPRIATE METHOD OF
DISPOSAL OF SUBSTANCE OR PREPARATION |
|
|
|
CONTACT A LICENSED
PROFESSIONAL WASTE DISPOSAL SERVICE TO DISPOSE |
|
|
|
OF THIS MATERIAL.
DISSOLVE OR MIX THE MATERIAL WITH A COMBUSTIBLE |
|
|
|
SOLVENT AND BURN IN A
CHEMICAL INCINERATOR EQUIPPED WITH AN |
|
|
|
AFTERBURNER AND SCRUBBER.
OBSERVE ALL FEDERAL, STATE, AND LOCAL |
|
|
|
ENVIRONMENTAL
REGULATIONS. |
|
|
| SECTION
14. TRANSPORT INFORMATION |
|
|
|
CONTACT PROFOLDIN FOR
TRANSPORTATION INFORMATION. |
|
|
| SECTION 15. REGULATORY INFORMATION |
|
|
| EU
ADDITIONAL CLASSIFICATION |
|
|
|
SYMBOL OF DANGER: XN |
|
|
|
INDICATION OF
DANGER: HARMFUL. |
|
|
|
R: 22 38 41 |
|
|
|
RISK STATEMENTS: HARMFUL IF SWALLOWED. IRRITATING TO SKIN.
RISK |
|
|
|
OF SERIOUS DAMAGE TO
EYES. |
|
|
|
S: 26 36/37/39 |
|
|
|
SAFETY STATEMENTS: IN CASE OF CONTACT WITH EYES, RINSE |
|
|
|
IMMEDIATELY WITH PLENTY
OF WATER AND SEEK MEDICAL ADVICE. WEAR |
|
|
|
SUITABLE PROTECTIVE
CLOTHING, GLOVES, AND EYE/FACE PROTECTION. |
|
|
| US
CLASSIFICATION AND LABEL TEXT |
|
|
|
INDICATION OF
DANGER: HARMFUL. |
|
|
|
RISK STATEMENTS: HARMFUL IF SWALLOWED. IRRITATING TO SKIN.
RISK |
|
|
|
OF SERIOUS DAMAGE TO
EYES. |
|
|
|
SAFETY STATEMENTS: IN CASE OF CONTACT WITH EYES, RINSE |
|
|
|
IMMEDIATELY WITH PLENTY
OF WATER AND SEEK MEDICAL ADVICE. WEAR |
|
|
|
SUITABLE PROTECTIVE
CLOTHING, GLOVES, AND EYE/FACE PROTECTION. |
|
|
| UNITED
STATES REGULATORY INFORMATION |
|
|
|
SARA LISTED: NO |
|
|
|
TSCA INVENTORY ITEM: YES |
|
|
| CANADA
REGULATORY INFORMATION |
|
|
|
WHMIS
CLASSIFICATION: THIS PRODUCT HAS
BEEN CLASSIFIED IN |
|
|
|
ACCORDANCE WITH THE
HAZARD CRITERIA OF THE CPR, AND THE MSDS |
|
|
|
CONTAINS ALL THE
INFORMATION REQUIRED BY THE CPR. |
|
|
|
DSL: YES |
|
|
|
NDSL: NO |
|
|
| SECTION
16. OTHER INFORMATION |
|
|
|
THIS
PRODUCT IS FOR R&D USE ONLY. IT IS NOT FOR DRUG, HOUSEHOLD |
|
|
|
OR
OTHER USES. EMPLOYERS SHOULD USE THIS
INFORMATION ONLY AS A |
|
|
|
SUPPLEMENT
TO OTHER INFORMATION GATHERED BY THEM, AND SHOULD MAKE |
|
|
|
INDEPENDENT
JUDGEMENT OF SUITABILITY OF THIS INFORMATION TO ENSURE |
|
|
|
PROPER
USE AND PROTECT THE HEALTH AND SAFETY OF EMPLOYEES. THIS |
|
|
|
INFORMATION
IS FURNISHED WITHOUT WARRANTY, AND ANY USE OF THE |
|
|
|
PRODUCT
NOT IN CONFORMANCE WITH THIS MATERIAL SAFETY DATA SHEET, |
|
|
|
OR IN
COMBINATION WITH ANY OTHER PRODUCT OR PROCESS, IS THE |
|
|
|
RESPONSIBILITY
OF THE USER. THE ABOVE INFORMATION IS
BELIEVED |
|
|
|
TO
BE CORRECT BUT DOES NOT PURPORT TO BE ALL INCLUSIVE AND SHALL |
|
|
|
BE
USED ONLY AS A GUIDE. PROFOLDIN SHALL
NOT BE HELD LIABLE FOR |
|
|
|
ANY
DAMAG RESULTING FROM HANDLING OR FROM CONTACT WITH THE ABOVE |
|
|
|
PRODUCT. |
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| |
|
| SECTION 1. CHEMICAL IDENTIFICATION |
|
|
|
CATALOG #: SFC01-10, SFC01, SFC02, SFC03, SFC04,
SFC05, SFC06, SFC07, SFC08, SFC09, SFC10 |
|
|
|
|
PFC01, PFC02, PFC03,
PFC04, PFC05, PFC06, PFC07, PFC08, PFC09, PFC10 |
|
|
NAME: B-CYCLODEXTRIN |
|
|
| SECTION
2. COMPOSITION/INFORMATION ON
INGREDIENT |
|
|
|
SUBSTANCE NAME |
|
CAS # |
|
SARA |
|
|
|
B-CYCLODEXTRIN |
|
7585-39-9 |
|
NO |
|
|
|
FORMULA: C42H70O35 |
|
|
|
SYNONYMS
BETA-CYCLOAMYLOSE * CYCLOHEPTAAMYLOSE * |
|
|
|
BETA-CYCLOHEPTAAMYLOSE *
CYCLOHEPTAGLUCAN * |
|
|
|
CYCLOHEPTAGLUCOSAN *
CYCLOMALTOHEPTAOSE * |
|
|
|
BETA-DEXTRIN *
SCHARDINGER BETA-DEXTRIN |
|
|
|
RTECS NUMBER: GU2293000 |
|
|
| SECTION
3. HAZARDS IDENTIFICATION |
|
|
| HMIS
RATING |
|
|
|
HEALTH: 0 |
|
|
|
FLAMMABILITY: 0 |
|
|
|
REACTIVITY: 0 |
|
|
| NFPA
RATING |
|
|
|
HEALTH: 0 |
|
|
|
FLAMMABILITY: 0 |
|
|
|
REACTIVITY: 0 |
|
|
|
FOR
ADDITIONAL INFORMATION ON TOXICITY, PLEASE REFER TO SECTION 11. |
|
|
| SECTION
4. FIRST AID MEASURES |
|
|
| ORAL
EXPOSURE |
|
|
|
IF SWALLOWED, WASH OUT
MOUTH WITH WATER PROVIDED PERSON IS |
|
|
|
CONSCIOUS. CALL A
PHYSICIAN. |
|
|
| INHALATION
EXPOSURE |
|
|
|
IF INHALED, REMOVE TO
FRESH AIR. IF BREATHING BECOMES DIFFICULT, |
|
|
|
CALL A PHYSICIAN. |
|
|
| DERMAL
EXPOSURE |
|
|
|
IN CASE OF CONTACT,
IMMEDIATELY WASH SKIN WITH SOAP AND COPIOUS |
|
|
|
AMOUNTS OF WATER. |
|
|
| EYE
EXPOSURE |
|
|
|
IN CASE OF CONTACT WITH
EYES, FLUSH WITH COPIOUS AMOUNTS OF |
|
|
|
WATER FOR AT LEAST 15
MINUTES. ASSURE ADEQUATE FLUSHING BY |
|
|
|
SEPARATING THE EYELIDS
WITH FINGERS. CALL A PHYSICIAN. |
|
|
| SECTION
5. FIRE FIGHTING MEASURES |
|
|
|
FLASH POINT |
|
|
|
N/A |
|
|
|
AUTOIGNITION TEMP |
|
|
|
N/A |
|
|
|
FLAMMABILITY |
|
|
|
N/A |
|
|
|
EXTINGUISHING MEDIA |
|
|
|
SUITABLE: WATER SPRAY. CARBON DIOXIDE, DRY CHEMICAL
POWDER, OR |
|
|
|
APPROPRIATE FOAM. |
|
|
| FIREFIGHTING |
|
|
| PROTECTIVE
EQUIPMENT: WEAR SELF-CONTAINED
BREATHING APPARATUS |
|
|
|
AND PROTECTIVE CLOTHING
TO PREVENT CONTACT WITH SKIN AND EYES. |
|
|
|
SPECIFIC HAZARD(S): EMITS TOXIC FUMES UNDER FIRE CONDITIONS. |
|
|
| SECTION
6. ACCIDENTAL RELEASE MEASURES |
|
|
| PROCEDURE(S)
OF PERSONAL PRECAUTION(S) |
|
|
|
EXERCISE APPROPRIATE
PRECAUTIONS TO MINIMIZE DIRECT CONTACT WITH |
|
|
|
SKIN OR EYES AND PREVENT
INHALATION OF DUST. |
|
|
| METHODS
FOR CLEANING UP |
|
|
|
SWEEP UP, PLACE IN A BAG
AND HOLD FOR WASTE DISPOSAL. AVOID |
|
|
|
RAISING DUST. VENTILATE
AREA AND WASH SPILL SITE AFTER MATERIAL |
|
|
|
PICKUP IS COMPLETE. |
|
|
| SECTION
7. HANDLING AND STORAGE |
|
|
| HANDLING |
|
|
|
USER EXPOSURE: AVOID INHALATION. AVOID CONTACT WITH
EYES, SKIN, |
|
|
|
AND CLOTHING. AVOID
PROLONGED OR REPEATED EXPOSURE. |
|
|
| STORAGE |
|
|
|
SUITABLE: KEEP TIGHTLY CLOSED. |
|
|
| SECTION
8. EXPOSURE CONTROLS / PPE |
|
|
| ENGINEERING
CONTROLS |
|
|
|
SAFETY SHOWER AND EYE
BATH. MECHANICAL EXHAUST REQUIRED. |
|
|
| PERSONAL
PROTECTIVE EQUIPMENT |
|
|
|
RESPIRATORY: WEAR DUST MASK. |
|
|
|
HAND: PROTECTIVE GLOVES. |
|
|
|
EYE: CHEMICAL SAFETY GOGGLES. |
|
|
| GENERAL
HYGIENE MEASURES |
|
|
|
WASH THOROUGHLY AFTER
HANDLING. |
|
|
| SECTION
9. PHYSICAL/CHEMICAL PROPERTIES |
|
|
| APPEARANCE
COLOR: WHITE |
|
|
|
FORM: POWDER |
|
|
| PROPERTY
VALUE AT TEMPERATURE OR PRESSURE |
|
|
|
MOLECULAR WEIGHT 1,135.01 AMU |
|
|
|
PH N/A |
|
|
|
BP/BP RANGE N/A |
|
|
|
MP/MP RANGE 290 °C |
|
|
|
FREEZING POINT N/A |
|
|
|
VAPOR PRESSURE N/A |
|
|
|
VAPOR DENSITY N/A |
|
|
|
SATURATED VAPOR
CONC. N/A |
|
|
|
SG/DENSITY
N/A |
|
|
|
BULK DENSITY N/A |
|
|
|
ODOR THRESHOLD N/A |
|
|
|
VOLATILE% N/A |
|
|
|
VOC CONTENT N/A |
|
|
|
WATER CONTENT 10 - 13 % |
|
|
|
SOLVENT CONTENT N/A |
|
|
|
EVAPORATION RATE N/A |
|
|
|
VISCOSITY N/A |
|
|
|
SURFACE TENSION N/A |
|
|
|
PARTITION
COEFFICIENT N/A |
|
|
|
DECOMPOSITION TEMP. N/A |
|
|
|
FLASH POINT N/A |
|
|
|
EXPLOSION LIMITS N/A |
|
|
|
FLAMMABILITY N/A |
|
|
|
AUTOIGNITION TEMP N/A |
|
|
|
REFRACTIVE INDEX N/A |
|
|
|
OPTICAL ROTATION DEGREE
OF ROTATION: 15 G/L SOLVENT: H2O |
|
|
|
+192 - +162 (+/-3) |
|
|
|
MISCELLANEOUS DATA N/A |
|
|
|
SOLUBILITY N/A |
|
|
|
N/A = NOT AVAILABLE |
|
|
| SECTION
10. STABILITY AND REACTIVITY |
|
|
| STABILITY |
|
|
|
STABLE: STABLE. |
|
|
|
MATERIALS TO AVOID: STRONG OXIDIZING AGENTS. |
|
|
|
HAZARDOUS DECOMPOSITION
PRODUCTS |
|
|
|
HAZARDOUS DECOMPOSITION
PRODUCTS: CARBON MONOXIDE, CARBON
DIOXIDE. |
|
|
| HAZARDOUS
POLYMERIZATION |
|
|
|
HAZARDOUS
POLYMERIZATION: WILL NOT OCCUR |
|
|
| SECTION
11. TOXICOLOGICAL INFORMATION |
|
|
| ROUTE
OF EXPOSURE |
|
|
|
SKIN CONTACT: MAY CAUSE SKIN IRRITATION. |
|
|
|
SKIN ABSORPTION: MAY BE HARMFUL IF ABSORBED THROUGH THE
SKIN. |
|
|
|
EYE CONTACT: MAY CAUSE EYE IRRITATION. |
|
|
|
INHALATION: MAY BE HARMFUL IF INHALED. MATERIAL MAY
BE |
|
|
|
IRRITATING TO MUCOUS
MEMBRANES AND UPPER RESPIRATORY TRACT. |
|
|
|
INGESTION: MAY BE HARMFUL IF SWALLOWED. |
|
|
| SIGNS
AND SYMPTOMS OF EXPOSURE |
|
|
|
TO THE BEST OF OUR
KNOWLEDGE, THE CHEMICAL, PHYSICAL, AND |
|
|
|
TOXICOLOGICAL PROPERTIES
HAVE NOT BEEN THOROUGHLY INVESTIGATED. |
|
|
| TOXICITY
DATA |
|
|
|
ORAL |
|
|
|
RAT |
|
|
|
18800 MG/KG |
|
|
|
LD50 |
|
|
|
INTRAPERITONEAL |
|
|
|
RAT |
|
|
|
356 MG/KG |
|
|
|
LD50 |
|
|
|
SUBCUTANEOUS |
|
|
|
RAT |
|
|
|
3700 MG/KG |
|
|
|
LD50 |
|
|
|
INTRAVENOUS |
|
|
|
RAT |
|
|
|
1008 MG/KG |
|
|
|
LD50 |
|
|
|
ORAL |
|
|
|
MOUSE |
|
|
|
> 12500 MG/KG |
|
|
|
LD50 |
|
|
|
INTRAPERITONEAL |
|
|
|
MOUSE |
|
|
|
330 MG/KG |
|
|
|
LD50 |
|
|
|
SUBCUTANEOUS |
|
|
|
MOUSE |
|
|
|
412 MG/KG |
|
|
|
LD50 |
|
|
|
CHRONIC EXPOSURE -
REPRODUCTIVE HAZARD |
|
|
|
SPECIES: RAT |
|
|
|
DOSE: 350 GM/KG |
|
|
|
ROUTE OF
APPLICATION: ORAL |
|
|
|
EXPOSURE TIME: (MULTIGENERATION) |
|
|
|
RESULT: MATERNAL EFFECTS: OTHER EFFECTS. EFFECTS ON NEWBORN: |
|
|
|
GROWTH STATISTICS (E.G.,
REDUCED WEIGHT GAIN). |
|
|
|
SPECIES: RAT |
|
|
|
DOSE: 155 GM/KG |
|
|
|
ROUTE OF
APPLICATION: ORAL |
|
|
|
EXPOSURE TIME: (MULTIGENERATION) |
|
|
|
RESULT: EFFECTS ON FERTILITY: POST-IMPLANTATION MORTALITY (E.G., |
|
|
|
DEAD AND/OR RESORBED
IMPLANTS PER TOTAL NUMBER OF IMPLANTS). |
|
|
|
EFFECTS ON NEWBORN: GROWTH STATISTICS (E.G., REDUCED WEIGHT |
|
|
|
GAIN). |
|
|
| SECTION
12. ECOLOGICAL INFORMATION |
|
|
|
NO DATA AVAILABLE. |
|
|
| SECTION
13. DISPOSAL CONSIDERATIONS |
|
|
|
APPROPRIATE METHOD OF
DISPOSAL OF SUBSTANCE OR PREPARATION |
|
|
|
CONTACT A LICENSED
PROFESSIONAL WASTE DISPOSAL SERVICE TO DISPOSE |
|
|
|
OF THIS MATERIAL.
DISSOLVE OR MIX THE MATERIAL WITH A COMBUSTIBLE |
|
|
|
SOLVENT AND BURN IN A
CHEMICAL INCINERATOR EQUIPPED WITH AN |
|
|
|
AFTERBURNER AND SCRUBBER.
OBSERVE ALL FEDERAL, STATE, AND LOCAL |
|
|
|
ENVIRONMENTAL
REGULATIONS. |
|
|
| SECTION
14. TRANSPORT INFORMATION |
|
|
|
CONTACT PROFOLDIN FOR
TRANSPORTATION INFORMATION. |
|
|
| SECTION 15. REGULATORY INFORMATION |
|
|
| UNITED
STATES REGULATORY INFORMATION |
|
|
|
SARA LISTED: NO |
|
|
|
TSCA INVENTORY ITEM: YES YES |
|
|
| CANADA
REGULATORY INFORMATION |
|
|
|
WHMIS
CLASSIFICATION: THIS PRODUCT HAS
BEEN CLASSIFIED IN |
|
|
|
ACCORDANCE WITH THE
HAZARD CRITERIA OF THE CPR, AND THE MSDS |
|
|
|
CONTAINS ALL THE
INFORMATION REQUIRED BY THE CPR. |
|
|
|
DSL: YES |
|
|
|
NDSL: NO |
|
|
| SECTION
16. OTHER INFORMATION |
|
|
|
THIS
PRODUCT IS FOR R&D USE ONLY. IT IS NOT FOR DRUG, HOUSEHOLD |
|
|
|
OR
OTHER USES. EMPLOYERS SHOULD USE THIS
INFORMATION ONLY AS A |
|
|
|
SUPPLEMENT
TO OTHER INFORMATION GATHERED BY THEM, AND SHOULD MAKE |
|
|
|
INDEPENDENT
JUDGEMENT OF SUITABILITY OF THIS INFORMATION TO ENSURE |
|
|
|
PROPER
USE AND PROTECT THE HEALTH AND SAFETY OF EMPLOYEES. THIS |
|
|
|
INFORMATION
IS FURNISHED WITHOUT WARRANTY, AND ANY USE OF THE |
|
|
|
PRODUCT
NOT IN CONFORMANCE WITH THIS MATERIAL SAFETY DATA SHEET, |
|
|
|
OR IN
COMBINATION WITH ANY OTHER PRODUCT OR PROCESS, IS THE |
|
|
|
RESPONSIBILITY
OF THE USER. THE ABOVE INFORMATION IS
BELIEVED |
|
|
|
TO
BE CORRECT BUT DOES NOT PURPORT TO BE ALL INCLUSIVE AND SHALL |
|
|
|
BE
USED ONLY AS A GUIDE. PROFOLDIN SHALL
NOT BE HELD LIABLE FOR |
|
|
|
ANY
DAMAG RESULTING FROM HANDLING OR FROM CONTACT WITH THE ABOVE |
|
|
|
PRODUCT. |
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| |
|
| SECTION 1. CHEMICAL IDENTIFICATION |
|
| |
CATALOG #: SFC01-10, SFC01, SFC02, SFC03, SFC04,
SFC05, SFC06, SFC07, SFC08, SFC09, SFC10 |
|
|
|
PFC01, PFC02, PFC03,
PFC04, PFC05, PFC06, PFC07, PFC08, PFC09, PFC10 |
|
| |
NAME: L-ARGININE
MONOHYDROCHLORIDE* |
|
| SECTION 2. COMPOSITION/INFORMATION ON INGREDIENTS |
|
| |
CAS #: 1119-34-2 |
|
| |
MF: C6H14N4O2.HCL |
|
| |
EC NO: 214-275-1 |
|
| SYNONYMS |
|
| |
ARGAMINE * ARGININE
HYDROCHLORIDE * ARGININE, HYDROCHLORIDE, L- * L- |
|
| |
ARGININE HYDROCHLORIDE *
ARGININE MONOHYDROCHLORIDE * L-ARGININE, |
|
| MONOHYDROCHLORIDE
* ARGIVENE * DETOXARGIN * LEVARGIN * MINOPHAGEN A * R-GENE * |
|
| SECTION 3. HAZARDS IDENTIFICATION |
|
| |
DATA NOT AVAILABLE |
|
| SECTION 4. FIRST-AID MEASURES |
|
| IF
SWALLOWED, WASH OUT MOUTH WITH WATER PROVIDED PERSON IS CONSCIOUS. |
|
| |
CALL A PHYSICIAN. |
|
| |
IF INHALED, REMOVE TO
FRESH AIR. IF BREATHING BECOMES DIFFICULT, |
|
| |
CALL A PHYSICIAN. |
|
| |
IN CASE OF CONTACT,
IMMEDIATELY WASH SKIN WITH SOAP AND COPIOUS |
|
| |
AMOUNTS OF WATER. |
|
| |
IN CASE OF CONTACT WITH
EYES, FLUSH WITH COPIOUS AMOUNTS OF WATER |
|
| |
FOR AT LEAST 15 MINUTES.
ASSURE ADEQUATE FLUSHING BY SEPARATING |
|
| |
THE EYELIDS WITH FINGERS.
CALL A PHYSICIAN. |
|
| SECTION 5. FIRE FIGHTING MEASURES |
|
| EXTINGUISHING MEDIA |
|
| |
WATER SPRAY. |
|
| |
CARBON DIOXIDE, DRY
CHEMICAL POWDER OR APPROPRIATE FOAM. |
|
| SPECIAL FIREFIGHTING PROCEDURES |
|
| |
WEAR SELF-CONTAINED
BREATHING APPARATUS AND PROTECTIVE CLOTHING TO |
|
| |
PREVENT CONTACT WITH SKIN
AND EYES. |
|
| UNUSUAL FIRE AND EXPLOSIONS HAZARDS |
|
| |
EMITS TOXIC FUMES UNDER
FIRE CONDITIONS. |
|
| SECTION 6. ACCIDENTAL RELEASE MEASURES |
|
| |
WEAR RESPIRATOR, CHEMICAL
SAFETY GOGGLES, RUBBER BOOTS AND HEAVY |
|
| |
RUBBER GLOVES. |
|
| |
SWEEP UP, PLACE IN A BAG
AND HOLD FOR WASTE DISPOSAL. |
|
| |
AVOID RAISING DUST. |
|
| |
VENTILATE AREA AND WASH
SPILL SITE AFTER MATERIAL PICKUP IS COMPLETE. |
|
| SECTION 7. HANDLING AND STORAGE |
|
| |
REFER TO SECTION 8. |
|
| SECTION 8. EXPOSURE CONTROLS/PERSONAL PROTECTION |
|
| |
SAFETY SHOWER AND EYE
BATH. |
|
| |
MECHANICAL EXHAUST
REQUIRED. |
|
| |
AVOID INHALATION. |
|
| |
AVOID CONTACT WITH EYES,
SKIN AND CLOTHING. |
|
| |
AVOID PROLONGED OR
REPEATED EXPOSURE. |
|
| |
NIOSH/MSHA-APPROVED
RESPIRATOR. |
|
| |
COMPATIBLE
CHEMICAL-RESISTANT GLOVES. |
|
| |
CHEMICAL SAFETY GOGGLES. |
|
| |
KEEP TIGHTLY CLOSED. |
|
| |
STORE IN A COOL DRY
PLACE. |
|
| |
WASH THOROUGHLY AFTER
HANDLING. |
|
| SECTION 9. PHYSICAL AND CHEMICAL PROPERTIES |
|
| PHYSICAL PROPERTIES |
|
| |
MELTING POINT: 226 - 230 C |
|
| |
SOLUBILITY: WATER -Z26130 |
|
| |
PH: 5.5 - 7.0 |
|
| SECTION 10. STABILITY AND REACTIVITY |
|
| STABILITY |
|
| |
STABLE. |
|
| INCOMPATIBILITIES |
|
| |
STRONG OXIDIZING AGENTS |
|
| HAZARDOUS COMBUSTION OR DECOMPOSITION
PRODUCTS |
|
| |
CARBON MONOXIDE, CARBON
DIOXIDE |
|
| |
NITROGEN OXIDES |
|
| |
HYDROGEN CHLORIDE GAS |
|
| HAZARDOUS POLYMERIZATION |
|
| |
WILL NOT OCCUR. |
|
| SECTION 11. TOXICOLOGICAL INFORMATION |
|
| ACUTE EFFECTS |
|
| |
MAY CAUSE SKIN
IRRITATION. |
|
| |
MAY BE HARMFUL IF
ABSORBED THROUGH THE SKIN. |
|
| |
MAY CAUSE EYE IRRITATION. |
|
| |
MAY BE HARMFUL IF
INHALED. |
|
| |
MATERIAL MAY BE
IRRITATING TO MUCOUS MEMBRANES AND UPPER |
|
| |
RESPIRATORY TRACT. |
|
| |
MAY BE HARMFUL IF
SWALLOWED. |
|
| |
TO THE BEST OF OUR
KNOWLEDGE, THE CHEMICAL, PHYSICAL, AND |
|
| |
TOXICOLOGICAL PROPERTIES
HAVE NOT BEEN THOROUGHLY INVESTIGATED. |
|
| RTECS #:
CF1995500 |
|
| |
ARGININE,
MONOHYDROCHLORIDE, L- |
|
| TOXICITY DATA |
|
| |
IVN-CHD LDLO: 3900 MG/KG/30M-C JTCTDW 35,621,1997 |
|
| |
ORL-RAT LD50: 12 GM/KG JPMSAE 62,49,1973 |
|
| |
IPR-RAT LD50: 3793 MG/KG ABBIA4 58,253,1955 |
|
| TARGET ORGAN DATA |
|
| |
SPECIFIC DEVELOPMENTAL
ABNORMALITIES (MUSCULOSKELETAL SYSTEM) |
|
| |
ONLY SELECTED REGISTRY OF
TOXIC EFFECTS OF CHEMICAL SUBSTANCES |
|
| |
(RTECS) DATA IS PRESENTED
HERE. SEE ACTUAL ENTRY IN RTECS FOR |
|
| |
COMPLETE INFORMATION. |
|
| SECTION 12. ECOLOGICAL INFORMATION |
|
| |
DATA NOT YET AVAILABLE. |
|
| SECTION 13. DISPOSAL CONSIDERATIONS |
|
| DISSOLVE
OR MIX THE MATERIAL WITH A COMBUSTIBLE SOLVENT AND BURN IN A CHEMICAL
INCINERATOR EQUIPPED WITH AN AFTERBURNER AND SCRUBBER. |
|
| |
OBSERVE ALL FEDERAL,
STATE AND LOCAL ENVIRONMENTAL REGULATIONS. |
|
| SECTION 14. TRANSPORT INFORMATION |
|
| |
CONTACT PROFOLDIN FOR
TRANSPORTATION INFORMATION. |
|
| SECTION 15. REGULATORY INFORMATION |
|
| REVIEWS, STANDARDS, AND REGULATIONS |
|
| |
OEL=MAK |
|
| |
NOHS 1974: HZD 81859; NIS 2; TNF 86; NOS 3; TNE 857 |
|
| |
NOES 1983: HZD 81859; NIS 3; TNF 585; NOS 13; TNE
5477; TFE 2954 |
|
| |
EPA TSCA SECTION 8(B)
CHEMICAL INVENTORY |
|
| SECTION 16. OTHER INFORMATION |
|
|
THIS
PRODUCT IS FOR R&D USE ONLY. IT IS NOT FOR DRUG, HOUSEHOLD |
|
|
OR
OTHER USES. EMPLOYERS SHOULD USE THIS
INFORMATION ONLY AS A |
|
|
SUPPLEMENT
TO OTHER INFORMATION GATHERED BY THEM, AND SHOULD MAKE |
|
|
INDEPENDENT
JUDGEMENT OF SUITABILITY OF THIS INFORMATION TO ENSURE |
|
|
PROPER
USE AND PROTECT THE HEALTH AND SAFETY OF EMPLOYEES. THIS |
|
|
INFORMATION
IS FURNISHED WITHOUT WARRANTY, AND ANY USE OF THE |
|
|
PRODUCT
NOT IN CONFORMANCE WITH THIS MATERIAL SAFETY DATA SHEET, |
|
|
OR IN
COMBINATION WITH ANY OTHER PRODUCT OR PROCESS, IS THE |
|
|
RESPONSIBILITY
OF THE USER. THE ABOVE INFORMATION IS
BELIEVED |
|
|
TO
BE CORRECT BUT DOES NOT PURPORT TO BE ALL INCLUSIVE AND SHALL |
|
|
BE
USED ONLY AS A GUIDE. PROFOLDIN SHALL
NOT BE HELD LIABLE FOR |
|
|
ANY
DAMAG RESULTING FROM HANDLING OR FROM CONTACT WITH THE ABOVE |
|
|
PRODUCT. |
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| |
|
| SECTION 1. CHEMICAL IDENTIFICATION |
|
| |
CATALOG #: SFC01-10, SFC01, SFC02, SFC03, SFC04,
SFC05, SFC06, SFC07, SFC08, SFC09, SFC10 |
|
|
|
PFC01, PFC02, PFC03,
PFC04, PFC05, PFC06, PFC07, PFC08, PFC09, PFC10 |
|
| |
NAME: CALCIUM CHLORIDE
DIHYDRATE |
|
| SECTION 2. COMPOSITION/INFORMATION ON INGREDIENTS |
|
| |
CAS #: 10035-04-8 |
|
| |
MF: CACL2.2*H2O |
|
| |
EC NO: 233-140-8 |
|
| SYNONYMS |
|
| CALCIUM
DICHLORIDE DIHYDRATE * CAL PLUS * REPLENISHER (CALCIUM) * |
|
| SECTION 3. HAZARDS IDENTIFICATION |
|
| LABEL PRECAUTIONARY STATEMENTS |
|
| |
HARMFUL |
|
| |
HARMFUL IF SWALLOWED. |
|
| |
IRRITATING TO EYES,
RESPIRATORY SYSTEM AND SKIN. |
|
| |
IN CASE OF CONTACT WITH
EYES, RINSE IMMEDIATELY WITH PLENTY OF |
|
| |
WATER AND SEEK MEDICAL
ADVICE. |
|
| |
WEAR SUITABLE PROTECTIVE
CLOTHING. |
|
| SECTION 4. FIRST-AID MEASURES |
|
| |
IN CASE OF CONTACT,
IMMEDIATELY FLUSH EYES WITH COPIOUS AMOUNTS OF |
|
| |
WATER FOR AT LEAST 15
MINUTES. |
|
| |
IN CASE OF CONTACT,
IMMEDIATELY WASH SKIN WITH SOAP AND COPIOUS |
|
| |
AMOUNTS OF WATER. |
|
| |
IF INHALED, REMOVE TO
FRESH AIR. IF NOT BREATHING GIVE ARTIFICIAL |
|
| |
RESPIRATION. IF BREATHING
IS DIFFICULT, GIVE OXYGEN. |
|
| IF
SWALLOWED, WASH OUT MOUTH WITH WATER PROVIDED PERSON IS CONSCIOUS. |
|
| |
CALL A PHYSICIAN. |
|
| |
WASH CONTAMINATED
CLOTHING BEFORE REUSE. |
|
| SECTION 5. FIRE FIGHTING MEASURES |
|
| EXTINGUISHING MEDIA |
|
| |
NONCOMBUSTIBLE. |
|
| |
USE EXTINGUISHING MEDIA
APPROPRIATE TO SURROUNDING FIRE CONDITIONS. |
|
| SPECIAL FIREFIGHTING PROCEDURES |
|
| |
WEAR SELF-CONTAINED
BREATHING APPARATUS AND PROTECTIVE CLOTHING TO |
|
| |
PREVENT CONTACT WITH SKIN
AND EYES. |
|
| UNUSUAL FIRE AND EXPLOSIONS HAZARDS |
|
| |
EMITS TOXIC FUMES UNDER
FIRE CONDITIONS. |
|
| SECTION 6. ACCIDENTAL RELEASE MEASURES |
|
| |
WEAR SELF-CONTAINED
BREATHING APPARATUS, RUBBER BOOTS AND HEAVY |
|
| |
RUBBER GLOVES. |
|
| |
SWEEP UP, PLACE IN A BAG
AND HOLD FOR WASTE DISPOSAL. |
|
| |
AVOID RAISING DUST. |
|
| |
VENTILATE AREA AND WASH
SPILL SITE AFTER MATERIAL PICKUP IS COMPLETE. |
|
| SECTION 7. HANDLING AND STORAGE |
|
| |
REFER TO SECTION 8. |
|
| ADDITIONAL INFORMATION |
|
| |
CALCIUM CHLORIDE IS
ATTACKED BY BROMINE TRIFLUORIDE. |
|
| SECTION
8. - EXPOSURE CONTROLS/PERSONAL
PROTECTION |
|
| WEAR
APPROPRIATE NIOSH/MSHA-APPROVED RESPIRATOR, CHEMICAL-RESISTANT GLOVES, SAFETY
GOGGLES, OTHER PROTECTIVE CLOTHING. |
|
| |
SAFETY SHOWER AND EYE
BATH. |
|
| |
MECHANICAL EXHAUST
REQUIRED. |
|
| |
DO NOT BREATHE DUST. |
|
| |
AVOID CONTACT WITH EYES,
SKIN AND CLOTHING. |
|
| |
AVOID PROLONGED OR
REPEATED EXPOSURE. |
|
| |
WASH THOROUGHLY AFTER
HANDLING. |
|
| |
KEEP TIGHTLY CLOSED. |
|
| |
STORE IN A COOL DRY
PLACE. |
|
| SECTION 9. PHYSICAL AND CHEMICAL PROPERTIES |
|
| APPEARANCE AND ODOR |
|
| |
WHITE POWDER |
|
| PHYSICAL PROPERTIES |
|
| |
VAPOR PRESSURE: 0.01MM 20 C |
|
| SECTION 10. STABILITY AND REACTIVITY |
|
| INCOMPATIBILITIES |
|
| |
STRONG ACIDS |
|
| HAZARDOUS COMBUSTION OR DECOMPOSITION
PRODUCTS |
|
| |
HYDROGEN CHLORIDE GAS |
|
| SECTION
11. TOXICOLOGICAL INFORMATION |
|
| ACUTE EFFECTS |
|
| |
HARMFUL IF SWALLOWED. |
|
| |
MAY BE HARMFUL IF
INHALED. |
|
| |
MAY BE HARMFUL IF
ABSORBED THROUGH THE SKIN. |
|
| |
CAUSES EYE AND SKIN
IRRITATION. |
|
| |
MATERIAL IS IRRITATING TO MUCOUS MEMBRANES
AND UPPER |
|
| |
RESPIRATORY TRACT. |
|
| |
TO THE BEST OF OUR
KNOWLEDGE, THE CHEMICAL, PHYSICAL, AND |
|
| |
TOXICOLOGICAL PROPERTIES
HAVE NOT BEEN THOROUGHLY INVESTIGATED. |
|
| RTECS #:
EV9810000 |
|
| |
CALCIUM CHLORIDE,
DIHYDRATE |
|
| TOXICITY DATA |
|
| |
IPR-MUS LD50: 20500 MG/KG CYLPDN 4,110,1983 |
|
| |
ONLY SELECTED REGISTRY OF
TOXIC EFFECTS OF CHEMICAL SUBSTANCES |
|
| |
(RTECS) DATA IS PRESENTED
HERE. SEE ACTUAL ENTRY IN RTECS FOR |
|
| |
COMPLETE INFORMATION. |
|
| SECTION 12. ECOLOGICAL INFORMATION |
|
| |
DATA NOT YET AVAILABLE. |
|
| SECTION 13. DISPOSAL CONSIDERATIONS |
|
| |
CONTACT A LICENSED
PROFESSIONAL WASTE DISPOSAL SERVICE TO DISPOSE OF |
|
| |
THIS MATERIAL. |
|
| |
OBSERVE ALL FEDERAL,
STATE AND LOCAL ENVIRONMENTAL REGULATIONS. |
|
| SECTION 14. TRANSPORT INFORMATION |
|
| |
CONTACT PROFOLDIN FOR
TRANSPORTATION INFORMATION. |
|
| SECTION 15. REGULATORY INFORMATION |
|
| EUROPEAN INFORMATION |
|
| |
HARMFUL |
|
| |
R 22 |
|
| |
HARMFUL IF SWALLOWED. |
|
| |
R 36/37/38 |
|
| |
IRRITATING TO EYES,
RESPIRATORY SYSTEM AND SKIN. |
|
| |
S 26 |
|
| |
IN CASE OF CONTACT WITH
EYES, RINSE IMMEDIATELY WITH PLENTY OF |
|
| |
WATER AND SEEK MEDICAL
ADVICE. |
|
| |
S 36 |
|
| |
WEAR SUITABLE PROTECTIVE
CLOTHING. |
|
| REVIEWS, STANDARDS, AND REGULATIONS |
|
| |
OEL=MAK |
|
| |
NOES 1983: HZD X3586; NIS 12; TNF 1290; NOS 23; TNE
19024; TFE 10290 |
|
| SECTION 16. OTHER INFORMATION |
|
|
THIS
PRODUCT IS FOR R&D USE ONLY. IT IS NOT FOR DRUG, HOUSEHOLD |
|
|
OR
OTHER USES. EMPLOYERS SHOULD USE THIS
INFORMATION ONLY AS A |
|
|
SUPPLEMENT
TO OTHER INFORMATION GATHERED BY THEM, AND SHOULD MAKE |
|
|
INDEPENDENT
JUDGEMENT OF SUITABILITY OF THIS INFORMATION TO ENSURE |
|
|
PROPER
USE AND PROTECT THE HEALTH AND SAFETY OF EMPLOYEES. THIS |
|
|
INFORMATION
IS FURNISHED WITHOUT WARRANTY, AND ANY USE OF THE |
|
|
PRODUCT
NOT IN CONFORMANCE WITH THIS MATERIAL SAFETY DATA SHEET, |
|
|
OR IN
COMBINATION WITH ANY OTHER PRODUCT OR PROCESS, IS THE |
|
|
RESPONSIBILITY
OF THE USER. THE ABOVE INFORMATION IS
BELIEVED |
|
|
TO
BE CORRECT BUT DOES NOT PURPORT TO BE ALL INCLUSIVE AND SHALL |
|
|
BE
USED ONLY AS A GUIDE. PROFOLDIN SHALL
NOT BE HELD LIABLE FOR |
|
|
ANY
DAMAG RESULTING FROM HANDLING OR FROM CONTACT WITH THE ABOVE |
|
|
PRODUCT. |
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| |
|
| SECTION 1. CHEMICAL IDENTIFICATION |
|
| |
CATALOG #: SFC01-10, SFC01, SFC02, SFC03, SFC04,
SFC05, SFC06, SFC07, SFC08, SFC09, SFC10 |
|
|
|
PFC01, PFC02, PFC03,
PFC04, PFC05, PFC06, PFC07, PFC08, PFC09, PFC10 |
|
| |
NAME: 1,4-DITHIO-DL-THREITOL* |
|
| SECTION 2. COMPOSITION/INFORMATION ON INGREDIENTS |
|
| |
CAS #: 27565-41-9 |
|
| |
MF: C4H10O2S2 |
|
| |
EC NO: 248-531-9 |
|
| SYNONYMS |
|
| |
2,3-BUTANEDIOL,
1,4-DIMERCAPTO-, DL-THREO- * 2,3-BUTANEDIOL, 1,4- |
|
| |
DIMERCAPTO-, (R*,R*)-
(+-)- (9CI) * CLELAND'S REAGENT * DL-THREO-1,4- |
|
| |
DIMERCAPTO-2,3-BUTANEDIOL
* (R*,R*)-(+-)-1,4-DIMERCAPTO-2,3- |
|
| |
BUTANEDIOL *
DITHIOTHREITOL * DL-DITHIOTHREITOL * DL-1,4- |
|
| |
DITHIOTHREITOL *
RAC-DITHIOTHREITOL * |
|
| SECTION 3. HAZARDS IDENTIFICATION |
|
| LABEL PRECAUTIONARY STATEMENTS |
|
| |
IRRITANT |
|
| |
IRRITATING TO EYES,
RESPIRATORY SYSTEM AND SKIN. |
|
| |
UNPLEASANT ODOR. |
|
|
TARGET ORGAN(S): |
|
| |
CENTRAL NERVOUS SYSTEM |
|
| |
IN CASE OF CONTACT WITH
EYES, RINSE IMMEDIATELY WITH PLENTY OF |
|
| |
WATER AND SEEK MEDICAL
ADVICE. |
|
| |
WEAR SUITABLE PROTECTIVE
CLOTHING. |
|
| SECTION 4. FIRST-AID MEASURES |
|
| IF
SWALLOWED, WASH OUT MOUTH WITH WATER PROVIDED PERSON IS CONSCIOUS. |
|
| |
CALL A PHYSICIAN. |
|
| |
IF INHALED, REMOVE TO
FRESH AIR. IF NOT BREATHING GIVE ARTIFICIAL |
|
| |
RESPIRATION. IF BREATHING
IS DIFFICULT, GIVE OXYGEN. |
|
| |
IN CASE OF CONTACT,
IMMEDIATELY WASH SKIN WITH SOAP AND COPIOUS |
|
| |
AMOUNTS OF WATER. |
|
| |
IN CASE OF CONTACT,
IMMEDIATELY FLUSH EYES WITH COPIOUS AMOUNTS OF |
|
| |
WATER FOR AT LEAST 15
MINUTES. |
|
| SECTION 5. FIRE FIGHTING MEASURES |
|
| EXTINGUISHING MEDIA |
|
| |
WATER SPRAY. |
|
| |
CARBON DIOXIDE, DRY
CHEMICAL POWDER OR APPROPRIATE FOAM. |
|
| SPECIAL FIREFIGHTING PROCEDURES |
|
| |
WEAR SELF-CONTAINED
BREATHING APPARATUS AND PROTECTIVE CLOTHING TO |
|
| |
PREVENT CONTACT WITH SKIN
AND EYES. |
|
| |
USE WATER SPRAY TO COOL
FIRE-EXPOSED CONTAINERS. |
|
| UNUSUAL FIRE AND EXPLOSIONS HAZARDS |
|
| |
EMITS TOXIC FUMES UNDER
FIRE CONDITIONS. |
|
| SECTION 6. ACCIDENTAL RELEASE MEASURES |
|
| |
WEAR RESPIRATOR, CHEMICAL
SAFETY GOGGLES, RUBBER BOOTS AND HEAVY |
|
| |
RUBBER GLOVES. |
|
| |
SWEEP UP, PLACE IN A BAG
AND HOLD FOR WASTE DISPOSAL. |
|
| |
AVOID RAISING DUST. |
|
| |
VENTILATE AREA AND WASH
SPILL SITE AFTER MATERIAL PICKUP IS COMPLETE. |
|
| |
EVACUATE AREA. |
|
| SECTION 7. HANDLING AND STORAGE |
|
| |
REFER TO SECTION 8. |
|
| SECTION 8. EXPOSURE CONTROLS/PERSONAL PROTECTION |
|
| |
SAFETY SHOWER AND EYE
BATH. |
|
| |
MECHANICAL EXHAUST
REQUIRED. |
|
| |
WASH THOROUGHLY AFTER
HANDLING. |
|
| |
DO NOT BREATHE DUST. |
|
| |
AVOID CONTACT WITH EYES,
SKIN AND CLOTHING. |
|
| |
AVOID PROLONGED OR
REPEATED EXPOSURE. |
|
| |
NIOSH/MSHA-APPROVED
RESPIRATOR. |
|
| |
COMPATIBLE
CHEMICAL-RESISTANT GLOVES. |
|
| |
CHEMICAL SAFETY GOGGLES. |
|
| |
KEEP TIGHTLY CLOSED. |
|
| |
STORE AT 2-8'C
(35.6-46.4'F). |
|
| SECTION 9. PHYSICAL AND CHEMICAL PROPERTIES |
|
| APPEARANCE AND ODOR |
|
| |
SOLID. |
|
| PHYSICAL PROPERTIES |
|
| |
MELTING POINT: 41 - 44 C |
|
| |
FLASHPOINT
235 F |
113 C |
|
|
SOLUBILITY: |
|
| |
WATER -Z26130 |
|
| |
PH: 4.0 - 6.0 |
|
| SECTION 10. STABILITY AND REACTIVITY |
|
| STABILITY |
|
| |
STABLE. |
|
| CONDITIONS TO AVOID |
|
| |
MAY DECOMPOSE ON EXPOSURE
TO MOIST AIR OR WATER. |
|
| INCOMPATIBILITIES |
|
| |
BASES |
|
| |
OXIDIZING AGENTS |
|
| |
REDUCING AGENTS |
|
| |
ALKALI METALS |
|
| HAZARDOUS COMBUSTION OR DECOMPOSITION
PRODUCTS |
|
| |
CARBON MONOXIDE, CARBON
DIOXIDE |
|
| |
SULFUR OXIDES |
|
| |
HYDROGEN SULFIDE GAS |
|
| HAZARDOUS POLYMERIZATION |
|
| |
WILL NOT OCCUR. |
|
| SECTION 11. TOXICOLOGICAL INFORMATION |
|
| ACUTE EFFECTS |
|
| |
CAUSES SKIN IRRITATION. |
|
| |
MAY BE HARMFUL IF
ABSORBED THROUGH THE SKIN. |
|
| |
CAUSES EYE IRRITATION. |
|
| |
MAY BE HARMFUL IF
INHALED. |
|
| |
MATERIAL IS IRRITATING TO
MUCOUS MEMBRANES AND UPPER |
|
| RESPIRATORY TRACT. |
|
| |
MAY BE HARMFUL IF
SWALLOWED. |
|
| |
TO THE BEST OF OUR
KNOWLEDGE, THE CHEMICAL, PHYSICAL, AND |
|
| |
TOXICOLOGICAL PROPERTIES
HAVE NOT BEEN THOROUGHLY INVESTIGATED. |
|
| CHRONIC EFFECTS |
|
|
TARGET ORGAN(S): |
|
| |
CENTRAL NERVOUS SYSTEM |
|
| RTECS #:
XO8576500 |
|
| |
THREITOL, 1,4-DITHIO-,
DL- |
|
| TOXICITY DATA |
|
| |
IPR-MUS LD50: 169 MG/KG JMCMAR 15,600,1972 |
|
| |
SCU-MUS LD50: 333 MG/KG ARZNAD 22,1434,1972 |
|
| |
IVN-MUS LD50: 94 MG/KG ARZNAD 22,1434,1972 |
|
| |
ONLY SELECTED REGISTRY OF
TOXIC EFFECTS OF CHEMICAL SUBSTANCES |
|
| |
(RTECS) DATA IS PRESENTED
HERE. SEE ACTUAL ENTRY IN RTECS FOR |
|
| |
COMPLETE INFORMATION. |
|
| SECTION 12. ECOLOGICAL INFORMATION |
|
| |
DATA NOT YET AVAILABLE. |
|
| SECTION 13. DISPOSAL CONSIDERATIONS |
|
| DISSOLVE
OR MIX THE MATERIAL WITH A COMBUSTIBLE SOLVENT AND BURN IN A CHEMICAL
INCINERATOR EQUIPPED WITH AN AFTERBURNER AND SCRUBBER. |
|
| |
OBSERVE ALL FEDERAL,
STATE AND LOCAL ENVIRONMENTAL REGULATIONS. |
|
| SECTION 14. TRANSPORT INFORMATION |
|
| |
CONTACT PROFOLDIN FOR
TRANSPORTATION INFORMATION. |
|
| SECTION 15. REGULATORY INFORMATION |
|
| EUROPEAN INFORMATION |
|
| |
IRRITANT |
|
| |
R 36/37/38 |
|
| |
IRRITATING TO EYES,
RESPIRATORY SYSTEM AND SKIN. |
|
| |
S 26 |
|
| |
IN CASE OF CONTACT WITH
EYES, RINSE IMMEDIATELY WITH PLENTY OF |
|
| |
WATER AND SEEK MEDICAL
ADVICE. |
|
| |
S 36 |
|
| |
WEAR SUITABLE PROTECTIVE
CLOTHING. |
|
| REVIEWS, STANDARDS, AND REGULATIONS |
|
| |
OEL=MAK |
|
| |
NOES 1983: HZD X2950; NIS 1; TNF 35; NOS 3; TNE 627;
TFE 436 |
|
| SECTION 16. OTHER INFORMATION |
|
|
THIS
PRODUCT IS FOR R&D USE ONLY. IT IS NOT FOR DRUG, HOUSEHOLD |
|
|
OR
OTHER USES. EMPLOYERS SHOULD USE THIS
INFORMATION ONLY AS A |
|
|
SUPPLEMENT
TO OTHER INFORMATION GATHERED BY THEM, AND SHOULD MAKE |
|
|
INDEPENDENT
JUDGEMENT OF SUITABILITY OF THIS INFORMATION TO ENSURE |
|
|
PROPER
USE AND PROTECT THE HEALTH AND SAFETY OF EMPLOYEES. THIS |
|
|
INFORMATION
IS FURNISHED WITHOUT WARRANTY, AND ANY USE OF THE |
|
|
PRODUCT
NOT IN CONFORMANCE WITH THIS MATERIAL SAFETY DATA SHEET, |
|
|
OR IN
COMBINATION WITH ANY OTHER PRODUCT OR PROCESS, IS THE |
|
|
RESPONSIBILITY
OF THE USER. THE ABOVE INFORMATION IS
BELIEVED |
|
|
TO
BE CORRECT BUT DOES NOT PURPORT TO BE ALL INCLUSIVE AND SHALL |
|
|
BE
USED ONLY AS A GUIDE. PROFOLDIN SHALL
NOT BE HELD LIABLE FOR |
|
|
ANY
DAMAG RESULTING FROM HANDLING OR FROM CONTACT WITH THE ABOVE |
|
|
PRODUCT. |
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| |
|
| SECTION 1. CHEMICAL IDENTIFICATION |
|
| |
CATALOG #: SFC01-10, SFC01, SFC02, SFC03, SFC04,
SFC05, SFC06, SFC07, SFC08, SFC09, SFC10 |
|
|
|
PFC01, PFC02, PFC03,
PFC04, PFC05, PFC06, PFC07, PFC08, PFC09, PFC10 |
|
| |
NAME:
ETHYLENEDIAMINETETRAACETIC ACID* |
|
| SECTION 2. COMPOSITION/INFORMATION ON INGREDIENTS |
|
| |
CAS #: 60-00-4 |
|
| |
MF: C10H16N2O8 |
|
| |
EC NO: 200-449-4 |
|
| SYNONYMS |
|
| |
ACIDE
ETHYLENEDIAMINETETRACETIQUE (FRENCH) * CELON A * CELON ATH * |
|
| |
CHEELOX * CHEELOX BF ACID
* CHEMCOLOX 340 * CLEWAT TAA * COMPLEXON II |
|
| |
* 3,6-DIAZAOCTANEDIOIC
ACID, 3,6-BIS(CARBOXYMETHYL)- * EDATHAMIL * |
|
| |
EDETIC ACID * EDTA * EDTA
(CHELATING AGENT) * EDTA ACID * ENDRATE * N, |
|
| |
N'-1,2-ETHANEDIYLBIS(N-(CARBOXYMETHYL)GLYCINE)
* |
|
| |
ETHYLENEDIAMINETETRAACETATE
* ETHYLENEDIAMINETETRAACETIC ACID * |
|
| |
ETHYLENEDIAMINE-N,N,N',N'-TETRAACETIC
ACID * |
|
| |
ETHYLENEDINITRILOTETRAACETIC
ACID * GLUMA CLEANSER * GLYCINE, N,N'-1, |
|
| |
2-ETHANEDIYLBIS(N-(CARBOXYMETHYL)-
(9CI) * HAMP-ENE ACID * HAVIDOTE * |
|
| |
ICRF 185 * KOMPLEXON II * KYSELINA
ETHYLENDIAMINTETRAOCTOVA (CZECH) * |
|
| |
METAQUEST A * NERVANAID B
ACID * NULLAPON B ACID * NULLAPON BF ACID * |
|
| |
PERMA KLEER 50 ACID *
QUESTEX 4H * SEQ 100 * SEQUESTRENE AA * |
|
| |
SEQUESTRIC ACID *
SEQUESTROL * TETRINE ACID * TITRIPLEX * TRILON BS * |
|
| |
TRILON BW * VERSENE ACID
* VINKEIL 100 * WARKEELATE ACID * YD 30 * |
|
| SECTION 3. HAZARDS IDENTIFICATION |
|
| LABEL PRECAUTIONARY STATEMENTS |
|
| |
IRRITANT |
|
| |
IRRITATING TO EYES,
RESPIRATORY SYSTEM AND SKIN. |
|
| |
IN CASE OF CONTACT WITH
EYES, RINSE IMMEDIATELY WITH PLENTY OF |
|
| |
WATER AND SEEK MEDICAL
ADVICE. |
|
| |
WEAR SUITABLE PROTECTIVE
CLOTHING. |
|
| SECTION 4. FIRST-AID MEASURES |
|
| |
IN CASE OF CONTACT,
IMMEDIATELY FLUSH EYES WITH COPIOUS AMOUNTS OF |
|
| |
WATER FOR AT LEAST 15
MINUTES. |
|
| |
IN CASE OF CONTACT,
IMMEDIATELY WASH SKIN WITH SOAP AND COPIOUS |
|
| |
AMOUNTS OF WATER. |
|
| |
IF INHALED, REMOVE TO
FRESH AIR. IF NOT BREATHING GIVE ARTIFICIAL |
|
| |
RESPIRATION. IF BREATHING
IS DIFFICULT, GIVE OXYGEN. |
|
| IF
SWALLOWED, WASH OUT MOUTH WITH WATER PROVIDED PERSON IS CONSCIOUS. |
|
| |
CALL A PHYSICIAN. |
|
| |
WASH CONTAMINATED
CLOTHING BEFORE REUSE. |
|
| SECTION 5. FIRE FIGHTING MEASURES |
|
| EXTINGUISHING MEDIA |
|
| |
WATER SPRAY. |
|
| |
CARBON DIOXIDE, DRY
CHEMICAL POWDER OR APPROPRIATE FOAM. |
|
| SPECIAL FIREFIGHTING PROCEDURES |
|
| |
WEAR SELF-CONTAINED
BREATHING APPARATUS AND PROTECTIVE CLOTHING TO |
|
| |
PREVENT CONTACT WITH SKIN
AND EYES. |
|
| UNUSUAL FIRE AND EXPLOSIONS HAZARDS |
|
| |
EMITS TOXIC FUMES UNDER
FIRE CONDITIONS. |
|
| SECTION 6. ACCIDENTAL RELEASE MEASURES |
|
| |
WEAR RESPIRATOR, CHEMICAL
SAFETY GOGGLES, RUBBER BOOTS AND HEAVY |
|
| |
RUBBER GLOVES. |
|
| |
SWEEP UP, PLACE IN A BAG
AND HOLD FOR WASTE DISPOSAL. |
|
| |
AVOID RAISING DUST. |
|
| |
VENTILATE AREA AND WASH
SPILL SITE AFTER MATERIAL PICKUP IS COMPLETE. |
|
| SECTION 7. HANDLING AND STORAGE |
|
| |
REFER TO SECTION 8. |
|
| SECTION 8. EXPOSURE CONTROLS/PERSONAL PROTECTION |
|
| |
CHEMICAL SAFETY GOGGLES. |
|
| |
COMPATIBLE
CHEMICAL-RESISTANT GLOVES. |
|
| |
NIOSH/MSHA-APPROVED
RESPIRATOR. |
|
| |
SAFETY SHOWER AND EYE
BATH. |
|
| |
MECHANICAL EXHAUST
REQUIRED. |
|
| |
DO NOT BREATHE DUST. |
|
| |
AVOID CONTACT WITH EYES,
SKIN AND CLOTHING. |
|
| |
WASH THOROUGHLY AFTER
HANDLING. |
|
| |
IRRITANT. |
|
| |
KEEP TIGHTLY CLOSED. |
|
| |
STORE IN A COOL DRY
PLACE. |
|
| SECTION 9. PHYSICAL AND CHEMICAL PROPERTIES |
|
| APPEARANCE AND ODOR |
|
| |
WHITE CRYSTALS |
|
| SECTION 10. STABILITY AND REACTIVITY |
|
| |
INCOMPATIBILITIES |
|
| |
STRONG OXIDIZING AGENTS |
|
| |
STRONG BASES |
|
| |
COPPER, COPPER ALLOYS |
|
| |
NICKEL |
|
| HAZARDOUS COMBUSTION OR DECOMPOSITION
PRODUCTS |
|
| |
TOXIC FUMES OF: |
|
| |
CARBON MONOXIDE, CARBON
DIOXIDE |
|
| |
NITROGEN OXIDES |
|
| SECTION 11. TOXICOLOGICAL INFORMATION |
|
| ACUTE EFFECTS |
|
| |
MAY BE HARMFUL BY
INHALATION, INGESTION, OR SKIN ABSORPTION. |
|
| |
CAUSES EYE AND SKIN
IRRITATION. |
|
| |
MATERIAL IS IRRITATING TO
MUCOUS MEMBRANES AND UPPER |
|
| |
RESPIRATORY TRACT. |
|
| |
TO THE BEST OF OUR
KNOWLEDGE, THE CHEMICAL, PHYSICAL, AND |
|
| |
TOXICOLOGICAL PROPERTIES
HAVE NOT BEEN THOROUGHLY INVESTIGATED. |
|
| RTECS #:
AH4025000 |
|
| |
ACETIC ACID,
(ETHYLENEDINITRILO)TETRA- |
|
| TOXICITY DATA |
|
| |
IPR-RAT LD50: 397 MG/KG AHRTAN 13,295,1962 |
|
| |
ORL-MUS LD50: 30 MG/KG FCTOD7 29,845,1991 |
|
| |
IPR-MUS LD50: 250 MG/KG NTIS** AD691-490 |
|
| |
IVN-MUS LD50: 28500 UG/KG JJPAAZ 63,187,1993 |
|
| TARGET ORGAN DATA |
|
| |
BEHAVIORAL (CONVULSIONS
OR EFFECT ON SEIZURE THRESHOLD) |
|
| |
ONLY SELECTED REGISTRY OF
TOXIC EFFECTS OF CHEMICAL SUBSTANCES |
|
| |
(RTECS) DATA IS PRESENTED
HERE. SEE ACTUAL ENTRY IN RTECS FOR |
|
| |
COMPLETE INFORMATION. |
|
| SECTION 12. ECOLOGICAL INFORMATION |
|
| |
DATA NOT YET AVAILABLE. |
|
| SECTION 13. DISPOSAL CONSIDERATIONS |
|
| DISSOLVE
OR MIX THE MATERIAL WITH A COMBUSTIBLE SOLVENT AND BURN IN A CHEMICAL
INCINERATOR EQUIPPED WITH AN AFTERBURNER AND SCRUBBER. |
|
| |
OBSERVE ALL FEDERAL,
STATE AND LOCAL ENVIRONMENTAL REGULATIONS. |
|
| SECTION 14. TRANSPORT INFORMATION |
|
| |
CONTACT PROFOLDIN FOR
TRANSPORTATION INFORMATION. |
|
| SECTION 15. REGULATORY INFORMATION |
|
| EUROPEAN INFORMATION |
|
| |
IRRITANT |
|
| |
R 36/37/38 |
|
| |
IRRITATING TO EYES,
RESPIRATORY SYSTEM AND SKIN. |
|
| |
S 26 |
|
| |
IN CASE OF CONTACT WITH
EYES, RINSE IMMEDIATELY WITH PLENTY OF |
|
| |
WATER AND SEEK MEDICAL
ADVICE. |
|
| |
S 36 |
|
| |
WEAR SUITABLE PROTECTIVE
CLOTHING. |
|
| REVIEWS, STANDARDS, AND REGULATIONS |
|
| |
OEL=MAK |
|
| |
EPA FIFRA 1988 PESTICIDE
SUBJECT TO REGISTRATION OR RE-REGISTRATION |
|
| |
FEREAC 54,7740,1989 |
|
| |
NOHS 1974: HZD 80283; NIS 122; TNF 12157; NOS 93;
TNE 121906 |
|
| |
NOES 1983: HZD 80283; NIS 119; TNF 14680; NOS 116;
TNE 509055; TFE |
|
| |
315637 |
|
| |
EPA TSCA SECTION 8(B)
CHEMICAL INVENTORY |
|
| |
EPA TSCA SECTION 8(D)
UNPUBLISHED HEALTH/SAFETY STUDIES |
|
| |
EPA TSCA TEST SUBMISSION
(TSCATS) DATA BASE, OCTOBER 2000 |
|
| SECTION 16. OTHER INFORMATION |
|
|
THIS
PRODUCT IS FOR R&D USE ONLY. IT IS NOT FOR DRUG, HOUSEHOLD |
|
|
OR
OTHER USES. EMPLOYERS SHOULD USE THIS
INFORMATION ONLY AS A |
|
|
SUPPLEMENT
TO OTHER INFORMATION GATHERED BY THEM, AND SHOULD MAKE |
|
|
INDEPENDENT
JUDGEMENT OF SUITABILITY OF THIS INFORMATION TO ENSURE |
|
|
PROPER
USE AND PROTECT THE HEALTH AND SAFETY OF EMPLOYEES. THIS |
|
|
INFORMATION
IS FURNISHED WITHOUT WARRANTY, AND ANY USE OF THE |
|
|
PRODUCT
NOT IN CONFORMANCE WITH THIS MATERIAL SAFETY DATA SHEET, |
|
|
OR IN
COMBINATION WITH ANY OTHER PRODUCT OR PROCESS, IS THE |
|
|
RESPONSIBILITY
OF THE USER. THE ABOVE INFORMATION IS
BELIEVED |
|
|
TO
BE CORRECT BUT DOES NOT PURPORT TO BE ALL INCLUSIVE AND SHALL |
|
|
BE
USED ONLY AS A GUIDE. PROFOLDIN SHALL
NOT BE HELD LIABLE FOR |
|
|
ANY
DAMAG RESULTING FROM HANDLING OR FROM CONTACT WITH THE ABOVE |
|
|
PRODUCT. |
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| |
|
| SECTION 1. CHEMICAL IDENTIFICATION |
|
| |
CATALOG #: SFC01-10, SFC01, SFC02, SFC03, SFC04,
SFC05, SFC06, SFC07, SFC08, SFC09, SFC10 |
|
|
|
PFC01, PFC02, PFC03,
PFC04, PFC05, PFC06, PFC07, PFC08, PFC09, PFC10 |
|
| |
NAME: GUANIDINE HYDROCHLORIDE |
|
| SECTION 2. COMPOSITION/INFORMATION ON INGREDIENTS |
|
| |
CAS #: 50-01-1 |
|
| |
MF: CH5N3.HCL |
|
| |
EC NO: 200-002-3 |
|
| SYNONYMS |
|
| AMINOFORMAMIDINE
HYDROCHLORIDE * AMINOMETHANAMIDINE HYDROCHLORIDE * |
|
| |
CARBAMIDINE HYDROCHLORIDE
* GUANIDINE CHLORIDE * GUANIDINE |
|
| |
HYDROCHLORIDE *
GUANIDINIUM CHLORIDE * GUANIDINIUM HYDROCHLORIDE * |
|
| |
IMINOUREA HYDROCHLORIDE *
USAF EK-749 * |
|
| SECTION 3. HAZARDS IDENTIFICATION |
|
| LABEL PRECAUTIONARY STATEMENTS |
|
| |
TOXIC (USA) |
|
| |
HARMFUL (EU) |
|
| |
HARMFUL IF SWALLOWED. |
|
| |
IRRITATING TO EYES AND
SKIN. |
|
|
TARGET ORGAN(S): |
|
| |
BONE MARROW |
|
| |
NERVES |
|
| |
IN CASE OF CONTACT WITH
EYES, RINSE IMMEDIATELY WITH PLENTY OF |
|
| |
WATER AND SEEK MEDICAL
ADVICE. |
|
| |
WEAR SUITABLE PROTECTIVE
CLOTHING. |
|
| SECTION 4. FIRST-AID MEASURES |
|
| IF
SWALLOWED, WASH OUT MOUTH WITH WATER PROVIDED PERSON IS CONSCIOUS. |
|
| |
CALL A PHYSICIAN. |
|
| |
IF INHALED, REMOVE TO
FRESH AIR. IF NOT BREATHING GIVE ARTIFICIAL |
|
| |
RESPIRATION. IF BREATHING
IS DIFFICULT, GIVE OXYGEN. |
|
| |
IN CASE OF SKIN CONTACT,
FLUSH WITH COPIOUS AMOUNTS OF WATER |
|
| |
FOR AT LEAST 15 MINUTES.
REMOVE CONTAMINATED CLOTHING AND |
|
| |
SHOES. CALL A PHYSICIAN. |
|
| |
IN CASE OF CONTACT WITH
EYES, FLUSH WITH COPIOUS AMOUNTS OF WATER |
|
| |
FOR AT LEAST 15 MINUTES.
ASSURE ADEQUATE FLUSHING BY SEPARATING |
|
| |
THE EYELIDS WITH FINGERS.
CALL A PHYSICIAN. |
|
| SECTION 5. FIRE FIGHTING MEASURES |
|
| EXTINGUISHING MEDIA |
|
| |
CARBON DIOXIDE, DRY
CHEMICAL POWDER OR APPROPRIATE FOAM. |
|
| SPECIAL FIREFIGHTING PROCEDURES |
|
| |
WEAR SELF-CONTAINED
BREATHING APPARATUS AND PROTECTIVE CLOTHING TO |
|
| |
PREVENT CONTACT WITH SKIN
AND EYES. |
|
| UNUSUAL FIRE AND EXPLOSIONS HAZARDS |
|
| |
EMITS TOXIC FUMES UNDER
FIRE CONDITIONS. |
|
| SECTION 6. ACCIDENTAL RELEASE MEASURES |
|
| |
WEAR SELF-CONTAINED
BREATHING APPARATUS, RUBBER BOOTS AND HEAVY |
|
| |
RUBBER GLOVES. |
|
| |
SWEEP UP, PLACE IN A BAG
AND HOLD FOR WASTE DISPOSAL. |
|
| |
AVOID RAISING DUST. |
|
| |
VENTILATE AREA AND WASH
SPILL SITE AFTER MATERIAL PICKUP IS COMPLETE. |
|
| |
EVACUATE AREA. |
|
| SECTION 7. HANDLING AND STORAGE |
|
| |
REFER TO SECTION 8. |
|
| SECTION 8. EXPOSURE CONTROLS/PERSONAL PROTECTION |
|
| |
MECHANICAL EXHAUST
REQUIRED. |
|
| |
SAFETY SHOWER AND EYE
BATH. |
|
| |
WASH THOROUGHLY AFTER
HANDLING. |
|
| |
DO NOT BREATHE DUST. |
|
| |
AVOID CONTACT WITH EYES,
SKIN AND CLOTHING. |
|
| |
AVOID PROLONGED OR
REPEATED EXPOSURE. |
|
| |
NIOSH/MSHA-APPROVED
RESPIRATOR. |
|
| |
COMPATIBLE
CHEMICAL-RESISTANT GLOVES. |
|
| |
CHEMICAL SAFETY GOGGLES. |
|
| |
STORE IN A COOL DRY
PLACE. |
|
| |
KEEP TIGHTLY CLOSED. |
|
| SECTION 9. PHYSICAL AND CHEMICAL PROPERTIES |
|
| PHYSICAL PROPERTIES |
|
| |
MELTING POINT: 185 - 189 C |
|
|
SOLUBILITY: |
|
| |
WATER -Z26130 |
|
| PH:
4.5 - 6.0 |
|
| SECTION 10. STABILITY AND REACTIVITY |
|
| STABILITY |
|
| |
STABLE. |
|
| INCOMPATIBILITIES |
|
| |
PROTECT FROM MOISTURE. |
|
| |
STRONG OXIDIZING AGENTS |
|
| HAZARDOUS COMBUSTION OR DECOMPOSITION
PRODUCTS |
|
| |
CARBON MONOXIDE, CARBON
DIOXIDE |
|
| |
NITROGEN OXIDES |
|
| |
HYDROGEN CHLORIDE GAS |
|
| HAZARDOUS POLYMERIZATION |
|
| |
WILL NOT OCCUR. |
|
| SECTION 11. TOXICOLOGICAL INFORMATION |
|
| ACUTE EFFECTS |
|
| |
CAUSES SKIN IRRITATION. |
|
| |
MAY BE HARMFUL IF
ABSORBED THROUGH THE SKIN. |
|
| |
CAUSES EYE IRRITATION. |
|
| |
MAY BE HARMFUL IF
INHALED. |
|
| |
MATERIAL MAY BE
IRRITATING TO MUCOUS MEMBRANES AND UPPER |
|
| |
RESPIRATORY TRACT. |
|
| |
HARMFUL IF SWALLOWED. |
|
| |
TO THE BEST OF OUR
KNOWLEDGE, THE CHEMICAL, PHYSICAL, AND |
|
| |
TOXICOLOGICAL PROPERTIES
HAVE NOT BEEN THOROUGHLY INVESTIGATED. |
|
| |
MAY CAUSE NERVOUS SYSTEM
DISTURBANCES. |
|
| CHRONIC EFFECTS |
|
| |
TARGET ORGAN(S): |
|
| |
BONE MARROW |
|
| |
NERVES |
|
| RTECS #:
MF4300000 |
|
| |
GUANIDINE,
MONOHYDROCHLORIDE |
|
| IRRITATION DATA |
|
| |
SKN-RBT 500 MG/24H
SEV NTIS**
AD-A166-306 |
|
| |
EYE-RBT 81400 UG MOD NTIS** AD-A184-068 |
|
| TOXICITY DATA |
|
| |
ORL-RAT LD50: 475 MG/KG NTIS** AD-A165-747 |
|
| |
ORL-MUS LD50: 571 MG/KG ATDAEI 12,598,1993 |
|
| |
IPR-MUS LD50: 500 MG/KG NTIS** AD277-689 |
|
| TARGET ORGAN DATA |
|
| |
BEHAVIORAL (ALTERED SLEEP
TIME) |
|
| |
BEHAVIORAL (CONVULSIONS
OR EFFECT ON SEIZURE THRESHOLD) |
|
| |
BEHAVIORAL (EXCITEMENT) |
|
| |
BEHAVIORAL (MUSCLE
CONTRACTION OR SPASTICITY) |
|
| |
BEHAVIORAL (IRRITABILITY) |
|
| |
LUNGS, THORAX OR
RESPIRATION (DYSPNAE) |
|
| |
GASTROINTESTINAL
(HYPERMOTILITY, DIARRHEA) |
|
| |
ONLY SELECTED REGISTRY OF
TOXIC EFFECTS OF CHEMICAL SUBSTANCES |
|
| |
(RTECS) DATA IS PRESENTED
HERE. SEE ACTUAL ENTRY IN RTECS FOR |
|
| |
COMPLETE INFORMATION. |
|
| SECTION 12. ECOLOGICAL INFORMATION |
|
| |
DATA NOT YET AVAILABLE. |
|
| SECTION 13. DISPOSAL CONSIDERATIONS |
|
| |
CONTACT A LICENSED
PROFESSIONAL WASTE DISPOSAL SERVICE TO DISPOSE OF |
|
| |
THIS MATERIAL. |
|
| DISSOLVE
OR MIX THE MATERIAL WITH A COMBUSTIBLE SOLVENT AND BURN IN A CHEMICAL
INCINERATOR EQUIPPED WITH AN AFTERBURNER AND SCRUBBER. |
|
| |
OBSERVE ALL FEDERAL,
STATE AND LOCAL ENVIRONMENTAL REGULATIONS. |
|
| SECTION 14. TRANSPORT INFORMATION |
|
| |
CONTACT PROFOLDIN FOR
TRANSPORTATION INFORMATION. |
|
| SECTION 15. REGULATORY INFORMATION |
|
| EUROPEAN INFORMATION |
|
| |
EC INDEX NO: 607-148-00-0 |
|
| |
HARMFUL |
|
| |
R 22 |
|
| |
HARMFUL IF SWALLOWED. |
|
| |
R 36/38 |
|
| |
IRRITATING TO EYES AND
SKIN. |
|
| |
S 22 |
|
| |
DO NOT BREATHE DUST. |
|
| REVIEWS, STANDARDS, AND REGULATIONS |
|
| |
OEL=MAK |
|
| |
NOES 1983: HZD X3755; NIS 2; TNF 115; NOS 22; TNE
2097; TFE 589 |
|
| |
EPA TSCA SECTION 8(B)
CHEMICAL INVENTORY |
|
| SECTION 16. OTHER INFORMATION |
|
|
THIS
PRODUCT IS FOR R&D USE ONLY. IT IS NOT FOR DRUG, HOUSEHOLD |
|
|
OR
OTHER USES. EMPLOYERS SHOULD USE THIS
INFORMATION ONLY AS A |
|
|
SUPPLEMENT
TO OTHER INFORMATION GATHERED BY THEM, AND SHOULD MAKE |
|
|
INDEPENDENT
JUDGEMENT OF SUITABILITY OF THIS INFORMATION TO ENSURE |
|
|
PROPER
USE AND PROTECT THE HEALTH AND SAFETY OF EMPLOYEES. THIS |
|
|
INFORMATION
IS FURNISHED WITHOUT WARRANTY, AND ANY USE OF THE |
|
|
PRODUCT
NOT IN CONFORMANCE WITH THIS MATERIAL SAFETY DATA SHEET, |
|
|
OR IN
COMBINATION WITH ANY OTHER PRODUCT OR PROCESS, IS THE |
|
|
RESPONSIBILITY
OF THE USER. THE ABOVE INFORMATION IS
BELIEVED |
|
|
TO
BE CORRECT BUT DOES NOT PURPORT TO BE ALL INCLUSIVE AND SHALL |
|
|
BE
USED ONLY AS A GUIDE. PROFOLDIN SHALL
NOT BE HELD LIABLE FOR |
|
|
ANY
DAMAG RESULTING FROM HANDLING OR FROM CONTACT WITH THE ABOVE |
|
|
PRODUCT. |
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| |
|
| SECTION 1. CHEMICAL IDENTIFICATION |
|
| |
CATALOG #: SFC01-10, SFC01, SFC02, SFC03, SFC04,
SFC05, SFC06, SFC07, SFC08, SFC09, SFC10 |
|
|
|
PFC01, PFC02, PFC03,
PFC04, PFC05, PFC06, PFC07, PFC08, PFC09, PFC10 |
|
| |
NAME: SODIUM CHLORIDE* |
|
| SECTION 2. COMPOSITION/INFORMATION ON INGREDIENTS |
|
| |
CAS #: 7647-14-5 |
|
| |
MF: CLNA |
|
| |
EC NO: 231-598-3 |
|
| SYNONYMS |
|
| COMMON
SALT * DENDRITIS * EXTRA FINE 200 SALT * EXTRA FINE 325 SALT *HALITE * H.G.
BLENDING * NATRIUMCHLORID (GERMAN) * PUREX * ROCK SALT *SALINE * SALT * SEA
SALT * TABLE SALT * TOP FLAKE * USP SODIUM CHLORIDE * WHITE CRYSTAL * |
|
| SECTION 3. HAZARDS IDENTIFICATION |
|
| LABEL PRECAUTIONARY STATEMENTS |
|
| |
IRRITANT |
|
| |
IRRITATING TO EYES,
RESPIRATORY SYSTEM AND SKIN. |
|
| |
IN CASE OF CONTACT WITH
EYES, RINSE IMMEDIATELY WITH PLENTY OF |
|
| |
WATER AND SEEK MEDICAL
ADVICE. |
|
| |
WEAR SUITABLE PROTECTIVE
CLOTHING. |
|
| SECTION 4. FIRST-AID MEASURES |
|
| IF
SWALLOWED, WASH OUT MOUTH WITH WATER PROVIDED PERSON IS CONSCIOUS. |
|
| CALL
A PHYSICIAN. |
|
| |
IF INHALED, REMOVE TO
FRESH AIR. IF NOT BREATHING GIVE ARTIFICIAL |
|
| |
RESPIRATION. IF BREATHING
IS DIFFICULT, GIVE OXYGEN. |
|
| |
IN CASE OF CONTACT,
IMMEDIATELY WASH SKIN WITH SOAP AND COPIOUS |
|
| |
AMOUNTS OF WATER. |
|
| |
IN CASE OF CONTACT,
IMMEDIATELY FLUSH EYES WITH COPIOUS AMOUNTS OF |
|
| |
WATER FOR AT LEAST 15
MINUTES. |
|
| SECTION 5. FIRE FIGHTING MEASURES |
|
| EXTINGUISHING MEDIA |
|
| |
WATER SPRAY. |
|
| |
CARBON DIOXIDE, DRY
CHEMICAL POWDER OR APPROPRIATE FOAM. |
|
| SPECIAL FIREFIGHTING PROCEDURES |
|
| |
WEAR SELF-CONTAINED
BREATHING APPARATUS AND PROTECTIVE CLOTHING TO |
|
| |
PREVENT CONTACT WITH SKIN
AND EYES. |
|
| UNUSUAL FIRE AND EXPLOSIONS HAZARDS |
|
| |
EMITS TOXIC FUMES UNDER
FIRE CONDITIONS. |
|
| SECTION 6. ACCIDENTAL RELEASE MEASURES |
|
| |
WEAR RESPIRATOR, CHEMICAL
SAFETY GOGGLES, RUBBER BOOTS AND HEAVY |
|
| |
RUBBER GLOVES. |
|
| |
SWEEP UP, PLACE IN A BAG
AND HOLD FOR WASTE DISPOSAL. |
|
| |
AVOID RAISING DUST. |
|
| |
VENTILATE AREA AND WASH
SPILL SITE AFTER MATERIAL PICKUP IS COMPLETE. |
|
| SECTION 7. HANDLING AND STORAGE |
|
| |
REFER TO SECTION 8. |
|
| SECTION 8. EXPOSURE CONTROLS/PERSONAL PROTECTION |
|
| SAFETY
SHOWER AND EYE BATH. |
|
| MECHANICAL
EXHAUST REQUIRED. |
|
| WASH
THOROUGHLY AFTER HANDLING. |
|
| DO
NOT BREATHE DUST. |
|
| AVOID
CONTACT WITH EYES, SKIN AND CLOTHING. |
|
| AVOID
PROLONGED OR REPEATED EXPOSURE. |
|
| NIOSH/MSHA-APPROVED
RESPIRATOR. |
|
| COMPATIBLE
CHEMICAL-RESISTANT GLOVES. |
|
| CHEMICAL
SAFETY GOGGLES. |
|
| |
KEEP TIGHTLY CLOSED. |
|
| |
STORE IN A COOL DRY
PLACE. |
|
| SECTION 9. PHYSICAL AND CHEMICAL PROPERTIES |
|
| APPEARANCE AND ODOR |
|
| |
SOLID. |
|
| PHYSICAL PROPERTIES |
|
| |
MELTING POINT: 801 C |
|
| |
VAPOR PRESSURE: 1 MMHG |
|
| SPECIFIC GRAVITY: 2.165 |
|
| SECTION 10. STABILITY AND REACTIVITY |
|
| STABILITY |
|
| |
STABLE. |
|
| INCOMPATIBILITIES |
|
| |
STRONG OXIDIZING AGENTS |
|
| HAZARDOUS COMBUSTION OR DECOMPOSITION
PRODUCTS |
|
| |
SODIUM/SODIUM OXIDES |
|
| |
HYDROGEN CHLORIDE GAS |
|
| HAZARDOUS POLYMERIZATION |
|
| |
WILL NOT OCCUR. |
|
| SECTION 11. TOXICOLOGICAL INFORMATION |
|
| ACUTE EFFECTS |
|
| |
CAUSES SKIN IRRITATION. |
|
| |
MAY BE HARMFUL IF
ABSORBED THROUGH THE SKIN. |
|
| |
CAUSES EYE IRRITATION. |
|
| |
MAY BE HARMFUL IF
INHALED. |
|
| |
MATERIAL IS IRRITATING TO
MUCOUS MEMBRANES AND UPPER |
|
| |
RESPIRATORY TRACT. |
|
| |
MAY BE HARMFUL IF SWALLOWED. |
|
| |
TO THE BEST OF OUR
KNOWLEDGE, THE CHEMICAL, PHYSICAL, AND |
|
| |
TOXICOLOGICAL PROPERTIES
HAVE NOT BEEN THOROUGHLY INVESTIGATED. |
|
| RTECS #:
VZ4725000 |
|
| |
SODIUM CHLORIDE |
|
| IRRITATION DATA |
|
| |
SKN-RBT 50 MG/24H
MLD BIOFX*
20-3/1971 |
|
| |
SKN-RBT 500 MG/24H
MLD 28ZPAK
-,7,1972 |
|
| |
EYE-RBT 100 MG MLD BIOFX* 20-3/1971 |
|
| |
EYE-RBT 100 MG/24H
MOD 28ZPAK
-,7,1972 |
|
| |
EYE-RBT 10 MG MOD TXAPA9
55,501,1980 |
|
| TOXICITY DATA |
|
| |
ORL-MAN LDLO: 1 GM/KG MACPAJ 65,1587,1990 |
|
| |
ORL-RAT LD50: 3 GM/KG TXAPA9 20,57,1971 |
|
| |
IHL-RAT LC50: >42 GM/M3/1H BIOFX* 20-3/1971 |
|
| |
ORL-MUS LD50: 4 GM/KG FRPPAO 27,19,1972 |
|
| |
IPR-MUS LD50: 2602 MG/KG COREAF 256,1043,1963 |
|
| |
SCU-MUS LD50: 3 GM/KG ARZNAD 7,445,1957 |
|
| |
IVN-MUS LD50: 645 MG/KG ARZNAD 7,445,1957 |
|
| |
ICV-MUS LD50: 131 MG/KG TYKNAQ 27,131,1980 |
|
| |
SKN-RBT LD50: >10 GM/KG BIOFX* 20-3/1971 |
|
| TARGET ORGAN DATA |
|
| |
SENSE ORGANS AND SPECIAL
SENSES (OTHER EYE EFFECTS) |
|
| |
BEHAVIORAL (SOMNOLENCE) |
|
| |
BEHAVIORAL (CONVULSIONS
OR EFFECT ON SEIZURE THRESHOLD) |
|
| |
BEHAVIORAL (CHANGE IN
MOTOR ACTIVITY) |
|
| |
BEHAVIORAL (MUSCLE
CONTRACTION OR SPASTICITY) |
|
| |
CARDIAC (OTHER CHANGES) |
|
| |
ENDOCRINE (ESTROGENIC) |
|
| |
MATERNAL EFFECTS
(OVARIES, FALLOPIAN TUBES) |
|
| |
MATERNAL EFFECTS (OTHER
EFFECTS ON FEMALE) |
|
| |
EFFECTS ON FERTILITY
(PRE-IMPLANTATION MORTALITY) |
|
| |
EFFECTS ON FERTILITY
(POST-IMPLANTATION MORTALITY) |
|
| |
EFFECTS ON FERTILITY
(ABORTION) |
|
| |
EFFECTS ON EMBRYO OR
FETUS (FETOTOXICITY) |
|
| |
EFFECTS ON EMBRYO OR
FETUS (FETAL DEATH) |
|
| |
SPECIFIC DEVELOPMENTAL
ABNORMALITIES (MUSCULOSKELETAL SYSTEM) |
|
| |
NUTRITIONAL AND GROSS
METABOLIC (CHANGES IN: NA) |
|
| |
ONLY SELECTED REGISTRY OF
TOXIC EFFECTS OF CHEMICAL SUBSTANCES |
|
| |
(RTECS) DATA IS PRESENTED
HERE. SEE ACTUAL ENTRY IN RTECS FOR |
|
| |
COMPLETE INFORMATION. |
|
| SECTION 12. ECOLOGICAL INFORMATION |
|
| |
DATA NOT YET AVAILABLE. |
|
| SECTION 13. DISPOSAL CONSIDERATIONS |
|
| DISSOLVE
OR MIX THE MATERIAL WITH A COMBUSTIBLE SOLVENT AND BURN IN A CHEMICAL
INCINERATOR EQUIPPED WITH AN AFTERBURNER AND SCRUBBER. |
|
| |
OBSERVE ALL FEDERAL,
STATE AND LOCAL ENVIRONMENTAL REGULATIONS. |
|
| SECTION 14. TRANSPORT INFORMATION |
|
| |
CONTACT PROFOLDIN FOR
TRANSPORTATION INFORMATION. |
|
| SECTION 15. REGULATORY INFORMATION |
|
| EUROPEAN INFORMATION |
|
| |
IRRITANT |
|
| |
R 36/37/38 |
|
| |
IRRITATING TO EYES,
RESPIRATORY SYSTEM AND SKIN. |
|
| |
S 26 |
|
| |
IN CASE OF CONTACT WITH
EYES, RINSE IMMEDIATELY WITH PLENTY OF |
|
| |
WATER AND SEEK MEDICAL
ADVICE. |
|
| |
S 36 |
|
| |
WEAR SUITABLE PROTECTIVE
CLOTHING. |
|
| REVIEWS, STANDARDS, AND REGULATIONS |
|
| |
OEL=MAK |
|
| |
EPA FIFRA 1988 PESTICIDE
SUBJECT TO REGISTRATION OR RE-REGISTRATION |
|
| |
FEREAC 54,7740,1989 |
|
| |
NOHS 1974: HZD 68880; NIS 265; TNF 63391; NOS 163;
TNE 630453 |
|
| |
NOES 1983: HZD E0256; NIS 1; TNF 403; NOS 5; TNE
4029; TFE 2015 |
|
| |
NOES 1983: HZD 68880; NIS 336; TNF 69628; NOS 211;
TNE 1743954; TFE |
|
| |
817249 |
|
| EPA
GENETOX PROGRAM 1988, NEGATIVE: IN
VITRO CYTOGENETICS-NONHUMAN; |
|
| |
SPERM MORPHOLOGY-MOUSE |
|
| |
EPA GENETOX PROGRAM 1988,
INCONCLUSIVE: MAMMALIAN MICRONUCLEUS |
|
| |
EPA TSCA SECTION 8(B)
CHEMICAL INVENTORY |
|
| |
EPA TSCA SECTION 8(D)
UNPUBLISHED HEALTH/SAFETY STUDIES |
|
| |
EPA TSCA SECTION 8(E)
RISK NOTIFICATION, 8EHQ-0892-9201 |
|
| |
EPA TSCA TEST SUBMISSION
(TSCATS) DATA BASE, OCTOBER 2000 |
|
| SECTION 16. OTHER INFORMATION |
|
|
THIS
PRODUCT IS FOR R&D USE ONLY. IT IS NOT FOR DRUG, HOUSEHOLD |
|
|
OR
OTHER USES. EMPLOYERS SHOULD USE THIS
INFORMATION ONLY AS A |
|
|
SUPPLEMENT
TO OTHER INFORMATION GATHERED BY THEM, AND SHOULD MAKE |
|
|
INDEPENDENT
JUDGEMENT OF SUITABILITY OF THIS INFORMATION TO ENSURE |
|
|
PROPER
USE AND PROTECT THE HEALTH AND SAFETY OF EMPLOYEES. THIS |
|
|
INFORMATION
IS FURNISHED WITHOUT WARRANTY, AND ANY USE OF THE |
|
|
PRODUCT
NOT IN CONFORMANCE WITH THIS MATERIAL SAFETY DATA SHEET, |
|
|
OR IN
COMBINATION WITH ANY OTHER PRODUCT OR PROCESS, IS THE |
|
|
RESPONSIBILITY
OF THE USER. THE ABOVE INFORMATION IS
BELIEVED |
|
|
TO
BE CORRECT BUT DOES NOT PURPORT TO BE ALL INCLUSIVE AND SHALL |
|
|
BE
USED ONLY AS A GUIDE. PROFOLDIN SHALL
NOT BE HELD LIABLE FOR |
|
|
ANY
DAMAG RESULTING FROM HANDLING OR FROM CONTACT WITH THE ABOVE |
|
|
PRODUCT. |
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| |
|
| SECTION
1. CHEMICAL IDENTIFICATION |
|
| |
CATALOG #: SFC01-10, SFC01, SFC02, SFC03, SFC04,
SFC05, SFC06, SFC07, SFC08, SFC09, SFC10 |
|
|
|
PFC01, PFC02, PFC03,
PFC04, PFC05, PFC06, PFC07, PFC08, PFC09, PFC10 |
|
| |
NAME:
TRIS(HYDROXYMETHYL)AMINOMETHANE* |
|
| SECTION
2. COMPOSITION/INFORMATION ON
INGREDIENTS |
|
| |
CAS #: 77-86-1 |
|
| |
MF: C4-H11-N-O3 |
|
| |
EC NO: 201-064-4 |
|
| SYNONYMS |
|
| ADDEX-THAM
* 2-AMINO-2-(HYDROXYMETHYL)PROPANE-1,3-DIOL *
2-AMINO-2-(HYDROXYMETHYL)-1,3-PROPANEDIOL *
2-AMINO-2-METHYLOL-1,3-PROPANEDIOL * AMINOTRIMETHYLOLMETHANE *
AMINOTRIS(HYDROXYMETHYL)METHANE * METHYLAMINE, 1,1,1-TRIS(HYDROXYMETHYL)- *
PEHANORM * TALATROL * THAM-E * THAM SET * TRIMETHYLOLAMINOMETHANE * TRIS
(BUFFERING AGENT) * TRISAMINE * TRIS-AMINO * TRISAMINOL * TRIS BUFFER *
TRIS-HYDROXYMETHYL-AMINOMETHAN (GERMAN) * TRIS-HYDROXYMETHYLAMINOMETHANE *
TRIS(HYDROXYMETHYL)METHANAMINE * TRIS(HYDROXYMETHYL)METHYLAMINE * TRISPUFFER
* TRIS-STERIL * TROMETAMOL * TROMETAMOLE * TROMETHAMINE * TROMETHANE *
TROMETHANMIN * TUTOFUSIN TRIS * |
| SECTION 3. HAZARDS IDENTIFICATION |
|
| LABEL PRECAUTIONARY STATEMENTS |
|
| |
IRRITANT |
|
| |
IRRITATING TO EYES,
RESPIRATORY SYSTEM AND SKIN. |
|
| |
IN CASE OF CONTACT WITH
EYES, RINSE IMMEDIATELY WITH PLENTY OF |
|
| |
WATER AND SEEK MEDICAL
ADVICE. |
|
| |
WEAR SUITABLE PROTECTIVE
CLOTHING. |
|
| SECTION 4. FIRST-AID MEASURES |
|
| IF
SWALLOWED, WASH OUT MOUTH WITH WATER PROVIDED PERSON IS CONSCIOUS. |
|
| |
CALL A PHYSICIAN. |
|
| |
IF INHALED, REMOVE TO FRESH AIR. IF NOT
BREATHING GIVE ARTIFICIAL |
|
| |
RESPIRATION. IF BREATHING
IS DIFFICULT, GIVE OXYGEN. |
|
| |
IN CASE OF CONTACT,
IMMEDIATELY WASH SKIN WITH SOAP AND COPIOUS |
|
| |
AMOUNTS OF WATER. |
|
| |
IN CASE OF CONTACT,
IMMEDIATELY FLUSH EYES WITH COPIOUS AMOUNTS OF |
|
| |
WATER FOR AT LEAST 15
MINUTES. |
|
| SECTION 5. FIRE FIGHTING MEASURES |
|
| EXTINGUISHING MEDIA |
|
| |
WATER SPRAY. |
|
| |
CARBON DIOXIDE, DRY
CHEMICAL POWDER OR APPROPRIATE FOAM. |
|
| SPECIAL FIREFIGHTING PROCEDURES |
|
| |
WEAR SELF-CONTAINED
BREATHING APPARATUS AND PROTECTIVE CLOTHING TO |
|
| |
PREVENT CONTACT WITH SKIN
AND EYES. |
|
| UNUSUAL FIRE AND EXPLOSIONS HAZARDS |
|
| |
EMITS TOXIC FUMES UNDER
FIRE CONDITIONS. |
|
| SECTION 6. ACCIDENTAL RELEASE MEASURES |
|
| |
WEAR RESPIRATOR, CHEMICAL
SAFETY GOGGLES, RUBBER BOOTS AND HEAVY |
|
| |
RUBBER GLOVES. |
|
| |
SWEEP UP, PLACE IN A BAG
AND HOLD FOR WASTE DISPOSAL. |
|
| |
AVOID RAISING DUST. |
|
| |
VENTILATE AREA AND WASH
SPILL SITE AFTER MATERIAL PICKUP IS COMPLETE. |
|
| SECTION 7. HANDLING AND STORAGE |
|
| |
REFER TO SECTION 8. |
|
| SECTION 8. EXPOSURE CONTROLS/PERSONAL PROTECTION |
|
| |
SAFETY SHOWER AND EYE
BATH. |
|
| |
MECHANICAL EXHAUST
REQUIRED. |
|
| |
WASH THOROUGHLY AFTER
HANDLING. |
|
| |
DO NOT BREATHE DUST. |
|
| |
AVOID CONTACT WITH EYES,
SKIN AND CLOTHING. |
|
| |
AVOID PROLONGED OR
REPEATED EXPOSURE. |
|
| |
NIOSH/MSHA-APPROVED
RESPIRATOR. |
|
| |
COMPATIBLE
CHEMICAL-RESISTANT GLOVES. |
|
| |
CHEMICAL SAFETY GOGGLES. |
|
| |
KEEP TIGHTLY CLOSED. |
|
| |
STORE IN A COOL DRY
PLACE. |
|
| SECTION 9. PHYSICAL AND CHEMICAL PROPERTIES |
|
| APPEARANCE AND ODOR |
|
| |
SOLID. |
|
| PHYSICAL PROPERTIES |
|
| |
BOILING POINT: 219 - 220 C |
|
| |
MELTING POINT: 171.2 - 172.3 C |
|
|
SOLUBILITY: |
|
| |
WATER -Z26130 |
|
| PH: 10.5 - 12.0 |
|
| SECTION 10. STABILITY AND REACTIVITY |
|
| STABILITY |
|
| |
STABLE. |
|
| INCOMPATIBILITIES |
|
| |
STRONG OXIDIZING AGENTS |
|
| HAZARDOUS COMBUSTION OR DECOMPOSITION
PRODUCTS |
|
| |
CARBON MONOXIDE, CARBON
DIOXIDE |
|
| HAZARDOUS POLYMERIZATION |
|
| |
WILL NOT OCCUR. |
|
| SECTION 11. TOXICOLOGICAL INFORMATION |
|
| ACUTE EFFECTS |
|
| |
CAUSES SKIN IRRITATION. |
|
| |
MAY BE HARMFUL IF ABSORBED THROUGH THE SKIN. |
|
| |
CAUSES EYE IRRITATION. |
|
| |
MAY BE HARMFUL IF
INHALED. |
|
| |
MATERIAL IS IRRITATING TO
MUCOUS MEMBRANES AND UPPER |
|
| |
RESPIRATORY TRACT. |
|
| |
MAY BE HARMFUL IF SWALLOWED. |
|
| |
TO THE BEST OF OUR
KNOWLEDGE, THE CHEMICAL, PHYSICAL, AND |
|
| |
TOXICOLOGICAL PROPERTIES
HAVE NOT BEEN THOROUGHLY INVESTIGATED. |
|
| RTECS #:
TY2900000 |
|
| |
1,3-PROPANEDIOL,
2-AMINO-2-(HYDROXYMETHYL)- |
|
| TOXICITY DATA |
|
| |
ORL-RAT LD50: 5900 MG/KG BCFAAI 110,653,1971 |
|
| |
IVN-RAT LD50: 1800 MG/KG NIIRDN -,419,1990 |
|
| |
IVN-MUS LD50: 1210 MG/KG ABMGAJ 17,217,1966 |
|
| TARGET ORGAN DATA |
|
| |
BEHAVIORAL (SOMNOLENCE) |
|
| |
BEHAVIORAL (MUSCLE
WEAKNESS) |
|
| |
BEHAVIORAL (COMA) |
|
| |
ONLY SELECTED REGISTRY OF
TOXIC EFFECTS OF CHEMICAL SUBSTANCES |
|
| |
(RTECS) DATA IS PRESENTED
HERE. SEE ACTUAL ENTRY IN RTECS FOR |
|
| |
COMPLETE INFORMATION. |
|
| SECTION 12. ECOLOGICAL INFORMATION |
|
| |
DATA NOT YET AVAILABLE. |
|
| SECTION 13. DISPOSAL CONSIDERATIONS |
|
| |
CONTACT A LICENSED
PROFESSIONAL WASTE DISPOSAL SERVICE TO DISPOSE OF |
|
| |
THIS MATERIAL. |
|
| DISSOLVE OR MIX THE MATERIAL WITH A
COMBUSTIBLE SOLVENT AND BURN IN A CHEMICAL INCINERATOR EQUIPPED WITH AN
AFTERBURNER AND SCRUBBER. |
|
| |
OBSERVE ALL FEDERAL,
STATE AND LOCAL ENVIRONMENTAL REGULATIONS. |
|
| SECTION 14. TRANSPORT INFORMATION |
|
| |
CONTACT PROFOLDIN FOR
TRANSPORTATION INFORMATION. |
|
| SECTION
15. REGULATORY INFORMATION |
|
| EUROPEAN INFORMATION |
|
| |
IRRITANT |
|
| |
R 36/37/38 |
|
| |
IRRITATING TO EYES,
RESPIRATORY SYSTEM AND SKIN. |
|
| |
S 26 |
|
| |
IN CASE OF CONTACT WITH
EYES, RINSE IMMEDIATELY WITH PLENTY OF |
|
| |
WATER AND SEEK MEDICAL
ADVICE. |
|
| |
S 36 |
|
| |
WEAR SUITABLE PROTECTIVE
CLOTHING. |
|
| REVIEWS, STANDARDS, AND REGULATIONS |
|
| |
OEL=MAK |
|
| |
NOHS 1974: HZD 81165; NIS 4; TNF 850; NOS 6; TNE
7274 |
|
| |
NOES 1983: HZD 81165; NIS 9; TNF 2296; NOS 22; TNE
40897; TFE 30773 |
|
| |
EPA TSCA SECTION 8(B)
CHEMICAL INVENTORY |
|
| SECTION 16. OTHER INFORMATION |
|
|
THIS
PRODUCT IS FOR R&D USE ONLY. IT IS NOT FOR DRUG, HOUSEHOLD |
|
|
OR
OTHER USES. EMPLOYERS SHOULD USE THIS
INFORMATION ONLY AS A |
|
|
SUPPLEMENT
TO OTHER INFORMATION GATHERED BY THEM, AND SHOULD MAKE |
|
|
INDEPENDENT
JUDGEMENT OF SUITABILITY OF THIS INFORMATION TO ENSURE |
|
|
PROPER
USE AND PROTECT THE HEALTH AND SAFETY OF EMPLOYEES. THIS |
|
|
INFORMATION
IS FURNISHED WITHOUT WARRANTY, AND ANY USE OF THE |
|
|
PRODUCT
NOT IN CONFORMANCE WITH THIS MATERIAL SAFETY DATA SHEET, |
|
|
OR IN
COMBINATION WITH ANY OTHER PRODUCT OR PROCESS, IS THE |
|
|
RESPONSIBILITY
OF THE USER. THE ABOVE INFORMATION IS
BELIEVED |
|
|
TO
BE CORRECT BUT DOES NOT PURPORT TO BE ALL INCLUSIVE AND SHALL |
|
|
BE
USED ONLY AS A GUIDE. PROFOLDIN SHALL
NOT BE HELD LIABLE FOR |
|
|
ANY
DAMAG RESULTING FROM HANDLING OR FROM CONTACT WITH THE ABOVE |
|
|
PRODUCT. |
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|